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ABSTRACT
In chronic diseases, research often centers on discovering a latent trait trajectory that
manifests itself through multiple response variables on different measurement scales. In
longitudinal studies, it is common to collect multivariate response data consisting of
mixtures of continuous, survival, ordinal, count and multinomial variables. Development
of the methodology was motivated by situations when measuring and predicting the latent
trait can provide important insights for managing the observed phenotype.
In Chapter II, we study survival models of cancer where a latent trait is responsible for
the cure process. Traditional cure models assume that the cure status is determined at the
beginning of the follow up. However, patients often receive treatments during the follow
up time that may affect their chance of cure. We propose a dynamic joint cure model
where a cure process is affected by time-dependent covariates. Therapeutic interventions
and prognostic factors can follow two causal paths affecting survival directly or through
the latent cure process.
Chapter III addresses the challenge of latent trait measurement through multiple out-
comes of different scales, which are often collected when the construct of interest cannot be
measured directly. We proposed a shared latent variable model where a logistic link is used
to accommodate nonparametrically transformed continuous, ordinal, count, multinomial
and survival outcomes. The proposed model avoids restrictive normality assumptions and
allows for negative correlation among outcomes. The model provides a subject-specific
measure of the latent trait.
Chapter IV extends the method of Chapter III to allow for longitudinal responses of
mixed types. We proposed a joint modeling approach for nonparametrically transformed
xiv
multivariate longitudinal responses of mixed scales. Multivariate longitudinal responses of
mixed continuous, ordinal, count and multinomial outcomes and a time-to-event outcome
are linked through a shared latent trait trajectory measurement. The model is used to
provide a subject-specific measure of the latent trait trajectory through multiple correlated
responses observed repeatedly on the subject.
xv
CHAPTER I
Introduction
In chronic diseases, research often centers on discovering a latent trait trajectory that
manifests itself through multiple response variables on different measurement scales. In
longitudinal studies, it is common to collect multivariate response data consisting of
mixtures of continuous, survival, ordinal, count and multinomial variables. Development
of the methodology was motivated by situations when measuring and predicting the latent
trait can provide important insights for managing the observed phenotype. Joint models
are commonly used to provide an efficient and flexible framework to model correlated
longitudinal and survival data. A useful feature of a joint model is that it provides subject-
specific latent trait trajectories and enables survival risk predictions. Motivated by the
need to develop a general modeling framework for longitudinal responses of mixed types
and survival times, we proposed a semiparametric joint model for survival outcomes with
a latent dynamic cure process in Chapter II. In addition, we proposed a semiparametric
shared latent trait joint model for cross-sectional and longitudinal observed outcomes of
mixed types in Chapter III and Chapter IV, respectively.
In Chapter II, we study survival models of cancer where a latent trait is responsible for
the cure process. Cure with time-to-event data refers to an unobserved event when subject
is no longer at risk of death from the disease of interest. Two major classes of cure models
were developed to allow for a subgroup of non-susceptible subjects. One class is two-
1
component mixture cure models that explicitly model survival as a mixture of cured and
susceptible patients (Berkson and Gage (1952); Farewell (1982); Kuk and Chen (1992);
Peng and Dear (2000); Sy and Taylor (2000); Li and Taylor (2002); Othus et al. (2012);
Wang et al. (2012)). The other class of cure models is a Cox proportional hazards model
that allows for a cure fraction (Tsodikov (1998); Broet et al. (2001); Tsodikov (2002);
Tsodikov et al. (2003); Chen et al. (1999); Yin and Ibrahim (2005)). This class of model
is also referred to as non-mixture cure model or promotion time cure model. Current work
on cure models assume that, although unobserved, the cure status is determined at the
beginning of the follow up (t = 0). However, patients often receive treatments during the
follow up time that may affect their chance of cure. Also, the event of cure may not be an
immediate consequence of treatment and may include a period when the immune system
struggles to achieve it. In this chapter, we propose a dynamic joint cure model where a
cure process is affected by time-dependent covariates. The proposed model considers cure
as an outcome (a stopping point) of a latent stochastic process as it touches an absorbing
boundary at zero. Fundamental to the model is the mechanistic competing nature of cure
and failure, with time to cure representing a latent competing risk. As mentioned in Fine
and Gray (1999), time to cure is unobservable, so the estimation of overall survival is
tantamount to estimation of the subdistribution for failure. At the latent level the events
of cure and failure are competing. The latent cure event intercepts the failure process and
vice versa. We model the time to cure and time to failure with the proportional hazard
model. Two separate baseline hazards are estimated nonparametrically in the model to
allow different time scales for the time to cure and time to failure processes. The model
can easily be extended to other link functions, if needed. The proposed model is a new
class of cure models that allows the cure rate to change over time by introducing time-
dependent covariates into the cure process. Therapeutic interventions and prognostic
factors can follow two causal pathways affecting survival directly or through the latent
cure process. The proposed model is applied to study the effect of secondary cancer on
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primary prostate cancer-specific survival using data from the SEER program. The joint
modeling approach allows us to make subject-specific prediction of patient’s cure process
given the current follow-up time and the trajectory of patient’s characteristics.
There are previous works on promotion time cure model (2.1) that allow the cure
probability to change instantaneously at a pre-specified time point. For example, Tsodikov
(1998) used a promotion time cure model to study leukemia induced by the primary
and relapse treatments of Hodgkin’s disease (HD). The proposed model specifies a time-
dependent covariate θ(z(t)) = exp(β0−β1 1(t ≥ TR)), where TR is the time of HD relapse.
In this case, the probability of cure changes instantaneously at TR. The difference between
our dynamic cure model proposed in Chapter II and the model used in Tsodikov (1998)
is that our dynamic cure model models cure as a process. Cancer treatment initiates
a cure process that may or may not result in cure in the follow up. On the contrary,
the time-dependent promotion time cure model assumes cure happens immediately at the
time of the treatment. Considering the biological mechanism of how a medical treatment
functions on a human body, it is more reasonable to consider cure as a process instead of
an instantaneous event.
Chapter III addresses the challenge of latent trait measurement through multiple out-
comes of mixed categorical and continuous types. Multiple outcomes of different scales
are often collected when the construct of interest cannot be measured directly. A popular
approach to latent variable models maps observed continuous and ordinal outcomes to
underlying Gaussian continuous responses and is limited to mixed continuous and ordinal
outcomes (Muthe´n (1984); Shi and Lee (2000); Murray et al. (2013); Lin et al. (2014);
Snavely et al. (2014)). This approach does not accommodate nominal scale outcomes.
Another popular approach is the parametric generalized linear models (Sammel et al.
(1997); Moustaki and Knott (2000); Dunson and Herring (2005); Skrondal and Rabe-
Hesketh (2004)). This class of approach explicitly specifies transformation function for
the measurable outcomes of different scales and introduce dependence among mixed out-
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comes through shared latent variables. We propose a shared latent variable model where
a logistic link is used to accommodate nonparametrically transformed continuous, ordinal,
count, multinomial and survival outcomes. The model is used to provide a subject-specific
measure of the latent trait, given the information observed on the subject. The model-
ing framework is generic with respect to the parametric distribution assumed for the
trait. The proposed model avoids restrictive normality assumptions and allows for nega-
tive correlation among outcomes. We developed the model under the case of univariate
and multivariate measurable outcomes. An EM-DCA algorithm is developed to estimate
the nonparametric transformation functions for each observed outcome. Covariates are
modeled parametrically and their effects are estimated using the profile likelihood. In
the univariate model, the logistic link provides closed form conditional expectations that
yields computational efficient estimating procedure. The proposed method is applied to
measure the pain centrality trait of patients undergoing hysterectomy as a treatment for
pelvic pain and to explain the heterogeneity of patients reported outcomes. The method is
compared with the ad-hoc 2011 Fibromyalgia (FM) Survey Criteria instrument designed
to characterize a similar construct.
In Chapter IV, we extend the methods of Chapter III to allow for longitudinal re-
sponses of mixed types. Multidimensional longitudinal data of mixed types are collected
to fully explore the latent trait trajectory that is often of main interest but cannot be
measured directly. In addition, time-to-event data is often considered if the occurrence
of the terminal event is dependent on the latent trait of interest. Statistical approaches
were developed to jointly modeling longitudinal responses of mixed scales and the event
time data to improve inference for latent trait trajectory, and to account for the depen-
dency the two correlated processes. The previous work on the joint model of multivariate
longitudinal responses either maps the discrete outcomes to latent continuous variables
(Gueorguieva and Sanacora (2006)) or rely on explicitly specified link functions based on
exponential family (Dunson (2003); Jaffa et al. (2016)). Further, there is not a single
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longitudinal model that accommodates all continuous, ordinal, count and multinomial
outcome types. As for the joint model between longitudinal and survival outcomes, there
is no single joint model that allows for nonparametric transformation of the longitudinal
outcomes, and no single model accommodate all continuous, ordinal, count and multino-
mial outcome types. Motivated by the needs to develop a general statistical framework
for longitudinal responses of mixed types and survival times, we proposed a flexible joint
modeling approach for nonparametrically transformed multivariate longitudinal responses
of mixed scales. Multivariate longitudinal responses of mixed continuous, ordinal, count
and multinomial outcomes and a time-to-event outcome are linked through a shared latent
trait trajectory measurement. The model is used to provide a subject-specific measure of
the latent trait trajectory through multiple correlated responses observed repeatedly on
the subject. An EM-DCA algorithm is developed to estimate the nonparametric trans-
formation functions for each response and to estimate the population average latent trait
trajectory. The maximum likelihood estimators are consistent and asymptotically nor-
mal. The proposed method is applied to measure pain centrality trajectory of pelvic
pain patients undergoing hysterectomy. For each of the patient, multiple pain-related
responses of different scales were collected longitudinally. The model-based centrality
trajectory is more closely aligned to longitudinal pain-related outcomes compared with
the Fibromyalgia (FM) Survey Criteria trajectory across all the time points.
Overall, the dissertation provides a statistical framework for joint modeling multiple
outcomes of a variety of scales, to assess the effect of dynamic factor on the latent cure
process, and to provide prediction of subject-specific latent trait of interest, with the
scientific goal of understanding the heterogeneity among study population. These methods
can potentially be useful in areas of medical research, psychological research and social
research. We hope the application of our work can lead to a more effective subject-
specific latent trait construction and a better understanding in fundamental differences
among study subjects.
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CHAPTER II
A Semiparametric Joint Survival Model with A
Time-Dependent Cure Process
2.1 Introduction
Due to advances in modern medical practice and therapy, a substantial proportion of
patients may never experience the event of interest even after extended follow up. The
improvement in cause-specific survival may result in heavy censoring at the end of the
follow-up period. The need to account for long-term survivors has led to the development
of cure models. Cure models have the flexibility to estimate the cure rate and at the
same time incorporate non-proportional effects into the model through short-term and
long-term effects.
Two major classes of cure models were developed to allow for a subgroup of non-
susceptible subjects. One class is two-component mixture cure models that explicitly
model survival as a mixture of cured and susceptible patients
S(t|z, x) = p(x)S0(t|z) + ((1− p(x)).
Berkson and Gage (1952) first introduced the idea of two-component mixture cure model
in which the probability of cure p(x) was assumed an unknown constant and the survival
function for noncured patients, S0(t|z), was assumed to follow a parametric form. Farewell
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(1982) extended the model to allow covariate effects in the cure probability p(x) through
a logistic regression. Kuk and Chen (1992), Peng and Dear (2000), Sy and Taylor (2000),
Li and Taylor (2002), Peng (2003), Lu (2010), Zhang et al. (2013) further proposed
semiparametric models for the susceptible survival function S0(t|z). Othus et al. (2009)
allowed for dependent censoring. Most recently, Othus et al. (2012) proposed a change-
point mixture cure model that allows hazard rate and cure rate to jump at an unknown
covariate value. Wang et al. (2012) proposed a model with nonparametric forms for both
the cure probability and the hazard rate function.
The other class of cure models is a Cox proportional hazards model that allows for a
cure fraction Tsodikov (1998),
S(t|x) = exp[−θ(x)F (t)], (2.1)
where F (t) has the form of a cumulative distribution function and θ incorporates an inter-
cept term. The model was first proposed as a mechanistic promotion time model Yakovlev
and Tsodikov (1996), motivated by biological processes associated with development of
cancer. Therefore this model is also known as promotion time cure model. The model
was extended by Broet et al. (2001); Tsodikov (2002); Tsodikov et al. (2003) to allow the
latent distribution F (t) to be dependent on covariates. Bayesian formulations were also
considered Chen et al. (1999); Yin and Ibrahim (2005). Note that if θ(x) = exp(βx), then
β represents the log hazard ratio. The hazard function is λ(t|x) = exp(βx)f(t). There-
fore, the ratio of hazard for one unit increase in x is λ(t|x+1)
λ(t|x) =
exp(β(x+1))f(t)
exp(βx)f(t)
= exp(β).
Thus, promotion time cure model is a proportional hazard survival model.
Both classes of cure models can be interpreted as part of the univariate frailty model
family S(t|x) = E [e−V H(t)], where H is a cumulative hazard, and V ∼ P (t|x) is a non-
negative frailty random variable whose distribution P has a mass at zero ( Tsodikov et al.
(2003)). There is an extensive literature on developing cure models exploiting different
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frailty schemes (Cooner et al. (2007)). When V is a binary variable, S(t|x) recovers a
two-component mixture cure model. When V follows a Poisson distribution with mean
θ, S(t|x) recovers a promotion time cure model.
It should be noted that the standard Cox model just like most other semi-parametric
models naturally incorporates cure. Indeed, in semi-parametric models, the baseline sur-
vival function is arbitrary, and this includes functions that plateau with time. With
the exception of some rank-based methods that explicitly rely on the zero tail defect
assumption (Tsodikov (1998)), semiparametric MLE theory remains valid regardless of
cure. Exposing the cure rate as an explicit parameter in the model is a matter of repa-
rameterization that keeps the MLEs invariant. Semiparametric models in their non-cure
form provide as estimate of the probability of cure as the last value of the predicted
survival function. While initially specialized cure models may have been developed out
of underappreciation for the generality of semi-parametric survival models, they opened
the field to consideration of mechanistic models of heterogeneity and a more meaningful
interpretation of the data. In most of the previous work on cure models, including the
above formulations, it is assumed that the cure status is determined, if unknown, at the
beginning of the follow up (t = 0). In practice though, patients often receive treatments
or experience intermediate events during the follow up. In this case it is natural to expect
the chance of cure to change in response to dynamic factors. To account for this situa-
tion, one could consider models where survival times are based on stopping times for some
stochastic processes. A number of so-called first hit models (FHT) were proposed that
define the failure as a stochastic process reaching a boundary Lee and Whitmore (2006).
The event of cure appeared as an incidental finding when the process never reaches a
boundary with non-zero probability under certain conditions ensuring that the process
drifts away from boundary. The idea was operationalized by (Balka et al., 2009) using a
Wiener process. It it possible, within this framework, to have time-dependent covariates
affecting the process and the associated stopping time properties.
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In this paper, we propose a framework where cure is an outcome (a stopping point)
of a latent stochastic process as it touches an absorbing boundary at zero. Fundamental
to the model is the mechanistic competing nature of cure and failure, with time to cure
representing a latent competing risk. The latent cure event intercepts the failure process
and vice versa. We model the time to cure and time to failure with the proportional
hazard model. Two separate baseline hazards are estimated nonparametrically in the
model to allow different time scales for the time to cure and time to failure processes.
The model can easily be extended to other link functions, if needed. The proposed model
is a new class of cure models that allows the cure rate to change over time by introducing
time-dependent covariates into the cure process. Therapeutic interventions and prognostic
factors can follow two causal pathways affecting survival directly or through the latent
cure process.
Asymptotic properties are established using empirical process (Kosorok (2008)) and
martingale theory (Andersen et al. (1993)) with details in the Appendix A.6.
The paper is organized as follows. In section 2.2, we describe the framework of the
proposed cure model. Section 2.3 describes the likelihood and the corresponding martin-
gale properties, as well as the EM algorithm. Asymptotic theory is presented in Section
2.4. Section 2.5 provides simulation results. Section 2.6 gives an example of real data
analysis. In Section 2.7 we develop a prediction for the probability of cure over time,
given observed information. Section 2.9 provides conclusions and discussion.
2.2 Statistical Framework
Consider two time to event processes, time to failure and time to cure. We observe a
failure event if time to cure is longer than time to failure. However, time to cure is not
observed directly. If time to cure precedes the time to failure, we would eventually observe
a censored event. With this in mind, the observed failure time for a subject, denoted by
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T , can be defined as
T = 1(T ∗ < Tu)T ∗ + 1(T ∗ ≥ Tu)∞,
where T ∗ < ∞, denotes the potential time to failure in the absence of cure; T ∗ is only
observed if failure precedes cure; Tu is the potential time to cure; 1(·) is an indicator
function taking value of 1 if (·) is true, and 0 otherwise. P (T ∗ = Tu) = 0 for continuous
random variables. Let z(t) be a set of possibly time-dependent fully observed covariates
associated with T and Tu, and let z(t) = {z(s), s ≤ t} denote the covariate path associated
with z(·). Let C be the censoring time which is independent of (T ∗, Tu), given z(t).
Define X = min(T,C) and δ = 1(T ≤ C). Cure, once it happens, is irreversible. Cured
subjects are always censored but some censored subjects may experience failures beyond
their follow-up period. Because the cure event is unobserved, the survival function is a
conditional average over the cure process as explained in the next section.
2.2.1 Model Specification
Define a conditional hazard function for the failure event (given the cure process) as
a non-negative stochastic process dΛT = dU(t|z(t)) with an absorbing boundary of 0.
When cure event happens, the random process dU touches 0 and remains at 0 thereafter.
So cure is defined as a stopping point of the process dU .
The observed (marginal) survival function S(t) can be obtained by taking the expec-
tation over the trajectory U(t) of the stochastic process U from time 0 to t, that is,
S(t|z(t)) = E
[
e−
∫ t
0 dU(s)
]
. (2.2)
The marginal density function is then f(t) = E
[
dU(t)e−
∫ t
0 dU(s)
]
/dt, and the marginal
hazard function is a conditional expectation, given survival up to t, λ(t) = E [U(t)|T > t] =
f(t)/S(t), see Gjessing et al. (2003).
10
Specifically, as an example of this paper, consider a change point conditional hazard
process dΛT (t|Tu, z) = dU(t|z) = 1(Tu > t)θ(t|z(t))dH1(t) that models the conditional
hazard function for the failure event (given time to cure Tu). The rationale behind 1(Tu >
t) is that a subject is at risk of failure only if cure event has not yet occurred. Conditional
on the cure event, we assume a time-dependent Cox model for the failure time. In addition,
we specify a marginal hazard function for the cure event dΛTu as another time-dependent
Cox model. Specifically,
dΛTu(t|z(t)) = lim
∆→0
P (Tu ∈ [t, t+ ∆)|Tu ≥ t, z(t))
∆
= η(t|z(t))dH2(t), (2.3)
dΛT (t|Tu, z(t)) = lim
∆→0
P (T ∈ [t, t+ ∆)|T ≥ t, Tu, z(t))
∆
= 1(Tu > t)θ(t|z(t))dH1(t),
(2.4)
where z(t) is a vector of possibly time-dependent covariates of dimension p, η(t|z(t)) =
eβηz(t), θ(t|z(t)) = eβθz(t) and β = (βη, βθ) is the combined vector of regression coefficients.
The predictor η models covariate effects on the time to cure Tu and the predictor θ
models covariate effects on the failure time T . For the rest of the paper, we omit z(t) as
an argument for brevity and denote θ(t|z(t)) by θ(t) and η(t|z(t)) by η(t).
To account for potentially different time scales for the time to cure and the time to
failure processes, separate nonparametrically specified cumulative baseline hazard func-
tions H1, H2 were used. The baseline cumulative hazard function H1(t) summarizes the
underlying disease progression time pattern leading to a failure event. Another unspeci-
fied cumulative baseline hazard function H2(t) summarizes the immune function process
leading to a cure event.
The conditional survival function of the time to event T given Tu is
S(t|Tu) = e−
∫ t
0 1(Tu>s)θ(s)dH1(s). (2.5)
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The conditional probability density function (pdf ) of time to event T given Tu is
f(t|Tu) = 1(Tu > t)θ(t)h1(t)e−
∫ t
0 θ(s)dH1(s). (2.6)
2.2.2 Marginal Distribution of Time to The Failure Event
According to (2.2), for our model, the marginal survival function of the time to failure
event T , can be obtained by taking expectation of (2.5) over latent time to cure Tu
S(t) = E[S(t|Tu)] =
e−
∫ t
0 θ(s)dH1(s)e−
∫ t
0 η(s)dH2(s) +
t∫
0
η(s)e−
∫ s
0 θ(y)dH1(y)e−
∫ s
0 η(y)dH2(y)dH2(s). (2.7)
The marginal probability density function of time to event T , can be obtained by
taking expectation of (2.6):
f(t) = θ(t)h1(t)e
− ∫ t0 θ(s)dH1(s)e− ∫ t0 η(s)dH2(s). (2.8)
Details can be found in Appendix A.1.
The proposed model can be considered as a stochastic process frailty model with a
latent stochastic process V(t) = 1(t < Tu)θ(t|z(t)) acting multiplicatively on the baseline
hazard of failure.
2.2.3 A Special Case: Static Cure Model
Excluding time-dependent covariates z(t) from the cure part of the model, and making
the time to cure a degenerate improper distribution with a single mass at t = 0 makes it
a two-component mixture model. Another way to get a two-component mixture model
as a nested special case would be to impose a proportionality assumption as follows.
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If the cure process intensity is proportional to failure process, that is,
η(t|x, z(t))dH2(t)
θ(t|x, z(t))dH1(t) = a(x)
uniformly over t in the observation period, where a(x) depends only on time-independent
covariate set x, then the model can be formally written as a static two-component mixture
cure model with the logistic probability of cure p(x) =
a(x)
1 + a(x)
. The corresponding
survival function is
S(t|x, z(t)) = a(x)
1 + a(x)
+
1
1 + a(x)
e−(1+a(x))
∫ t
0 θ(s|x,z(s))dH1(s).
Any such model can also be represented as a promotion time cure model
S(t|x) = exp[−γ(x)F (t|x, z(t))], where γ = − log(a/(1 + a)), and F = −(logS)/γ.
In general, unlike the two-component mixture model, the promotion time cure model
does not loose its formal validity if all of its predictors contain time-dependent covariates,
S(t|z(t)) = exp[−γ(z(t))F (t|z(t))]. However, in this context exp(−γ) cannot be inter-
preted as the probability of cure. Also, to ensure a cure model, γ may be restricted to be
bounded resulting in a non-zero probability of cure regardless of the behavior of z(t).
2.3 Estimation
We assume each patient is subjected to random right censoring and the censoring
time C is independent of T , given z(t). The observed time is X = min(T,C), and let
δ = 1(T ≤ C) be the censoring indicator. The observed time-to-event data for subject
i = 1, · · · , n consist of i.i.d. {Xi, δi, zi(t) : 0 < t ≤ Xi}, i = 1, ..., n. For a subject with
observed data (X, δ, z(t)) and unobserved time to cure Tu, the contribution to complete
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data likelihood is
L0(β|X, δ, z(·), Tu) = [1(Tu > X)θ(X)dH1(X)]δe−
∫X
0 1(Tu>s)θ(s)dH1(s). (2.9)
The subject’s contribution to the marginal likelihood can be obtained by taking the ex-
pectation of complete data likelihood (2.9) over Tu
L(β|X, δ, z(·)) =
[
θ(X)dH1(X)e
− ∫X0 θ(s)dH1(s)e− ∫X0 η(s)dH2(s)]δe− ∫X0 θ(s)dH1(s)e− ∫X0 η(s)dH2(s) + X∫
0
η(s)e−
∫ s
0 θ(y)dH1(y)e−
∫ s
0 η(y)dH2(y)dH2(s)
1−δ . (2.10)
2.3.1 Martingale Theory
In counting process notation, let Yi(t) = 1(Xi ≥ t) be the observed at-risk process for
failure in subject i, and Ni(t) = δi 1(Xi ≤ t) be the counting process that records the
number of events that occurred by time t for subject i. Define the filtration as Ft− =
σ{Ni(x), Yi(x), zi(x) : x ∈ [0, t), i = 1, · · · , n}, and consider the continuous (orthogonal)
case where no two counting processes can jump simultaneously and the process zi(x) is
predictable.
Our model is semiparametric in the sense that the baseline cumulative hazard for fail-
ure and cure processes H1(·) and H2(·) are unspecified non-decreasing step functions with
jumps dH1 and dH2 at the times where failure events are observed. The full parameter
set is Ω = (β,H1(·), H2(·)), where β = (βθ, βη) is finite-dimensional parameter vector and
H1(·) and H2(·) are infinite-dimensional. We use the EM algorithm (Tsodikov (2003)) to
derive estimation procedures for our joint model. Following Taylor (1995) and Sy and
Taylor (2000), for our model to be identifiable, and to obtain stable MLEs, we impose
a zero-tail constraint on our joint model, namely, S(t(k)|Tu > t(k)) = 0, or equivalently,
dH1(t(k)) = ∞, where t(k) is the last event time. Consistency is established based on
empirical processes (Zeng and Lin (2007); Kosorok (2008)). Weak convergence is proved
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based on the martingale structure of the score equations elucidated by Chen (2009), and
used by Chen (2010), Chen (2012), Hu and Tsodikov (2014a) and Rice and Tsodikov
(2017).
We can write the marginal log-likelihood (2.10) in counting process form:
`(Ω) =
n∑
i=1
τ∫
0
{[
log γi
(
t; β,H1(t), H2(t)
)
+ log dH1(t)
]
dNi(t)
−Yi(t)γi
(
t; β,H1(t), H2(t)
)
dH1(t)
}
, (2.11)
where
γi =
θ(t)e−
∫ t
0 θ(s)dH1(s)e−
∫ t
0 η(s)dH2(s)
e−
∫ t
0 θ(s)dH1(s)e−
∫ t
0 η(s)dH2(s) +
∫ t
0
η(s)e−
∫ s
0 θ(y)dH1(y)e−
∫ s
0 η(y)dH2(y)dH2(s)
and τ is the maximum follow-up time in the study such that τ = inf{t : P (T > t) = 0}.
H1(t) and H2(t) represent the trajectory of the hazard functions H1 and H2 from time 0
to time t. Under independent censoring,
E[dNi(t)|Ft−] = Yi(t)P (dNi(t) = 1|Ft−) = Yi(t)γi
(
t; β,H1(t), H2(t)
)
dH1(t),
and the process dMi(t) = dNi(t)− Yi(t)γi
(
t; β,H1(t), H2(t)
)
dH1(t) where we assume
γ
(
t; β,H1(t), H2(t)
)
is predictable, is a martingale under the true model.
2.3.2 Functional Derivatives and Score Equations
As in Hu and Tsodikov (2014a), for a functional J(f), f = f(x), the local functional
derivative at s is defined as
∂J(f)
∂df(s)
=
∂J(f + g)
∂
∣∣∣∣
=0,g=1(x>s)
.
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The above functional derivative corresponds to differentiating over the ”jumps” of f func-
tion in both discrete and continuous cases. Detailed definition of functional derivative is
described in Appendix A.3.
Denote the partial derivatives of γi with respect to its dH1(t), dH2(t) and β arguments
as
γ˙i,dH1(s)
(
t; β,H1(t), H2(t)
)
=
∂γi
(
t; β,H1(t), H2(t)
)
∂dH1(s)
γ˙i,dH2(s)
(
t; β,H1(t), H2(t)
)
=
∂γi
(
t; β,H1(t), H2(t)
)
∂dH2(s)
γ˙i,β
(
t; β,H1(t), H2(t)
)
=
∂γi
(
t; β,H1(t), H2(t)
)
∂β
Because
∂ log dH(t)
∂dH(s)
=
1
dH(t)
∂dH(t)
∂dH(s)
=
1
dH(t)
1(t < s), applying the functional deriva-
tive to the log-likelihood (2.11) gives the score equations for the infinite-dimensional pa-
rameters {dH1(s) : UdH1(s) = 0} and {dH2(s) : UdH2(s) = 0}, uniformly over t. We obtain
the score functions for dH1 and dH2
UdH1(s) =
n∑
i=1
τ∫
s
[
γ˙i,dH1(s)
(
t; β,H1(t), H2(t)
)
γi
(
t; β,H1(t), H2(t)
) dMi(t) + dMi(s)
dH1(s)
]
, (2.12)
UdH2(s) =
n∑
i=1
τ∫
s
γ˙i,dH2(s)
(
t; β,H1(t), H2(t)
)
γi
(
t; β,H1(t), H2(t)
) dMi(t). (2.13)
The score function for the finite-dimensional parameter β is
Uβ =
n∑
i=1
τ∫
0
γ˙i,β
(
t; β,H1(t), H2(t)
)
γi
(
t; β,H1(t), H2(t)
) dMi(t). (2.14)
Given β, the iterative EM algorithm solves the estimating equations UdH1(s) = 0 and
UdH2(s) = 0 uniformly over s, giving the profile likelihood of β as discussed in the next
section.
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2.3.3 Nonparametric Maximum Likelihood Estimation
(NPMLE)
We estimate β and {dH1, dH2} jointly using the profile likelihood approach. This
is accomplished by applying an EM algorithm to obtain implicit estimators for haz-
ards {dHˆ1(β), dHˆ2(β)} that depend on β being held fixed. Replacing {dH1, dH2} in
the marginal log-likelihood `(β, dH1, dH2) with {dHˆ1(β), dHˆ2(β)} we obtain the profile
log-likelihood
`pr(β) = `
(
β, dHˆ1(β), dHˆ2(β)
)
.
The estimate of βˆ is obtained by maximizing the profile likelihood over a finite-dimensional
Euclidean space. The derivation of the EM algorithm for our model is shown in Appendix
A.4. For a single observation data (X, δ), it’s contribution to the joint complete-data
likelihood of time to failure and time to cure can be expressed as
L0 ({dH1}, {dH2} | X, δ, Tu) f(Tu) =
[1(Tu > X)θ(X)dH1(X)]
δe−
∫X
0 1(Tu>s)θ(s)dH1(s)η(Tu)dH2(Tu)e
− ∫ Tu0 η(x)dH2(x).
The joint likelihood is given by L0 marginalized over Tu. In the spirit of EM (Appendix
2.3), L0 is parameterized by the next iteration (k + 1) parameters, and the expectation
E [
∑
i logL0i |Observed data] is taken, where the expectation is parameterized by the
current iteration (k) parameters. On differentiation of the result, we obtain the score
functions for dH1 and dH2 (at iteration k+1):
U
dH
(k+1)
1 (s)
(
dH
(k)
1
)
=
n∑
i=1
{
dNi(s)
dH
(k+1)
1 (s)
− Yi(s)θi(s)p(k)i (s)
}
, (2.15)
U
dH
(k+1)
2 (s)
(
dH
(k)
2
)
=
n∑
i=1
{
−ηi(s)Ψ(k)i (s) +
[
dH
(k+1)
2 (s)
dH
(k)
2
− 1
]
ηi(s)µ
(k)
i (s)
}
, (2.16)
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where
p
(k)
i (s) =
[
G
(k)
1i (Xi, Xi) +G
(k)
2i (s
+, Xi)
G
(k)
1i (Xi, Xi) +G
(k)
2i (0, Xi)
]1−δi
,
Ψ
(k)
i (s) = Yi(s)
[
G
(k)
1i (Xi, Xi)−G(k)1i (s, s) +G(k)2i (s,Xi)
G
(k)
1i (Xi, Xi) +G
(k)
2i (0, Xi)
]1−δi
,
µ
(k)
i (s) =
[
Yi(s)G
(k)
1i (s, s) + (1− Yi(s))G(k)1i (Xi, s)
G
(k)
1i (Xi, Xi) +G
(k)
2i (0, Xi)
]1−δi [
(1− Yi(s)) G
(k)
1i (Xi, s)
G
(k)
1i (Xi, Xi)
]δi
,
G
(k)
1i (u, v) = e
− ∫ u0 θi(y)dH(k)1 (y)e− ∫ v0 ηi(y)dH(k)2 (y),
G
(k)
2i (u, v) =
v∫
u
ηi(x)e
− ∫ x0 θi(y)dH(k)1 (y)e− ∫ x0 ηi(y)dH(k)2 (y)dH(k)2 (x).
Equations (2.15) and (2.16) constitute self-consistency equations that can be solved iter-
atively k = 0, 1, 2, . . . , given a suitable initial model at k = 0. Setting score equations
(2.15) and (2.16) to zero, we obtain the Breslow-type estimators
dH
(k+1)
1 (s) =
∑n
i=1 dNi(s)∑n
i=1 Yi(s)θi(s)p
(k)
i (s)
, (2.17)
dH
(k+1)
2 (s) =
[∑n
i=1 ηi(s)µ
(k)
i (s)
]
dH
(k)
2 (s)∑n
i=1 ηi(s)
[
µ
(k)
i (s) + Ψ
(k)
i (s)
] (2.18)
Note that p
(k)
i (s) may be thought of as the imputed subject-specific probability of staying
uncured for subjects in the risk set at time s. The numerator of equation (2.18) may be
thought of as the imputed subject-specific probability of cure happening exactly at time s
for subjects at risk. At the convergence when dH
(k+1)
2 (s) = dH
(k)
2 (s), the second term in
(2.16) disappears, and we have
∑n
i=1 ηi(s)Ψ
(k)
i (s) = 0. The term Ψ
(k)
i (s) can be interpreted
as the imputed probability of failing in the future [s,Xi] for censored subjects in the risk
set at time s, and this term is equal to 1 for failed subjects in the risk set. We can also
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observe the following self-consistency principle. The solution to
∑n
i=1 ηi(s)Ψ
(k)
i (s) = 0 is
achieved if for the risk set at time s, the sum of cure intensities ηi(s) for failed subjects
is equal to the sum of imputed cure intensities among censored subjects weighted by the
imputed probability of failing in the future [s,Xi].
By replacing dH1(s) and dH2(s) in the log-likelihood by the point of convergence
{dHˆ1(β), dHˆ2(β)} of the above EM algorithm, we obtain the profile log-likelihood `pr(β) =
`
(
β, dHˆ1(β), dHˆ2(β)
)
. Asymptotic properties of the NPMLE estimators are established
in Section 2.4 and in Appendix A.6.
2.3.4 Estimation Procedure
The estimation procedure consists of two nested parts, maximize the likelihood over
H(β), given β (inner loop), and maximize the profile log-likelihood over β (outer loop).
Specifically, we proceed with the following procedure for estimation.
Part 1. Maximize the likelihood over H(β), given β:
(1) Set k = 0. Initialize dHˆ
(k)
1 (s) as Nelson-Aalen estimates. dHˆ
(k)
2 (s) is initialized
as dHˆ
(k)
1 (s)/1000.
(2) Given β fixed, calculate dHˆ
(k+1)
1 (s) and dHˆ
(k+1)
2 (s) using (2.15) and (2.16).
(3) Keep updating dHˆ
(k+1)
1 (s) and dHˆ
(k+1)
2 (s) as in previous step until convergence∥∥∥dHˆ(k+1)1 (s)− dHˆ(k)1 (s)∥∥∥2 <  and ∥∥∥dHˆ(k+1)2 (s)− dHˆ(k)2 (s)∥∥∥2 < .
Part 2. Maximize the profile likelihood `pr(β) = `
(
β, dHˆ1(β), dHˆ2(β)
)
over β:
(1) Set j = 0. Set βˆ(j) = 0 to start.
(2) Find βˆ(j+1) by taking one step toward maximizing the profile likelihood with
respect to β using a general optimization routine.
(3) This step is nested within (2). Update dHˆ
(j+1)
1 (t) = dHˆ
(j+1)
1 (β
(j+1))(t) and
dHˆ
(j+1)
2 (t) = dHˆ
(j+1)
2 (β
(j+1))(t) using steps in Part 1.
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(4) Repeat steps (2) and (3) until convergence
∥∥∥βˆ(j+1) − βˆ(j)∥∥∥2 < 10.
Note that Part 1 steps represent the inner loop nested within Part 2 step (2). The
convergence tolerance for inner loop (Part 1) has to be stricter than for the outer loop in
Part 2.
2.4 Asymptotic Properties
The proposed NPMLE is shown to be consistent and asymptotically normal by making
use of the empirical process (Kosorok (2008); Van Der Vaart and Wellner (1996)) and
martingale theory following a general line of Zeng and Lin (2007, 2010), Chen (2009,
2010), Hu and Tsodikov (2014b,a), Rice and Tsodikov (2017)). Regularity conditions are
listed in Appendix A.6.
By integrating the score functions (2.12) and (2.13) over time s, we obtain the alter-
native form of the score functions for cumulative baseline hazards H1(s) and H2(s) in
martingale form:
UH1(s) =
n∑
i=1
τ∫
0
[
γ˙i,dH1
(
t; β,H1(t), H2(t)
)
γi
(
t; β,H1(t), H2(t)
) H1(t ∧ s) + 1(t < s)] dMi(t), (2.19)
UH2(s) =
n∑
i=1
τ∫
0
γ˙i,dH2
(
t; β,H1(t), H2(t)
)
γi
(
t; β,H1(t), H2(t)
) H2(t ∧ s)dMi(t) (2.20)
Define 1i(t, s;H1, H2, β) =
γ˙i,dH1
(
t; β,H1(t), H2(t)
)
γi
(
t; β,H1(t), H2(t)
) H1(t ∧ s) + 1(t < s) and
2i(t, s;H1, H2, β) =
γ˙i,dH2
(
t; β,H1(t), H2(t)
)
γi
(
t; β,H1(t), H2(t)
) H2(t ∧ s). As we show in Appendix A.5,
since ki(t, s;H1, H2, β), k = 1, 2, does not depend on s for t < s, the linear transform∫ τ
0
ki(t, s;H1, H2, β)dMi(t), k = 1, 2, is a martingale.
As for the score function for β (2.14), since
γ˙i,β
(
t; β,H1(t), H2(t)
)
γi
(
t; β,H1(t), H2(t)
) is a predictable
process, the linear transform
∫ τ
0
γ˙i,β
(
t; β,H1(t), H2(t)
)
γi
(
t; β,H1(t), H2(t)
) dMi(t) is also a martingale. There-
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fore, under the true model the score functions for H1(s), H2(s) and for β are martingales.
The following propositions present the consistency and weak convergence for the pro-
posed NPMLE Ωˆ =
(
βˆ, {dHˆ1}, {dHˆ2}
)
with details given in Appendix A.6.
Proposition II.1. Let β0 and H0(t) = (H01 (t), H
0
2 (t)) be the true values of βˆ and Hˆ(t) =(
Hˆ1(t), Hˆ2(t)
)
, respectively. Assuming regularity conditions hold, then with probability
one, βˆ converges to β0, Hˆ(t) converges to H0(t) uniformly in the interval [0, τ ].
Consider a linear functional of the NPMLE Ωˆ
n1/2
aT (βˆ − β0) +
τ∫
0
b(t)Td
(
Hˆ(t)−H(t)0
) , (2.21)
where a is real vector, b(t) = {b1(t), b2(t)} is in BV [0, τ ] × BV [0, τ ], where BV [0, τ ] is
the space of functions with bounded total variation in [0, τ ]. Let BT = (BT1 , B
T
2 ), and
ET = (aT , BT ), where Bk is the vector consisting of the values of bk(t) evaluated at the
observed failure times corresponding to the jumps of Hˆk, and {dHˆk} is the vector of jump
sizes at the observed failure times, for k=1,2, respectively.
Proposition II.2. Assuming regularity conditions hold, n1/2{βˆ − β0, Hˆ(t)−H0(t)} con-
verges weakly to a zero-mean Gaussian process. In addition, the linear functional (2.21)
converges weakly to a zero-mean Gaussian process with variance-covariance matrix ET (I0)−1E
which can be consistently estimated by nET (In)−1E, where In is the negative Hessian ma-
trix of the observed log-likelihood function with respect to Ωˆ =
(
βˆ, {dHˆ1}, {dHˆ2}
)
and
ET = (aT , BT ).
For a Hadamard differentiable functional F (Ω) of Ω, based on the functional delta
method (Andersen et al. (1993) Section II.8), n1/2{F (Ωˆ)− F (Ω)} converges weakly to a
zero-mean Gaussian process with variance-covariance function F˙ (Ω)T (I0)−1F˙ (Ω), where
F˙ (Ω) is the gradient of F (Ω) with respect to Ω. The information operator I0 can be
consistently estimated by n−1In. The observed information matrix In is obtained by
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evaluating the negative Hessian matrix I at Ωˆ. The explicit expression of In is derived
in Appendix A.6.
Proposition II.3. Assuming regularity conditions hold, the variance-covariance matrix
of β from profile likelihood is a consistent estimator of true variance-covariance matrix of
β.
The variance-covariance matrix of β from profile likelihood can be obtained from
inverse profile information matrix. We proved Proposition II.3 in Appendix A.6.3.
2.5 Simulation Study
To examine the finite-sample performance of the parameter estimates obtained by
the proposed model, we conducted a Monte Carlo simulation study. We generated the
survival times T from the marginal survival function with settings as follows.
Table 2.1: Simulation results using the proposed method. β1 describes the effect of
time-dependent covariates z1(t) = 1(t > v1) on failure process. β3 describes the effect of
time-dependent covariates z2(t) = 1(t > v2) on cure process. β2 and β4 describe the effect
of time-independent covariate z3 ∼ B(0.5) on the failure and cure process, respectively.
v1 and v2 are simulated from exponential distribution for each subject. The results are
based on 500 simulated datasets with sample size of n = 300 and n = 500.
N Process β Truth Avg. est. ESD ASE 95% CP
300 failure β1 1 1.01 0.23 0.21 0.93
β2 -0.5 -0.45 0.23 0.22 0.91
cure β3 1 1.13 0.42 0.38 0.95
β4 0.5 0.62 0.33 0.30 0.91
500 failure β1 1 0.97 0.17 0.16 0.93
β2 -0.5 -0.48 0.18 0.18 0.94
cure β3 1 1.10 0.30 0.31 0.95
β4 0.5 0.55 0.25 0.24 0.94
Avg. est.: average of Monte Carlo estimates of the true parameter values over the 500 simulations
ESD: empirical standard deviation based on Monte Carlo estimates
ASE: average of numerically estimated standard errors
95% CP: 95% coverage probability
The true baseline cumulative hazard for failure process is specified as H1(t) = t
2/2
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and the true baseline cumulative hazard for cure process is specified as H2(t) = t
2/4. The
true failure intensity is θ(t|z(t)) = eβ1z1(t)+β2z3 and the true cure intensity is η(t|z(t)) =
eβ3z2(t)+β4z3 . For simplicity, we consider two change-point binary covariates, z1(t) = 1(t >
v1) that changes its value at time v1, and z2(t) = 1(t > v2) that changes its value at time
v2 as time-dependent covariates. The covariate times v1 and v2 are both generated from
an exponential distribution with rate 1. Additionally, we consider a time-independent
binary covariate z3 ∼ B(0.5). The true parameters were β1 = β3 = 1,β2 = −0.5, and
β4 = 0.5. Censoring is simulated from a uniform distribution U(0, 3), which yields 50% of
censoring. We examined the performance of estimation for the proposed model under the
sample size of n = 300 and n = 500; each was replicated 500 times. Initial values were
chosen to be Nelson-Aalen estimates for the two baseline hazards and set to be 0 for all
βs. Standard errors were obtained from the numerically evaluated Hessian matrix at the
solution.
The results of the simulation study are summarized in Table 2.1. The proposed estima-
tion and inference procedures perform well with diminishing bias as sample sizes increases,
and coverage probability approaching 95% nominal level. With the larger sample size,
we see better agreement between empirical standard deviations and asymptotic standard
errors. This suggests that the asymptotic approximation of the covariance matrix for the
profile likelihood is reasonable for the sample size of n ∼ 500 or larger. Note that the
standard errors for β associated with the cure process are substantially larger than for the
β associated with failure process. This phenomenon is typical of models incorporating a
latent component.
2.6 Real Data Analysis: The SEER Prostate Cancer Data
We applied the proposed time-dependent cure model to SEER registry data on prostate
cancer patients with the aim to study if diagnosis and treatment of a secondary cancer
affects the prostate cancer specific survival. Secondary cancer is a new cancer diagnosed
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in a prostate cancer patient, i.e. a subject who already is a (primary) prostate cancer
survivor. The primary cancer is a cancer that has been diagnosed in the subject for the
first time in a lifetime. Both primary and secondary cancers are classified based on disease
spread into three categories: localized (tumor confined to the organ), regional (regional
spread beyond the organ; merged with localized category in prostate cancer SEER data),
and distant (with distant metastases). In addition, the first primary cancer is coded based
on the tumor grade into two groups: 0=”Low grade” for well differentiated or moderately
differentiated cells; 1=”High grade” for poorly differentiated or undifferentiated anaplastic
cells.
Specifically, we looked at males diagnosed with prostate cancer between 2000 and 2011
in the United States. We restricted our sample to males whose prostate cancer was their
first cancer diagnosis and who survived for at least one month. If there was a secondary
cancer diagnosis, we restricted our sample to males with secondary cancer diagnosis that
is at least one month after the first primary cancer. To avoid potential biases associated
with the variable use of PSA screening, we only consider cases diagnosed in and after
year 2000. There are a total of 200,994 men in our sample; 8,516 of them died of prostate
cancer. Among the 11,730 men who developed secondary cancer during the follow up
period, 48% were diagnosed with localized, 23.7% with regional and 28.3% with distant
stage secondary cancers. 488 of the secondary cancer patients died of prostate cancer,
(180 localized, 113 regional, 113 distant stage secondary cancer patients). Characteristics
of the studied patients are presented in Appendix Table A.1, A.2 and A.3.
Our main interest lies is estimating the effects of secondary cancer occurrence and
treatment in patients who are primary cancer survivors. The survival time is defined to
be the time from diagnosis of prostate cancer to death due to prostate cancer. In our
models we include three time-dependent variables 1(t > localized C2), 1(t > regional C2)
and 1(t > distant C2), where “localized C2”, “regional C2”, and “distant C2” is the
time to the localized, regional and distant stage secondary cancer diagnosis, respectively.
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Additionally, we control for the stage and grade of the first primary (prostate) cancer by
including them as time-independent covariates. The hypothesis regarding the effect of the
time-dependent covariates is that of an incidental treatment effect on the primary cancer.
Namely, diagnosis of a secondary cancer and its treatment in a primary prostate cancer
survivor affects the time to death from prostate cancer. Also, it is interesting to study
whether the stage of secondary cancer matters, because treatment of the distant stage
disease is usually systemic and has a chance to affect latent primary cancer elsewhere.
We start by using a standard Cox model incorporating secondary cancer occurrence
and its stage as time-dependent covariates potentially affecting the time to death specific
to primary cancer (Table 2.2). We find that the risk of prostate cancer death increases with
the degree of cancer spread. The effect may have to do with compromised immune system
under a systemic treatment that is not prostate specific. And it affects growth of prostate
tumor cells that managed to survive the secondary cancer treatment. Also, prostate cancer
cells surviving additional treatment may become more aggressive on average as a survival
of the fittest selection effect. Alternatively, in a non-treatment related pathway, occurrence
of secondary cancer may identify the subject as having a compromised immune system
or adverse genetics. However, this analysis does not shed any light on the hypothesized
incidental therapeutic effect of secondary treatment on prostate cancer that is lost in the
combined effects reported by the Cox model.
The proposed cure model allows a richer interpretation as it incorporates a more
sophisticated mechanism of dynamic counteraction between failure and cure. In the cure
model a similar set of effects is incorporated in the failure process and cure components
(Table 2.3).
Regarding the failure process, the results are very similar to the Cox model presented
earlier. Prostate cancer patients who were diagnosed with secondary cancer have elevated
risk of death from prostate cancer compared to those who have one primary cancer only
(β = 0.22, 0.81, 1.70 for localized, regional and distant stage secondary cancer, respec-
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Table 2.2: Parameter estimates, standard error and p-values from analysis of SEER
data on prostate cancer in the United States, using a Cox model with time-dependent
secondary cancer effect. C2 denotes the time to the secondary cancer from the diagnosis of
the first primary cancer. Stage refers to the distant vs. localized/regional stage contrast of
patient’s first primary cancer. Grade refers to the high (poor or undifferentiated) vs. low
(well or moderately differentiated) contrast of patient’s first primary cancer. Localized,
regional and distant in the time-dependent covariates refer to the stage of secondary
cancer.
Parameter Group Estimate Standard Error p
1(t > localized C2) 0.23 0.08 0.003
1(t > regional C2) 0.69 0.10 < 0.0001
1(t > distant C2) 1.66 0.07 < 0.0001
Stage 1 3.22 0.02 < 0.0001
Grade 1 1.33 0.03 < 0.0001
Stage: 0=Local/Regional vs. 1=Distant
Grade: 0=Low Grade vs. 1=High Grade
1(t > localized C2): indicator of whether there exists localized stage secondary cancer at time t
1(t > regional C2): indicator of whether there exists regional stage secondary cancer at time t
1(t > distant C2): indicator of whether there exists distant stage secondary cancer at time t
tively, vs. no secondary cancer).
As hypothesized, the cure process component reveals a possible incidental therapeutic
effect of secondary cancer systemic treatment in its distant stage. Patients diagnosed with
and treated for distant stage secondary cancer have shorter times to cure from prostate
cancer (β = 0.53, p = 0.0004) compared to those without secondary cancer.
The primary prostate cancer stage and grade present no surprises and show higher
risk of prostate cancer death with more advanced stage and with higher grade, in both
failure and cure components, although the grade effect in the cure component does not
reach significance.
We treated death from other causes as random censoring. This implies that we assume
there is no relationship between death from prostate cancer and death from other causes.
And we assume the censoring mechanism is random censoring.
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Table 2.3: Parameter estimates, standard error and p-values from analysis of SEER data
on prostate cancer in the United States, using the proposed dynamic cure model. C2
denotes the time to the secondary cancer from the diagnosis of the first primary cancer.
Stage refers to the distant vs. localized/regional stage contrast of patient’s first primary
cancer. Grade refers to the high (poor or undifferentiated) vs. low (well or moderately
differentiated) contrast of patient’s first primary cancer. For all the patients, their first
primary cancer is prostate cancer. Localized, regional and distant in the time-dependent
covariates refer to the stage of secondary cancer.
Process Parameter Group Estimate Standard Error p
failure 1(t > localized C2) 0.22 0.08 0.009
1(t > regional C2) 0.81 0.11 < 0.0001
1(t > distant C2) 1.70 0.07 < 0.0001
Stage 1 3.48 0.03 < 0.0001
Grade 1 1.37 0.03 < 0.0001
cure 1(t > localized C2) −0.07 0.17 0.69
1(t > regional C2) 0.27 0.29 0.34
1(t > distant C2) 0.53 0.15 0.0004
Stage 1 0.59 0.08 < 0.0001
Grade 1 −0.06 0.05 0.22
Stage: 0=Local/Regional vs. 1=Distant
Grade: 0=Low Grade vs. 1=High Grade
1(t > localized C2): indicator of whether there exists localized stage secondary cancer at time t
1(t > regional C2): indicator of whether there exists regional stage secondary cancer at time t
1(t > distant C2): indicator of whether there exists distant stage secondary cancer at time t
2.7 Prediction
Although cure is an unobserved event, a benefit of our joint cure model is that it
provides a tool for making predictions of the distribution of the time to cure, given
current follow up time and secondary cancer information. The prediction is relevant for
those who do not experience the failure event (δ = 0). Derived in Appendix A.2 are the
predicted conditional survival functions for onset of cure given patient’s follow up time
X, and first primary cancer and secondary cancer information. Specifically, we have the
following conditional survival distribution for cure onset at time point tu, given a follow
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up of X:
S(tu | X, δ = 0) =
e−
∫X
0 θ(y)dH1(y)e−
∫X∨tu
0 η(y)dH2(y) +
∫ X∨tu
tu
η(s)e−
∫ s
0 θ(y)dH1(y)e−
∫ s
0 η(y)dH2(y)dH2(s)
e−
∫X
0 θ(y)dH1(y)e−
∫X
0 η(y)dH2(y) +
∫ X
0
η(s)e−
∫ s
0 θ(y)dH1(y)e−
∫ s
0 η(y)dH2(y)dH2(s)
.
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Figure 2.1: Conditional survival functions for onset of cure given 5 years of follow up
(X ≥ 60 months), localized/regional and low grade first primary cancer, and secondary
cancer diagnosed at 3rd year (C2 = 36 months, if exist) by secondary cancer stage
Shown in Figure 2.1 are the conditional survival functions for onset of cure for a
local/regional and low grade first primary cancer patient followed up for 5 years (X ≥ 60
months) with localized, regional or distant stage secondary cancer diagnosed at the 3rd
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year post the diagnosis of a prostate cancer (first primary), compared to a similar patient
without a secondary cancer diagnosis.
A feature to notice is that these four curves are identical until the 36th month when
the secondary cancer is diagnosed, indicating the cure rate changes in response to the
discovery and/or treatment of secondary cancer. The ordering of these curves gives us
an idea of how the cure rate changes as the stage of the secondary cancer increases.
Compared to those who are not diagnosed with secondary cancer, patients with distant
and regional stage secondary cancer have lower curves, indicating an earlier onset of cure.
While for a localized secondary cancer, a rather mild treatment effect is observed, and
we don’t see much of a difference in predicted cure rate between those who are diagnosed
with a localized secondary cancer and those who are not diagnosed with secondary cancer.
2.8 Practical Concept of Cure: Death from Other Causes
The prediction of the time to cure in Section 2.7 is based on the biological concept
of cure, that is, cure in absence of death from other causes. In practice, patients with
prostate cancer diagnosed at older age are more likely to die of other causes compared to
younger patients. Applying treatment to prostate cancer for older patients may not be
so relevant as for those who are younger because older patients are more likely to die of
other causes, not of prostate cancer itself. Therefore, practical concept of cure considers
death from other causes as another source of cure, on top of biological concept of cure.
Modeling practical concept of cure requires modeling residual survival for other causes
from the age of prostate cancer diagnosis. Denote Toc as the time to death from other
causes from birth and Soc(t|Z) as the survival function of Toc. Then the residual survival
for other causes is
P (Toc > t+ a|Toc > a,Z) = P (Toc > t+ a|Z)
P (Toc > a|Z) =
Soc(t+ a|Z)
Soc(a|Z) = Soc(t|a, Z)
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where a is the age at prostate cancer diagnosis. Assume age at prostate cancer diagnosis
is proportional hazard covariate for Soc(t|a, Z), then this survival function must follow the
form a Gompertz survival model. The derivation is based on differential equation. Details
can be found in Appendix A.8. This is called ”characterization of Gompertz distribution”.
Gompertz survival model is a popular survival model used in studies of longevity. Using
the SEER registry data as in Section 2.6, we fitted a Gompertz survival model to the time
to death from other causes, with age at prostate cancer diagnosis as a covariate, adjusting
for prostate cancer stage and grade. Death from prostate cancer is treated as censored.
Age was centered at 47 years old and scaled by 10 year. The Gompertz model survival
function is
Soc(t|a, Z) = e−λr (eγt−1),
and the hazard function is
hoc(t|a, Z) = λeγt
where λ = eβ0+β1age+β2stage+β3grade describes the covariate effects.
The parameter estimates of the fitted Gompertz survival model to death from other
causes are: γˆ = 0.012, βˆ0 = −7.28, βˆ1 = 1.05, βˆ2 = 0.68, βˆ3 = 0.15. Figure 2.2 shows the
probability of death from other causes within the interval of last follow up (143 months),
as a function of age at diagnosis. Figure 2.2 shows the probability of death from other
causes within the interval of total follow up is 1 − Soc(t = 143|a, Z). The probability of
death from other causes increases rapidly after age of 60. Patients with distant, high grade
prostate cancer are more likely to die from other causes, compared to localized/regional,
low grade prostate cancer patients. This may be due to the side effects of the more
aggressive therapy applied to distant prostate cancer. According to the practical concept
of cure, patients with distant, high grade prostate cancer has a higher probability of
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Figure 2.2: Probability of death from other causes within the interval of last follow up
(143 months) for distant high grade prostate cancer (blue) and for localized/regional low
grade prostate cancer (red)
cure compare to localized/regional low grade prostate cancer patients due to a higher
probability of death from other causes for distant high grade prostate cancer patients.
The biological cure from prostate cancer is S(∞|Z), which can be obtained from
estimated survival function from Section 2.6. The probability of die from other causes at
age a given patient is at risk (have not died from prostate cancer) is
P (die from other causes|a, Z) =
∞∫
0
foc(t|a, Z)S(t|Z)dt
where foc(t|a, Z) = hoc(t|a, Z)Soc(t|a, Z) is the density function for time to death from
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other causes. Probability of practically cured is S(∞|Z) + ∫∞
0
foc(t|a, Z)S(t|Z)dt. Figure
2.3 and 2.4 shows the probability of being biologically cured (blue) versus the probability
of being practically cured (red), as a function of age at diagnosis. The biological cure is
basically the same as the practical cure before age of 40. After age of 60, there is a greater
chance of being practically cured by the source of death from other causes. Therefore,
treatment for a prostate cancer is not that relevant for people of older age. Caution should
be applied to the use of practical concept of cure when choosing the type of treatment
for prostate cancer. Choosing the treatment based on practical cure may favor a therapy
that has serious side effects leading to higher probability of dying from other causes. It
is not appropriate to use practical concept of cure that consider death from other causes
as a source of cure when making decision on the type of treatment.
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Figure 2.3: Probability of being biologically cured (blue) and probability of being practi-
cally cured (red) within interval of last follow up (141 months), for regional/localized low
grade prostate cancer patients.
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Figure 2.4: Probability of being biologically cured (blue) and probability of being prac-
tically cured (red) within interval of last follow up (141 months), for distant high grade
prostate cancer patients.
2.9 Discussion
Using a mechanistic competing nature of cure and failure within the subject, we con-
structed a new class of cure models driven by a latent stochastic cure process that allowed
us to incorporate time dependent covariates into the cure. Unlike other typical cure mod-
els, we do not assume that the cure status is predetermined at time zero. As an example,
we modeled the conditional hazard function for terminal event as a change-point function
driven by the latent event of cure. In general, any stochastic hazard process U(t) that
has an absorbing boundary of 0 leads to a cure model. The proposed model framework
has the flexibility to incorporate a wide variety of dynamic cure models. We model the
time to cure and time to failure with a proportional hazard model. Other link functions
can be naturally incorporated, for example, using artificial frailties (Tsodikov (2003)).
If the time to cure model is itself a cure model, the baseline hazard for cure H2 is
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bounded, and the cure event may not happen. The PH model just like most other semi-
parametric model families includes the corresponding family of cure models. Cure model
becomes a way to reparameterize the corresponding non-cure model to expose an explicit
parameter responsible for the cure rate, when this parameter is of main interest. However,
in our model, the cure rate for the time to cure distribution is a nuisance and does not
bear direct relevance to the probability of cure for the observed time to failure. The time
to cure is modeled by a PH model in its traditional non-cure parameterization accordingly.
If pc is the probability of cure in the time to cure model, then 1− pc represents the upper
boundary for the probability of cure in the population that would be achieved if all cures
in the 1− pc fraction happened at time 0. The predicted probability of cure based on the
data in the example is smaller than 1 − pc, because the time to cure distribution is not
degenerate and failure has a chance to happen before cure. Figure 2.1 shows predictions
of pc as the value of the time to cure survival functions at the right extreme of the data
at 141 months. They are quite small so time to cure is estimated as a virtually proper
distribution.
Predicting something that is fully unobserved, such as the time to cure, should be
treated with caution because the model typically has less power for parameters associated
with latent components. However, the model-based predictions represent a useful tool
to generate hypotheses on the latent effects and to guide further confirmatory studies
pursuing more explicit measurements.
A variety of stochastic processes U can be chosen to generate various rich classes of cure
models by imposing an absorbing boundary. These include squared Gaussian (Yashin and
Manton (1997)) and Le´vy processes (Gjessing et al. (2003)) and their extensions (Putter
and van Houwelingen (2015)).
Many patients with prostate cancer who are detected by screening are not expected
to die from the disease in their lifespan. Screening leads to some cancer diagnoses that
would not occur during the subject’s lifespan in the absence of screening. Even though
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such overdiagnosed patients have a latent disease, they present as cured for all practical
purposes. Separation of biological cure vs. overdiagnosis is a challenge that requires joint
modeling of diagnosis and survival. Because overdiagnosed patients are not expected to be
affected by secondary cancer as far as their prostate cancer survival goes, the interesting
effects found in this paper are conservative.
In the data analysis, the terminal event of interest is prostate cancer specific death.
In clinical practice, sometimes patients die with prostate cancer instead of die of prostate
cancer. The effects found in this paper depend on how the cause of death was assigned and
recorded in SEER registry. If misattributed causes of death is a concern, additional ad-
justment for misclassification error should be applied. Methods to adjust for misclassified
cause of failure was addressed by Ha and Tsodikov (2015).
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CHAPTER III
A Semiparametric Latent Trait Model for Multiple
Mixed Continuous, Categorical, and Time-to-event
Outcomes
3.1 Introduction
In chronic diseases, research often centers on discovering a latent trait that manifests
itself through a variety of observable responses and covariates. Multiple outcomes (phe-
notype) are often collected when the construct of interest cannot be measured directly.
Mixed continuous, binary, ordinal and survival outcomes are commonly collected in stud-
ies of complex health conditions in order to capture different aspects of patient specific
latent trait. Generalized latent variable models with mixed outcomes are developed to
accommodate outcomes of mixed measurement scales and estimate the latent trait of
interest.
Existing research on generalized latent variable models for mixed outcomes focuses
on two strategies. The first approach is parametric and utilizes joint Gaussian frame-
work by linking observed categorical outcomes to underlying continuous normally dis-
tributed latent responses (Muthe´n (1984); Shi and Lee (2000)). These models are related
to Gaussian copula model of dependence between the phenotypes. Hoff (2007) proposed
a semiparametric Gaussian copula model, leaving marginal distributions of mixed scale
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outcomes unspecified. Associations among mixed-scale outcomes are induced by correla-
tions among the latent Gaussian variables. Murray et al. (2013) and Gruhl et al. (2013)
extend this approach to incorporate a latent factor model with mixed continuous and
ordinal outcomes under Bayesian framework. Lin et al. (2014) proposed a semiparamet-
ric normal transformation latent variable model for continuous and ordinal outcomes.
Snavely et al. (2014) extended this model to further allow for censored outcomes. This
approach maps observable outcomes to underlying Gaussian continuous responses and is
limited to mixed continuous and ordinal outcomes. This type of models require estimat-
ing a set of unknown thresholds for ordinal outcomes. For the semiparametric models
proposed by Lin et al. (2014) and Snavely et al. (2014), the parameter estimates come
from maximizing a pseudo-likelihood through a set of estimating equations, an approach
potentially less efficient than the standard maximum likelihood. Standard errors of esti-
mates are estimated through nonparametric bootstrap. In addition, this approach does
not accommodate the multinomial scale outcomes.
The second approach is the shared latent variable models that induce dependence
among mixed outcomes through shared latent variables (Sammel et al. (1997); Moustaki
and Knott (2000); Dunson (2000); Dunson and Herring (2005)). This class of models are
mainly parametric generalized linear models. Skrondal and Rabe-Hesketh (2004) extended
generalized latent trait model to accommodate censored outcomes. This approach is more
flexible in modeling non-normal outcomes, however, existing work on these models requires
explicitly specified transformation function for the measurable outcomes of different scales.
In this paper, we propose a semiparametric shared latent variable model where a
logistic link is used to accommodate continuous, ordinal, count, multinomial and sur-
vival outcomes. The model is used to provide a subject-specific measure of the latent
trait, given the information observed on the subject. The proposed model avoids the
restrictive multivariate normal assumption of the underlying continuous latent responses.
Furthermore, the proposed model does not require implicitly or explicitly estimating a
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set of unknown thresholds inherent in latent normal models for categorical data. Our
model incorporates a nonparametric transformation of the outcomes of different scales.
Unlike current work on the shared latent variable models that rely on explicit specifi-
cation of the baseline distributions of the measureable outcomes on different scales, we
use non-parametric transformation functions that are completely data-driven. Since our
model is a joint model of outcomes of mixed types, we can estimate the subject-specific
shared latent trait even when some of the outcomes are missing. Unlike Lin et al. (2014)
and Snavely et al. (2014), our model parameters are estimated by maximizing the full-
likelihood so likelihood based standard errors can be used for inference and the estimates
are asymptotically efficient. Furthermore, our model accommodates measurable outcomes
of multinomial scale. The modeling framework is also generic with respect to the para-
metric distribution assumed for the latent trait, allowing a choice of the distribution of
the trait. Our model has the potential to avoid direct specification of the distribution for
shared latent variable as long as the marginal model is specified in terms of a Laplace
transform, as described in Section 3.2. Unlike the gamma frailty model that implicitly
assumes positive correlation between outcomes, our model allows for both positive and
negative correlation between outcomes through the sign of factor loadings. And the pro-
posed model needs not assume Gaussian distribution for the latent variable to allow for
negative correlation among outcomes.
The proposed method is applied to measure pain centrality trait of patients under-
going hysterectomy as a treatment for pelvic pain and to explain the heterogeneity of
patients’ reported outcomes. The method is compared with the ad-hoc 2011 Fibromyal-
gia (FM) Survey Criteria instrument designed to characterize a similar construct. Differ-
ence of convex functions algorithm (DCA) is used to estimate the nonparametric data-
driven link functions of the model. Covariate parameters and distributional parameter
for latent variable are estimated by maximizing the profile likelihood using the Broy-
den–Fletcher–Goldfarb–Shanno (BFGS) algorithm. The rest of the article is organized as
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follows. Section 3.2 introduces the logistic link function. In Section 3.3, we show how the
logistic link can accommodate measurements of a variety of scales. In addition, we show
how it enables a closed form conditional expectations in a typical EM algorithm under
univariate case. Section 3.4 extends the framework to the multivariate case. The proposed
multivariate model framework and the likelihood function are presented in Section 3.4.
The estimation procedures are described in Section 3.5. The asymptotic properties are
shown in Section 3.6. Section 3.7 shows the simulation study. In Section 3.8 we applied
the proposed model to construct latent pain centrality score from pelvic pain patients.
Section 3.9 concludes the proposed method and discussion.
3.2 Logistic Link Function
We propose using the logistic link function to accommodate outcomes of a variety of
scales. Consider a logistic link function L given a non-negative random variable U ,
G(s|U) = U
α
1 + Uαs
,
and its expectation over U ,
G(s) = EU [G(s|U)] = EU
[
Uα
1 + Uαs
]
where U is a non-negative random variable that represents the latent trait of interest and
α is a fix constant that represents the association across outcomes, similar to the factor
loading in the factor analysis. We have the following general propositions:
Proposition 1. The function G is a special function such that the product of the
functions can be expressed as a first order difference/ratio. For a 6= b,
G(a|U)G(b|U) = G(a|U)−G(b|U)
b− a .
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By the linearity of the expectation operator, the expectation of the product over U can
be expressed as
EU [G(a|U)G(b|U)] = G(a)− G(b)
b− a .
Proposition 2. The squared function G2(s) can be expressed as the derivative of the
function:
G2(s|U) = −G′(s|U)
By the Leibniz’s rule for differentiation under the integral sign, the expectation of the
squared function G2(s) can be expressed as
EU
[
G2(s|U)] = −G ′(s).
In general, the power function Gn+1(s|U) can be expressed as the nth order derivative
of the function:
Gn+1(s|U) = (−1)
n
n!
G(n)(s|U)
And the expectation of the power function Gn+1(s|U) can be expressed as
E
[
Gn+1(s|U)] = (−1)n
n!
G(n)(s).
Proposition 3. The function 1−sG(s|U) is a Laplace transform. Consider a random
variable W that has a unit exponential distribution and W ⊥ U . Then 1− sG(s|U) is a
Laplace transform of the random variable W :
EW
(
e−WU
αs | U) = 1
1 + Uαs
= 1− sG(s|U)
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And the expectation of 1− sG(s|U) is a Laplace transform of the random variable WUα.
EUEW
(
e−WU
αs
)
= EU
(
1
1 + Uαs
)
= 1− sG(s).
The above propositions yield a convenient form of the likelihood amenable to the EM
algorithm applied to profile out the infinite dimensional parameters, similar to the role of
the Laplace transform in shared frailty Archimedian copula models. As a particular case
of the above framework, we propose unified treatment of univariate models for responses
of a variety of scales in the next section. The univariate model framework is generic
with respect to the distribution for the latent variable U . We do not need to specify the
distribution for U as long as we know the form of G(·).
3.3 The Univariate Model
3.3.1 Model Framework
Under the case of univariate outcome, α is not identifiable, so we set α = 1 throughout
this section. Consider an observed outcome Y which can be a continuous, ordinal, count,
or time-to-event outcome. Let U be a latent variable which represents the latent trait of
interest but cannot be measured directly. Let F¯ (y) = P (Y > y) denotes the tail/survival
distribution of the variable Y . We define the conditional tail/survival distribution function
for Y as
F¯ (Y | U) = 1
1 + UγH(y)
= 1− γH(y)G (γH(y)|U) ,
where H(y) is an unspecified non-decreasing function of y, and γ = exp(ZTβ) where Z
is the covariate matrix and β is the vector of regression coefficients. The conditional
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probability mass/density function for Y is
P (Y = y | U) = F¯ (y− | U)− F¯ (y | U) = 1
1 + UγH(y−)
− 1
1 + UγH(y)
= γH(y)G (γH(y)|U)− γH(y−)G (γH(y−)|U) ,
where y− = lim
∆→0
(y −∆).
The marginal tail/survival distribution Y is the expectation of F¯ (y | U) over U and
by Proposition 3 is a Laplace transform. Specifically,
F¯ (y) = EU
(
1
1 + UγH(y)
)
= 1− γH(y)G (γH(y)) .
The marginal probability mass/density function for Y can be expressed as
E
[
F¯ (y− | U)]− E [F¯ (y | U)] = γH(y)G (γH(y))− γH(y−)G (γH(y−)) .
Suppose there are n independent subjects with observed outcome (y1, · · · , yn) and
covariate matrix (Z1, · · · ,Zn). For the time-to-event outcome, we assume for each subject
i, the censoring time C∗i is independent of true event time Ti, given covariate set Zi. The
observed event time is Yi = (Ti ∧ Ci) and Ci = (C∗i ∧ τ). Let δi = 1(Ti ≤ Ci) be the
censoring indicator. Here 1(·) is the indicator function, and τ denotes the time to the
end of the study. The latent variable Ui is the latent trait of interest for subject i. The
complete data likelihood for the ithe subject can be written using the properties of the
logistic link function as
L0i = [γiH(yi)G(γiH(yi)|Ui)− γiH(yi)G(γiH(y−i )|Ui)]δi [1− γiH(yi)G(γiH(yi)|Ui)]1−δi ,
and the complete data likelihood for all n subject is L0 =
∏n
i=1 L0i.
The observed data likelihood for the ith subject can be obtained by taking expectation
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of L0i,
Li = E[L0i] = [γiH(yi)G(γiH(yi))− γiH(yi)G(γiH(y−i ))]δi [1− γiH(yi)G(γiH(yi))]1−δi
and the observed data likelihood for all n subject is L =
∏n
i=1 Li.
Notice L has a closed form representation given the form of L. The complete data
log-likelihood is
`0 =
n∑
i=1
{
δi log
(
UiγidH(yi)
[1 + UiγiH(y
−
i )][1 + UiγiH(yi)]
)
+ (1− δi) log
(
1
1 + UiγiH(yi)
)}
.
Here we assume H is an arbitrary step function that only jumps at the set of observed
values of yi and we denote the jump of H at s as dH(s). Notice H is similar to a cumu-
lative hazard function in a survival model, can be treated as an unknown outcome/time
transformation.
If the observed outcome is nominal, then the modeling framework is as follows. For
a K-category multinomial observable outcome with an observed response category c, we
define the conditional probability mass function as
p(Y = c | U) =

Uθc
1+U
∑K
k=2 θk
= θcG
(∑K
k=2 θk|U
)
, c ≥ 1,
1
1+U
∑K
k=2 θk
= 1−∑Kk=2 θkG(∑Kk=2 θk|U) , c = 1,
where θk is the covariate effect for category c versus the reference category 1.
The marginal probability mass function can be expressed as
p(Y = c) =

θcG
(∑K
k=2 θk
)
, c ≥ 1,
1−∑Kk=2 θkG (∑Kk=2 θk) , c = 1.
Estimation of multinomial outcomes follows the methods described in Tsodikov and
Chefo (2008).
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3.3.2 Estimation Procedure
Let Ω = {β, η} where η is the parameter characterizing the distribution of the latent
variable U . We estimate Ω and {dH} jointly using the profile likelihood approach. This
is accomplished by applying an EM algorithm (Tsodikov (2003)) to obtain implicit profile
likelihood estimators dH(·|Ω) for dH(·) that depends on Ω. To obtain stable MLEs,
we impose a zero-tail constraint on non-survival outcome, namely, F¯ (y(n)|U) = 0, or
equivalently, dH(y(n)) = ∞. Replacing dH(·|Ω) in the marginal log-likelihood we obtain
the profile log-likelihood `pr(Ω) = ` (Ω, {dH(·|Ω)}). On differentiation of the conditional
log-likelihood with respect to dH(s), we obtain the conditional score function for dH(s)
as
U0,dH(s) = ∂`0
∂dH(s)
=
∑n
i=1 1(yi = s)
dH(yi)
−
n∑
i=1
δi
1(y−i ≥ s)Uiγi
1 + UiγiH(y
−
i )
−
n∑
i=1
1(yi ≥ s)Uiγi
1 + UiγiH(yi)
=
∑n
i=1 1(yi = s)
dH(yi)
−
n∑
i=1
δi 1(y
−
i ≥ s)γiG(γiH(y−i )|Ui)−
n∑
i=1
1(yi ≥ s)γiG(γiH(yi)|Ui)
Define the conditional expectation operator E [f‖g] = E[f ·g]E[g] . We use the EM-DCA al-
gorithm to estimate the NPMLE. The derivation of the EM algorithm and the condi-
tional expectation operator E [·‖L0] that is used in the rest of the article are presented
in Appendix B.2. The EM algorithm involves iteratively update model parameters by
maximizing the conditional expectation of the complete data likelihood E [`0‖L0]. The
model parameters are updated by maximizing E [`0‖L0]. This can be achieved by setting
the derivative of E [`0‖L0] with respect to model parameters to 0. Specifically, we calcu-
late the conditional expectation of the conditional score function given the observed data,
latent variable U and the model parameters at the kth iteration. For the following deriva-
tion of the EM algorithm, we use the expression E
[
U0
∥∥∥L(k)0 ] to represent the conditional
expectation of the conditional score function given the observed data, latent variable U
and the model parameters at the kth iteration. Note that E [U0‖L0] is the marginal score
44
function as derived in Appendix B.2. Specifically, at the kth iteration, the conditional
expectation of the conditional score function for dH can be expressed as
E
[
U0,dH(s)
∥∥∥L(k)0 ] = E
[
U0,dH(s)L(k)0
]
E
[
L
(k)
0
] = ∑ni=1 1(yi = s)
dH
(k+1)
j (s)
−
n∑
i=1
1(y−i ≥ s)γiE
[
G(γiH
(k+1)(y−i )|Ui)
∥∥∥L(k)0 ]− n∑
i=1
1(yi ≥ s)γiE
[
G(γiH
(k+1)(yi)|Ui)
∥∥∥L(k)0 ] .
(3.1)
where L
(k)
0 notation is used to indicate that the complete data likelihood L0 is parame-
terized by the kth iteration copy of {dH}.
Notice the complete data log-likelihood `0 can be represented as a difference between
two concave functions. Consequently, the conditional score equation U0,dH(s) has a rep-
resentation of a difference between derivatives of two concave functions. Since the condi-
tional expectation operator E
[
·
∥∥∥L(k)0 ] is a linear operator, it does not alter convexity
properties. Therefore, the unconditional score function E
[
U0,dH(s)
∥∥∥L(k)0 ] is also a differ-
ence between derivatives of two concave functions.
For the M-step, we employ the difference of convex functions algorithm (DCA) to iter-
atively maximize log-likelihood with respect to dHj. DCA was first introduced by Pham
Dinh Tao in their preliminary form in 1985. DCA is a version of the MM-algorithm
(Lange et al. (2000)) that has been extensively developed since 1994 by Le Thi Hoai An
and Pham Dinh Tao for nonconvex optimization problems (Tao and An (1997, 1998);
An and Tao (2005)). DCA is particularly efficient when the target function to be min-
imized/maximized can be represented as a difference between two convex/concave func-
tions. Equation (3.1) equals to zero is a self-consistency equation that can be solved
iteratively. Solving the conditional expectation of the score equation (3.1) equals to zero
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using DCA, we obtain a Breslow-type estimator for dH(s) at the (k + 1)th iteration
dH(k+1)(s)
=
∑n
i=1 1(yi = s)∑n
i=1 δi 1(y
−
i ≥ s)γiE
[
G(γiH(k)(y
−
i )|Ui)
∥∥∥L(k)0 ]+∑ni=1 1(yi ≥ s)γiE [G(γiH(k)(yi)|Ui)∥∥∥L(k)0 ]
(3.2)
Iterations proceed until ‖dH(k+1)(s) − dH(k)(s)‖2 < . The derivation of EM-DCA al-
gorithm is presented in Appendix B.3 when J = 1 and αJ = 1, with the conditional
expectation terms calculated as follows.
Equation (3.2) is computationally efficient since the conditional expectations
E
[
G(γiH
(k)(y−i )|Ui)
∥∥∥L(k)0 ] and E [G(γiH(k)(yi)|Ui)∥∥∥L(k)0 ] have closed form solutions given
G. Specifically,
E
[
G(γiH
(k)(yi)|Ui)
∥∥∥L(k)0 ] = E
[
G(γiH
(k)(yi)|Ui)L(k)0i
]
E[L(k)0i ]
The denominator is the observed data likelihood for the ith subject evaluated at the kth
iteration,
E[L(k)0i ] = [γiH(k)(yi)G(γiH(k)(yi))− γiH(k)(yi)G(γiH(k)(y−i ))]δi [1− γiH(k)(yi)G(γiH(k)(yi))]1−δi
(3.3)
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For the numerator, the term inside the expectation is
G(γiH
(k)(yi)|Ui)L(k)0i
={G(γiH(k)(yi)|Ui)[γiH(yi)G(γiH(k)(yi)|Ui)− γiH(k)(yi)G(γiH(k)(y−i )|Ui)]}δi
{G(γiH(k)(yi)|Ui)[1− γiH(k)(yi)G(γiH(k)(yi)|Ui)]}1−δi
By proposition 1 and 2,
=
{
γiH
(k)(yi)
[
−G′(γiH(k)(yi)|Ui)− G(γiH
(k)(yi)|Ui)−G(γiH(k)(y−i )|Ui)
γiH(k)(y
−
i )− γiH(k)(yi)
]}δi
{
G(γiH
(k)(yi)|Ui) + γiH(k)(yi)G′(γiH(k)(yi)|Ui)
}1−δi
Therefore, the numerator can be expressed as
E
[
G(γiH
(k)(yi)|Ui)L(k)0i
]
=
{
γiH
(k)(yi)
[
−G ′(γiH(k)(yi))− G(γiH
(k)(yi))− G(γiH(k)(y−i ))
γiH(k)(y
−
i )− γiH(k)(yi)
]}δi
{G(γiH(k)(yi)) + γiH(k)(yi)G ′(γiH(k)(yi))}1−δi (3.4)
Notice that (3.3) and (3.4) are closed form expressions given G. Therefore,
E
[
G(γiH
(k)(yi)|Ui)
∥∥∥L(k)0 ] has a closed form expression. Similarly, applying the same
techniques, the other conditional expectation E
[
G(γiH
(k)(y−i )|Ui)
∥∥∥L(k)0 ] has a closed form
expression. Therefore, the Breslow type estimator (3.2) for updating dH(s) in the EM-
DCA algorithm has a closed form expression, which results in a computationally efficient
estimating algorithm for the nonparametric transformation function H. In addition, the
modeling framework is generic with respect to the distribution for the latent variable U .
There is no need to specify the distribution for U as long as we know the form of G(·).
The estimation procedure consists of two nested loops, maximize {dH(·|Ω)}, given
Ω = (β, η), and then maximize the profile log-likelihood over Ω. The two nested loops are
described in Section 3.5.2 when J = 1 and αJ = 1.
The next section describes the statistical setting of the model specified using a logis-
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tic link and the corresponding likelihood under the case of multivariate outcomes with
multiple scales.
3.4 The Multivariate Model
Suppose there are m distinct continuous, ordinal, count or time-to-event outcomes
with observed responses Y = (Y1, . . . , Ym) with values in domain space D = (D1, · · · , Dm)
respectively. For any j, if the jth outcome Yj is a time-to-event outcome, we assume for
each subject, the censoring time C∗j is independent of true event time Tj, given covariate
set Zj. The observed event time is Yj = (Tj∧Cj) and Cj = (C∗j ∧τj). Let δj = 1(Tj ≤ Cj)
be the censoring indicator. Here 1(·) is the indicator function, and τj denotes the time
to the end of the study for the jth outcome. The domain space for Yj is Dj = [0, τj].
For any j, if the jth outcome Yj is non-censored continuous, ordinal, or count outcome,
then δj = 1 for every such observation. We develop the main framework for continuous,
ordinal, count and survival outcomes first. Such outcome distributions can be represented
by a tail/survival function. Later at the end of this section, we show how the approach is
extended to include multinomial responses.
Let U be the latent variable that is shared by all observable outcomes. The observed
outcomes are assumed to be conditionally independent given U . Let F¯ (x) = P (X > x) de-
note the tail/survival distribution of the variable x. We define the conditional tail/survival
distribution function for the jth outcome Yj as a semiparametric transformation model
through a logistic link
F¯j(y | U) = 1
1 + UαjγjHj(y)
, (3.5)
where Hj(y) is an unspecified non-negative and non-decreasing function of y that ranges
from 0 to ∞. The covariate effect is γj = exp(ZTj βj), where Zj is the covariate vector
and βj is the vector of regression coefficients for the jth outcome. αj is the factor loading
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for the jth outcome. Notice that βj is the proportional odds ratio for one unit increase
in Zj on Yj, given U . See Appendix B.1 for derivation. The conditional probability
mass/density function for Yj is
P (Yj = y | U) = F¯j(y− | U)− F¯j(y | U) = 1
1 + UαjγjHj(y−)
− 1
1 + UαjγjHj(y)
, (3.6)
where y− = lim
∆→0
(y −∆).
Consider a subject with observed outcomes y1, . . . , ym, then the conditional joint prob-
ability distributional function is
m∏
j=1
[
F¯j(y
−
j | U)− F¯j(yj | U)
]
=
m∏
j=1
[
1
1 + UαjγjHj(y
−
j )
− 1
1 + UαjγjHj(yj)
]δj [
1
1 + UαjγjHj(yj)
]1−δj
.
For identifiability, Zj do not contain constant terms, α1 = 1 and γ1 = 1. The factor
loading αj determines the dependence between Yj and Y1.
Suppose there are n subjects with m distinct observed outcomes. Let i = 1, . . . , n
denote the ith participant, and j = 1, . . . ,m denote the jth outcome. Let yij denote the
observed response of participant i on outcome j. The latent variable Ui is the latent trait
of interest for the ith participant. For participant i = 1, . . . , n, we observe the covariate
matrix Zi = (Zi1, . . . , Zim), each corresponding to a vector of outcomes Yi = (Yi1, . . . , Yim)
and censoring status δi = (δi1, · · · , δim). The observed data for subject i = 1, . . . , n consist
of i.i.d. {Yi, δi, Zi} observations. Note that for non-survival outcomes, δij is always 1.
Let H = (H1, . . . , Hm). The complete data likelihood for the observed data (Yi, Zi, Ui)
for i = 1, . . . , n is
L0(β, α,H|Y, Z, U) =
n∏
i=1
m∏
j=1
[
1
1 + U
αj
i γijHj(y
−
ij)
− 1
1 + U
αj
i γijHj(yij)
]δij [
1
1 + U
αj
i γijHj(yij)
]1−δij
,
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and the complete data log-likelihood can be written as
`0(β, α,H|Y, Z, U)
=
n∑
i=1
m∑
j=1
{
δij log
[
1
1 + U
αj
i γijHj(y
−
ij)
− 1
1 + U
αj
i γijHj(yij)
]
+ (1− δij) log
[
1
1 + U
αj
i γijHj(yij)
]}
=
n∑
i=1
m∑
j=1
δij log
(
U
αj
i γijdHj(yij)
[1 + U
αj
i γijHj(y
−
ij)][1 + U
αj
i γijHj(yij)]
)
+ (1− δij) log
(
1
1 + U
αj
i γijHj(yij)
)
=
n∑
i=1
m∑
j=1
δij logU
αj
i γijdHj(yij)−
n∑
i=1
m∑
j=1
δij log[1 + U
αj
i γijHj(y
−
ij)][1 + U
αj
i γijHj(yij)]
−
n∑
i=1
m∑
j=1
(1− δij) log[1 + Uαji γijHj(yij)].
Here we assume Hj is an outcome-specific arbitrary step function that only jumps at the
set of observed values of yij, i = 1, . . . , n. We denote the jump of Hj at value s as dHj(s).
Notice Hj is similar to a cumulative hazard function in a survival model, and can be
treated as an unknown outcome/time transformation.
Let Ω = (α, β, η), where η is the parameter characterizing the distribution of the latent
variable U . Denote fU(u; η) as the distribution of the shared latent variable U . Note
that each subject may have subject-specific distributional parameters θi that depend on
subject-specific covariates Zi. For example, in Appendix B.3 and the real data application
in Section 3.8, we consider θi(η) = (exp(η1Zi), exp(η2Zi)) and we estimate η = (η1, η2)
that characterizes the subject-specific distribution fU(u; θi(η)) of shared latent variable
Ui. The observed data likelihood is the expectation of the complete data likelihood over
U ,
L(Ω, H|Y, Z) =
n∏
i=1
Eη

m∏
j=1
[
1
1 + U
αj
i γijHj(y
−
ij)
− 1
1 + U
αj
i γijHj(yij)
]δij [
1
1 + U
αj
i γijHj(yij)
]1−δij .
Our model has the flexibility to accommodate multinomial outcomes. For a K-
category multinomial observable outcome Y with an observed response category c, we
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define the conditional probability mass function as
p(Y = c | U) =

Uαθc
1+Uα
∑K
k=2 θk
, c ≥ 1,
1
1+Uα
∑K
k=2 θk
, c = 1,
where θk is the covariate effect for category k versus the reference category 1.
Notice that since our model is a joint model of multiple outcomes, the model parameter
and subject-specific latent variable can be estimated even if some outcomes are missing.
3.5 Estimation
3.5.1 Nonparametric Maximum Likelihood Estimation
(NPMLE)
The full parameter sets include finite-dimensional parameter vectors Ω = (α, β, η) and
infinite-dimensional H = (H1(·), . . . , Hm(·)). We estimate Ω and {dHj}j=1,...,m jointly
using the profile likelihood approach. This is accomplished by applying an EM algorithm
(Tsodikov (2003)) to obtain implicit profile likelihood estimators dHj(·|Ω) for dHj(·) that
depend on Ω. To obtain stable MLEs and maintain proper density functions for each
outcome, we impose a zero-tail constraint on non-survival outcomes, namely, F¯j(y(n) |
U) = 0, or equivalently, dHj(y(n)) = ∞, where y(n) = max{y1j, . . . , ynj}, the maximum
observed value for the jth outcome.
Replacing dHj(·|Ω) in the marginal log-likelihood we obtain the profile log-likelihood
`pr(Ω) = ` (Ω, {dHj(·|Ω)}j=1,...,m). On differentiation of the log-likelihood with respect to
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dHj(s), we obtain the conditional score function for dHj(s) as
U0,dHj(s) =
∂`0
∂dHj(s)
=
∑n
i=1 δij 1(yij = s)
dHj(yij)
−
n∑
i=1
δij
1(y−ij ≥ s)Uαji γij
1 + U
αj
i γijHj(y
−
ij)
−
n∑
i=1
1(yij ≥ s)Uαji γij
1 + U
αj
i γijHj(yij)
=
∑n
i=1 dNij(s)
dHj(yij)
−
n∑
i=1
δij
1(y−ij ≥ s)Uαji γij
1 + U
αj
i γijHj(y
−
ij)
−
n∑
i=1
1(yij ≥ s)Uαji γij
1 + U
αj
i γijHj(yij)
.
where
∑n
i=1 dNij(s) =
∑n
i=1 δij 1(yij = s) records the number of observations in outcome
Yj are of value s.
Define the conditional expectation operator E [f‖g] = E[f ·g]E[g] . We use the EM-DCA
algorithm to estimate the NPMLE. The derivation of the EM algorithm and the condi-
tional expectation operator E [·‖L0] that is used in the rest of the article are presented
in Appendix B.2. The EM algorithm involves iteratively update model parameters by
maximizing the conditional expectation of the complete data likelihood E [`0‖L0]. The
model parameters are updated by maximizing E [`0‖L0]. This can be achieved by setting
the derivative of E [`0‖L0] with respect to model parameters to 0. Specifically, we calcu-
late the conditional expectation of the conditional score function given the observed data,
latent variable U and the model parameters at the kth iteration. For the following deriva-
tion of the EM algorithm, we use the expression E
[
U0
∥∥∥L(k)0 ] to represent the conditional
expectation of the conditional score function given the observed data, latent variable U
and the model parameters at the kth iteration. Note that E [U0‖L0] is the marginal score
function as derived in Appendix B.2. Specifically, at the kth iteration, the conditional
expectation of the conditional score function for dHj can be expressed as
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E
[
U0,dHj(s)
∥∥∥L(k)0 ] = E
[
U0,dHj(s)L(k)0
]
E
[
L
(k)
0
]
=
∑n
i=1 dNij(s)
dH
(k+1)
j (s)
−
n∑
i=1
δij 1(y
−
ij ≥ s)γijE
[
U
αj
i
1 + U
αj
i γijH
(k+1)
j (y
−
ij)
∥∥∥∥∥L(k)0
]
−
n∑
i=1
1(yij ≥ s)γijE
[
U
αj
i
1 + U
αj
i γijH
(k+1)
j (yij)
∥∥∥∥∥L(k)0
]
, (3.7)
where L
(k)
0 notation is used to indicate that the complete data likelihood L0 is parame-
terized by the kth iteration version dH
(k)
j (·|Ω) of the function dHj(·|Ω).
Notice the complete data log-likelihood `0 can be represented as a difference between
two concave functions. Consequently, the conditional score equation U0,dHj(s) has a rep-
resentation of a difference between derivatives of two concave functions. Since the condi-
tional expectation operator E
[
·
∥∥∥L(k)0 ] is a linear operator, it does not alter convexity
properties. Therefore, the unconditional score function E
[
U0,dHj(s)
∥∥∥L(k)0 ] is also a differ-
ence between derivatives of two concave functions.
For the M-step, we employ the difference of convex functions algorithm (DCA) to iter-
atively maximize log-likelihood with respect to dHj. DCA was first introduced by Pham
Dinh Tao in their preliminary form in 1985. DCA is a version of the MM-algorithm
(Lange et al. (2000)) that has been extensively developed since 1994 by Le Thi Hoai An
and Pham Dinh Tao for nonconvex optimization problems (Tao and An (1997, 1998);
An and Tao (2005)). DCA is particularly efficient when the target function to be min-
imized/maximized can be represented as a difference between two convex/concave func-
tions. Equation (3.7) equals to zero is a self-consistency equation that can be solved
iteratively. Solving the conditional expectation of the score equation (3.7) equals to zero
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using DCA, we obtain a Breslow-type estimator for dHj(s) at the (k + 1)
th iteration
dH
(k+1)
j (s)
=
∑n
i=1 dNij(s)∑n
i=1 δij 1(y
−
ij ≥ s)γijE
[
U
αj
i
1+U
αj
i γijH
(k)
j (y
−
ij)
∥∥∥∥L(k)0 ]+∑ni=1 1(yij ≥ s)γijE [ Uαji1+Uαji γijH(k)j (yij)
∥∥∥∥L(k)0 ]
(3.8)
Iterations proceed until ‖dH(k+1)j (s)− dH(k)j (s)‖2 < .
The conditional expectations E
[
U
αj
i
1+U
αj
i γijH
(k)
j (y
−
ij)
∥∥∥∥L(k)0 ] and E [ Uαji1+Uαji γijH(k)j (yij)
∥∥∥∥L(k)0 ]
are computed by Laplace approximation (Laplace (1986)). The derivation of the EM
algorithm along with DCA and Laplace approximation is shown in Appendix B.3. If a
subject has only one non-missing outcome, the conditional expectations have closed form
solution using the expression described in Section 3.3.
3.5.2 Estimation Procedure
The estimation procedure consists of two nested parts; maximize the full likelihood
over {dHj(·|Ω)}j=1,...,m, given Ω = {α, β, η}, and then maximize the profile log-likelihood
over Ω. Specifically, we proceed with the following procedure for estimation.
Part 1. Maximize the full likelihood over {dHj(·|Ω)}j=1,...,m, given Ω:
(1) Set k = 0. For each of the m outcomes, initialize dHˆ
(0)
j (s) as Breslow estimates∑n
i=1 dNij(s)∑n
i=1 1(yij≥s)γij .
(2) Given Ω fixed, calculate dHˆ
(k+1)
j (s) using the Breslow-type estimator (3.8).
(3) Keep updating dHˆ
(k+1)
j (s) as in previous step until convergence∥∥∥dHˆ(k+1)j (s)− dHˆ(k)j (s)∥∥∥
2
<  for all j = 1, . . . ,m.
Part 2. Maximize the profile likelihood `pr(Ω) = `
(
Ω, {dHˆj(·|Ω)}j=1,...,m)
)
over Ω = {α, β, η},
when dHˆj(·|Ω) is obtained using Part 1.
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(1) Set r = 0. Set αˆ(0) = 1, βˆ(0) = 0 to start.
(2) Find αˆ(r+1), βˆ(r+1) and ηˆ(r+1) by taking one step towards maximizing the pro-
file likelihood with respect to α, β and η using an optimization routine (e.g.,
BFGS).
(3) Repeat step (2) until convergence
∥∥∥Ωˆ(r+1) − Ωˆ(r)∥∥∥
2
< 10.
Note that Part 1 represents the inner loop nested within Part 2. The convergence tolerance
for inner loop in Part 1 has to be stricter than for the outer loop in Part 2.
3.6 Asymptotic Properties
The proposed NPMLE is shown to be consistent and asymptotically normal by making
use of the empirical process (Murphy (1995), Zeng et al. (2005), Zeng and Lin (2007), Zeng
and Lin (2010)). The following regularity conditions are required to establish asymptotic
properties of NPMLE.
1. If the kth outcome is continuous or time-to-event, the true function H0k(y) of Hk(y),
is strictly increasing and continuously differentiable. If the kth outcome is discrete,
the true function H0k(y) of Hk(y), is increasing. The true value of parameter set
Ω0 = (β0, α0, η0) and {H0} fall in the interior of a compact convex set H.
2. For survival outcome, there exists a positive constant ν0 such that P (C
∗ ≥ τ |z(t)) ≥
ν0 almost surely.
3. The number of non-missing outcomes for subject i, denoted as mi, is bounded by
some positive integer m0 and P (mi ≥ 2) > 0 with probability 1.
4. All the covariate set Zij are bounded. Further, if there exist a constant vector c
such that [1,ZTij]c = 0 almost surely, then c = 0.
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5. If
∫ ∏
j u
αjf(u; η)du =
∫ ∏
j u
α0jf(u; η0)du for any subset of j = 1, · · · ,m, then
η = η0, αj = α0j for all j = 1, · · · ,m.
6. The score operator for (Ω, H) is Fre´chet differentiable at (Ω0, H0) with a continuously
invertible derivative −I0. The hessian matrix In evaluated at the true values of
H and Ω is positive definite, and converges in probability to a deterministic and
invertible operator I0.
The following theorems present the consistency and weak convergence for the proposed
NPMLE Ωˆ =
(
βˆ, αˆ, ηˆ
)
and Hˆ = (Hˆ1(·), · · · , Hˆm(·)) with details given in the Appendix
Section B.4.
Theorem III.1. Let Ω0 = (β0, α0, η0) and H0(y) = (H01(y1), · · · , H0m(ym)) be the true
values of Ωˆ =
(
βˆ, αˆ, ηˆ
)
and Hˆ(y) = (Hˆ1(y1), · · · , Hˆm(ym)), respectively. Under regularity
conditions, ||Ωˆ− Ω0|| → 0 and
∑m
k=1 supyk∈Dk |Hˆk(yk)−H0k(yk)| → 0 almost surely.
Theorem III.2. Assuming regularity conditions hold, n1/2{Ωˆ− Ω0, Hˆ(y)−H0(y)} con-
verges weakly to a zero-mean Gaussian process in Rd × l∞(∏mk=1Qk), where Qk = {h(t) :
‖h‖BV [Dk] ≤ 1}. Furthermore, Ωˆ is asymptotically efficient.
Consider a linear functional of the NPMLE Ωˆ and Hˆ
n1/2
{
vT (Ωˆ− Ω0) +
m∑
k=1
∫
wkd(Hˆk −H0k)
}
, (3.9)
where v is real vector, hk is the vector consisting of the values of wk(·) evaluated at the
observed outcome values corresponding to the jumps of for Hˆk, and {dHˆk} is the vector
of jump sizes at the observed outcome values, for k = 1, · · · ,m respectively. wk(y) is in
BV [Dk], where BV [Dk] is the space of functions with bounded total variation in Dk.
Theorem III.3. Under regularity conditions, the linear function (3.9) converges weakly
to a zero-mean Gaussian process with variance-covariance matrix
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(vT ,wT1 , · · · ,wTm)I−10 (vT ,wT1 , · · · ,wTm)T which can be consistently estimated by
n(vT ,wT1 , · · · ,wTm)I−1n (vT ,wT1 , · · · ,wTm)T , where In is the negative Hessian matrix of the
observed log-likelihood function with respect to Ωˆ and the jump sizes of (Hˆ1, · · · , Hˆm).
If we are primarily interested in Ω, the profile likelihood method (Murphy and Van der
Vaart (2000)) can be used. Let lpr(Ω) = `n(Ω, Hˆ(Ω)|Y, Z) be the profile log-likelihood
function for Ω.
Theorem III.4. Assuming the regularity conditions hold, for εn = Op(n
−1/2) and any
vector v, −{lpr(Ωˆ + εnv)−2lpr(Ωˆ) + lpr(Ωˆ− εnv)}/nε2n converges in probability to vTΣ−1v,
where Σ is the asymptotic covariance matrix of
√
n(Ωˆ− Ω0).
The profile likelihood lpr(Ω) can be calculated via the EM-DCA algorithm by holding Ω
fixed. The negative second-order numerical difference of the profile log-likelihood function
at Ω is used to estimate the inverse covariance matrix. Specifically, the (i, j)th element
of the inverse covariance matrix can be consistently estimated by
−{lpr(Ωˆ + εnei + εnej)− lpr(Ωˆ + εnei − εnej)− lpr(Ωˆ− εnei + εnej) + lpr(Ωˆ)}/ε2n
where ei and ej are the i
th and jth canonical basis vectors respectively. Theorem III.4
can be verified by closely following the lines of Zeng and Lin (2010) Section 9 and Murphy
and Van der Vaart (2000).
3.7 Simulation Study
To examine the finite-sample performance of the parameter estimates obtained by
the proposed model, we conducted a Monte Carlo simulation study. We generated two
continuous outcome Y2, Y6 and four ordinal outcomes Y1, Y3, Y4 and Y5, each with five
levels, from the conditional cumulative probability function. The continuous outcome was
57
generated using inverse CDF transform sampling. The ordinal outcomes were generated
by random sampling with level-specific probability. To show the performance of the
proposed model under random missing outcomes, 10% of the subjects have part of their
outcome values missing. Specifically, 2% missing one outcome; 2% missing two outcomes;
2% missing three outcomes; 2% missing four outcomes and 2% missing five outcomes.
We consider three covariates Xi1 ∼ N(0, 1), Xi2 ∼ Binom(0.5) and Xi3 ∼ Binom(0.5).
The shared latent variable Ui was generated from a Gamma(ai = e
η1Xi3 , bi = e
η2Xi3)
distribution where the true parameter values are specified as η1 = 1 and η2 = 1.7. The
true Hj(y) =
1
2
y2 for j = 2, 6 and the true Hj(y) =
1
4
y2 for j = 1, 3, 4, 5. The covariate
effect for each outcome is of the following forms: γi1 = 1, γi2 = e
β2Xi2 , γi3 = e
β3Xi3 , γi4 =
eβ4Xi1 , γi5 = e
β5Xi2 , γi6 = e
β6Xi3 , where the true parameters are β2 = 2, β3 = β4 = 0.5, β5 =
1 and β6 = 1.5. The true factor loading parameters are α1 = 1, α2 = 0.8, α3 = 0.6, α4 =
0.3, α5 = 0.5 and α6 = 1.
We examined the performance of estimation for the proposed model under the sample
size of n = 200 and n = 500; each was replicated 500 times. Standard errors were obtained
from the numerically evaluated Hessian matrix at the solution.
The results of the simulation study are summarized in Table 3.1. The proposed es-
timation and inference procedures perform well with diminishing bias as sample sizes
increases, and coverage probability at 95% nominal level. With the larger sample size,
we see better agreement between empirical standard deviation and asymptotic standard
errors. This suggests that the asymptotic approximation of the covariance matrix for the
profile likelihood is reasonable for the sample size of n = 200 or larger.
Next, we examine the finite-sample performance of the parameter estimates obtained
by the proposed model under the situation when one of the outcome is time-to-event data.
We generated two continuous outcome Y2, Y6 and six ordinal outcomes Y1, Y3, Y4, Y5, Y7 and
Y8, each with five levels, from the conditional cumulative probability function. The con-
tinuous outcome was generated using inverse CDF transform sampling. We generate one
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Table 3.1: Simulation results using proposed model. β1 to β6 are regression coefficients
describe the covariate effects on the outcome Y1 to Y6, respectively. α1 to α6 are factor
loadings for the outcome Y1 to Y6, respectively; η1, η2 are coefficient effects on the Gamma
distribution scale and rate parameters for the shared latent variable U . The results are
based on 500 simulated datasets with sample size of n = 200 and n = 500.
n Outcome Type parameter Truth Avg. est. ESD ASE 95% CP
200 Y1 ordinal β1 0
Y2 continuous β2 2 2.06 0.33 0.32 0.93
Y3 ordinal β3 0.5 0.51 0.33 0.33 0.90
Y4 ordinal β4 1 1.02 0.16 0.16 0.95
Y5 ordinal β5 0.5 0.52 0.29 0.28 0.92
Y6 continuous β6 1.5 1.54 0.38 0.38 0.92
Y1 ordinal α1 1
Y2 continuous α2 0.8 0.88 0.22 0.23 0.90
Y3 ordinal α3 0.6 0.66 0.24 0.24 0.91
Y4 ordinal α4 0.3 0.35 0.20 0.19 0.88
Y5 ordinal α5 0.5 0.56 0.22 0.22 0.91
Y6 continuous α6 1 1.04 0.23 0.27 0.92
U shape η1 1 1.16 0.55 0.73 0.86
U rate η2 1.7 1.85 0.65 0.85 0.85
500 Y1 ordinal β1 0
Y2 continuous β2 2 2.03 0.19 0.19 0.95
Y3 ordinal β3 0.5 0.52 0.20 0.20 0.94
Y4 ordinal β4 1 1.02 0.10 0.10 0.95
Y5 ordinal β5 0.5 0.51 0.17 0.17 0.94
Y6 continuous β6 1.5 1.51 0.22 0.22 0.92
Y1 ordinal α1 1
Y2 continuous α2 0.8 0.85 0.13 0.14 0.92
Y3 ordinal α3 0.6 0.65 0.15 0.15 0.91
Y4 ordinal α4 0.3 0.34 0.12 0.12 0.93
Y5 ordinal α5 0.5 0.55 0.13 0.13 0.93
Y6 continuous α6 1 1.03 0.14 0.16 0.93
U shape η1 1 1.25 0.42 0.50 0.90
U rate η2 1.7 1.96 0.49 0.58 0.91
Avg. est.: average of Monte Carlo estimates of the true parameter values over the 500 simulations
ESD: empirical standard deviation based on Monte Carlo estimates
ASE: average of numerically estimated standard errors
95% CP: 95% coverage probability
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time-to-event outcome Y9 using inverse CDF transform sampling with random censoring
time following Uniform(5, 20) distribution. This leads to around 5% censoring for Y9. The
ordinal outcomes were generated by random sampling with level-specific probability.
We consider three covariates Xi1 ∼ N(0, 1), Xi2 ∼ Binom(0.5) and Xi3 ∼ Binom(0.5).
The shared latent variable Ui was generated from a Gamma(ai = e
η1Xi3 , bi = e
η2Xi3)
distribution where the true parameter values are specified as η1 = 1 and η2 = 1.7. The true
Hj(y) =
1
2
y2 for j = 2, 6, 9 and the true Hj(y) =
1
4
y2 for j = 1, 3, 4, 5, 7, 8. The covariate
effect for each outcome is of the following forms: γi1 = 1, and γik = e
βkXik for k = 2, · · · , 9,
where the true parameters are β2 = β8 = 2, β3 = β5 = β7 = 0.5, β4 = 1, β6 = 1.5 and
β9 = 0.3. The true factor loading parameters are α1 = 1, α2 = α4 = α8 = 0.8, α3 = α9 =
0.6, α5 = 0.9 and α6 = α7 = 1.
The results of the simulation study based on 200 simulated datasets, each with n = 100
subjects, are summarized in Table 3.2. From our simulation experience, joint modeling
of multivariate outcomes including survival outcome requires either (1) more observed
outcomes per subjects (bigger m) or (2) larger sample size (bigger n), compared to joint
modeling non-censored observed outcomes. This is due to the fact that survival outcome
has random censoring, which in general contains less information available compared to a
regular non-censored continuous outcome. To achieve stable estimation, the contribution
of (1), increasing number of observed outcomes per subject, is more effective than (2),
increasing sample size n.
3.8 Real Data Analysis: Pain Centrality Measurement on Pelvic
Pain Patients
The proposed method was applied to measure pain centrality trait of patients un-
dergoing hysterectomy as a treatment for pelvic pain and explain the heterogeneity of
patients reported outcomes. The proposed joint shared variable model uses ad-hoc 2011
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Table 3.2: Simulation results using proposed model. β1 to β9 are regression coefficients
describe the covariate effects on the outcome Y1 to Y9, respectively. α1 to α9 are factor
loadings for the outcome Y1 to Y9, respectively; η1, η2 are coefficient effects on the Gamma
distribution scale and rate parameters for the shared latent variable U . The results are
based on 200 simulated datasets with sample size of n = 100.
n Outcome Type parameter Truth Avg. est. ESD ASE 95% CP
100 Y1 ordinal β1 0
Y2 continuous β2 2 2.01 0.43 0.43 0.94
Y3 ordinal β3 0.5 0.52 0.40 0.42 0.96
Y4 ordinal β4 1 1.07 0.26 0.25 0.94
Y5 ordinal β5 0.5 0.52 0.36 0.42 0.93
Y6 continuous β6 1.5 1.53 0.40 0.45 0.95
Y7 ordinal β7 0.5 0.51 0.24 0.21 0.92
Y8 ordinal β8 2 2.12 0.48 0.47 0.95
Y9 survival β9 0.3 0.25 0.42 0.36 0.89
Y1 ordinal α1 1
Y2 continuous α2 0.8 0.78 0.27 0.27 0.90
Y3 ordinal α3 0.6 0.61 0.32 0.28 0.88
Y4 ordinal α4 0.8 0.90 0.33 0.33 0.90
Y5 ordinal α5 0.9 0.90 0.34 0.33 0.89
Y6 continuous α6 1 0.95 0.28 0.29 0.90
Y7 ordinal α7 1 1.08 0.44 0.38 0.90
Y8 ordinal α8 0.8 0.87 0.35 0.33 0.89
Y9 survival α9 0.6 0.44 0.26 0.23 0.77
U shape η1 1 1.22 0.63 0.67 0.81
U rate η2 1.7 1.93 0.74 0.75 0.80
Avg. est.: average of Monte Carlo estimates of the true parameter values over the 200 simulations
ESD: empirical standard deviation based on Monte Carlo estimates
ASE: average of numerically estimated standard errors
95% CP: 95% coverage probability
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Fibromyalgia (FM) Survey Criteria (designed to characterize a similar latent construct)
as the baseline instrument (Y1) and extracts information from five other pain centrality
relevant outcomes. FM is an ad-hoc construct of pain centrality measure in the medical
field. FM is used for diagnosis of Fibromyalgia, a central pain disorder characterized by
widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood is-
sues. We intended to use our model to provide a model-based analogue to FM that would
measure a degree of pain centrality.
The study sample consists of 225 female pelvic pain patients. We consider six cross-
sectional responses of mixed scale collected prior to hysterectomy. Fibromyalgia (FM)
Survey Criteria score was included as the baseline instrument (Y1). Opioid use (OME),
BPI pain severity score, BPI surgical pain score, HADS depression score and HADS
anxiety score are the other five pain centrality relevant outcomes included in the model.
There are 9 missing values in the FM score, 2 missing values in OME, 6 missing values in
BPI pain severity score, 5 missing values in BPI surgical pain score, and 14 missing values
in HADS depression and anxiety scores. There are 5 patients with one missing outcome,
8 patients with two missing outcomes, 2 patients with three and four missing outcomes,
and 3 patients with 5 missing outcomes.
The distribution of each response is presented in Figure 3.1. All of them are right-
skewed. We can see the six pain responses are on very different scales. Notice that 80%
of the patients have 0 opioid use and one patient has extremely heavy opioid use of 120
(which is 80 higher than the second highest opioid use in the sample. Our model is robust
to outliers because of nonparametric transformation of the observable outcomes. While
analysis results from traditional latent variable models with pre-specified link may be
dominated by influential outliers.
We include age centered at 47 years old as a covariate in our model. The unit for age
is per 20 years. The subject specific latent trait, pain centrality Ui, is assumed to follow
a Gamma(ai, bi) distribution with ai = e
η1Agei and bi = e
η2Agei . The estimation results of
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Figure 3.1: Distribution of pain responses: Fibromyalgia (FM) Survey Criteria score,
Opioid use, BPI pain severity score, BPI surgical pain score, HADS depression score and
HADS anxiety score. All of them are right-skewed. Notice that 80% of the patients have
0 opioid use and one patient has extremely heavy opioid use of 120 (which is 80 higher
than the second highest opioid use in the sample.
63
the proposed joint latent trait model are shown in Table 3.3.
Table 3.3: Parameter estimates, factor loadings, standard error and p-value from analysis
of n = 225 female pelvic pain patients. The unit for age is per 20 years. Age is centered
at 47 years old.
Response Covariate Param Est Standard Error p
Fibromyalgia survey criteria Age 0
Opioid use Age 0.037 0.431 0.932
BPI pain severity Age −1.311 0.151 < 0.0001
BPI surgical pain Age 0.086 0.110 0.434
HADS depression Age −0.148 0.183 0.419
HADS anxiety Age 0.261 0.219 0.233
Response Factor loading Standard Error p
Fibromyalgia survey criteria 1
Opioid use 0.871 0.009 < 0.0001
BPI pain severity 2.529 0.134 < 0.0001
BPI surgical pain 2.531 0.169 < 0.0001
HADS depression 0.754 0.037 < 0.0001
HADS anxiety 0.530 0.030 < 0.0001
Latent trait distribution parameter Covariate Param Est Standard Error p
η1 Age 0.130 0.013 < 0.0001
η2 Age −0.893 0.099 < 0.0001
From the estimation results, we found that age has a larger effect on pain severity
relative to FM survey score, and younger people feel more severe pain. The proportional
odds ratio for every 20 years increase in age on BPI pain severity level is 0.27 (e−1.311),
given the model-based centrality is held constant. Thus, for every 20 years increase in
age, the odds of having higher pain severity decreases by 73%, given the model-based
centrality is held constant. In addition, age has significant effects on both the shape and
rate parameters of latent trait distribution. Based on the factor loadings we can see that
BPI pain severity and BPI surgical pain contribute the most to the construct of latent
trait.
Figure 3.3 shows the relationship of estimated pain centrality with each of the six
pain responses. Since the model-predicted log(U) represents how pain-uncentralized a
person is, − log(U) represents pain centrality. From Figure 3.2 we can see the model-
64
based pain centrality score − log(U) is positively correlated with all six pain responses.
The model-based pain centrality score is highly correlated with BPI pain severity, BPI
surgical pain and Fibromyalgia Survey Criteria score. Age is negatively correlated with
the model-based pain centrality score, as illustrated in Figure 3.4. This implies that
younger patients are more pain centralized. In fact, age is negatively correlated with all
six pain responses (see Appendix Table B.1 for Pearson correlations between age and all
six pain responses).
Figure 3.3 shows the relationship between Fibromyalgia survey criteria score with
each of the six pain responses, including our model-based pain centrality score. We can
see that Fibromyalgia survey criteria score is much less correlated with overall pain and
surgical pain compared to model-based pain centrality score by our model. Fibromyalgia
survey criteria score is also slightly less correlated with depression and anxiety compared
to model-based pain centrality score by our model. By examining the difference between
Figure 3.2 and Figure 3.3, we can see that the model-based pain centrality score by our
model picked up more information related to pain responses compared to the ad-hoc
Fibromyalgia survey criteria score.
3.9 Discussion
In this article, we proposed a new class of shared latent variable models where a
logistic link is used to accommodate nonparametrically transformed continuous, ordinal,
count, multinomial and survival outcomes. The resulting parametric and nonparametric
estimators are n−1/2 consistent and asymptotically normal. The proposed model has
independent nonparametrically specified transformations of different scales. Furthermore,
the proposed model does not require estimating unknown thresholds in latent normal
models for categorical data. Since our latent variable model is a joint model, we can
estimate subject-specific shared latent trait even when some of the outcomes are missing.
If a subject has only one non-missing outcome, the E-step integration for this subject can
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Figure 3.2: Model-based latent pain centrality score − log(U) versus each of six pain
responses
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Figure 3.3: Fibromyalgia survey criteria score − log(U) versus each of six pain responses
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Figure 3.4: Model-based latent pain centrality score − log(U) versus age
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be expressed in a closed form solution as described in Section 3.3.
Since our model assumes α1 = 1, in order for the latent variable U to be meaningful
and represent the latent trait of interest, Y1 has to be a latent trait relevant measurement
and other outcome measurements are correlated with Y1 through U .
Unlike gamma frailty models, the proposed model allows for both positive and negative
correlation between outcomes, and unlike Gaussian frailty models it does not have to make
Gaussian distributional assumption on the latent variable.
In the current framework, we consider only one latent factor in our model. However,
our model can be extended to allow for multiple factors. Extra care should be exercised
regarding model identifiability and factor selections.
Our method can also be extended to accommodate clustered data and longitudinal
data where additional correlation is introduce across time.
Application to hysterectomy patient data indicated that the proposed method can
offer an improved model-based measurement of the latent trait that better utilizes the
information encoded in the multivariate multi-scale observed phenotype.
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CHAPTER IV
A Semiparametric Joint Latent Trait Model for
Multiple Mixed Longitudinal Continuous,
Categorical Outcomes and Time-to-event Data
4.1 Introduction
In biomedical studies, multivariate response data consisting of mixtures of continuous
and discrete variables are often collected repeatedly over time. Multidimensional longitu-
dinal data of mixed types are collected to fully explore the latent trait trajectory that is
often of main interest but cannot be measured directly. In addition, time-to-event data is
often considered if the occurrence of the terminal event is dependent on the latent trait of
interest. Statistical approaches were developed to jointly modeling longitudinal responses
of mixed scales and the event time data to improve inference for latent trait trajectory, and
to account for the dependency the two correlated processes. Joint multivariate modeling
avoids the issue of multiple testing and substantially improves the efficiency of estimation
if the responses are correlated. Proper analysis of longitudinal responses of mixed scales
needs to account for dependency across responses and the dependency across time points.
A number of research articles addressed the analysis of multivariate longitudinal data
that incorporates the latent variable. Dunson (2003) proposed dynamic latent trait mod-
els to account for serial correlations using Gaussian latent variable. There are joint multi-
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variate models that incorporate random effects (Gueorguieva and Sanacora (2006), Jaffa
et al. (2016)). Ghosh and Hanson (2010)) proposed a semiparametric approach with a
mixture of Polya trees for random effect distributions. Proust-Lima et al. (2013) imple-
mented a latent process model for multivariate mixed longitudinal outcomes. Kunihama
et al. (2016) proposed a nonparametric Bayes models for mixed scale longitudinal sur-
veys which models the latent continuous variable through a Dirichlet process mixture of
Gaussian factor models and model the subject specific trajectory by time-varying latent
factors via Gaussian processes.
There are a couple of recent research on joint modeling longitudinal measurements and
survival data. Hickey et al. (2016) gave a comprehensive review of recent developments
and issues in joint modeling of time-to-event and multivariate longitudinal outcomes.
The majority of previous studies focus on longitudinal measurements of the same scale.
Regarding joint models incorporating multiple outcomes of mixed types with a time-
to-event data, Rizopoulos and Ghosh (2011) proposed a semiparametric joint model for
continuous and binary longitudinal outcomes and a time-to-event data, in which the latent
variable is modelled using a Dirichlet Process prior formulation. He and Luo (2016)
developed a joint model for continuous and ordinal longitudinal outcomes and a terminal
event time, linked through shared random effects. Proust-Lima et al. (2016) developed a
joint model for multiple longitudinal responses of different scales and competing risks, in
which a latent process model was used to describe the latent trait trajectory, and a latent
class structure links the longitudinal and cause-specific survival models.
The previous work on the joint model of multivariate longitudinal responses either
maps the discrete outcomes to latent continuous variables or rely on pre-specified link
functions based on exponential family. Further, there is not a single longitudinal model
that accommodates all continuous, ordinal, count and multinomial outcome types. As for
the joint model between longitudinal and survival outcomes, there is no single joint model
that allows for nonparametric transformation of the longitudinal outcomes, and no single
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model accommodate all continuous, ordinal, count and multinomial outcome types.
Motivated by the needs to develop a general statistical framework for longitudinal
responses of mixed types and survival times, we propose a semiparametric joint model
with shared latent trait trajectory for multiple longitudinal responses of mixed scales
and time-to-event data. A logistic link is used to accommodate continuous, ordinal,
count, and multinomial repeated measurements. A proportional odds survival model is
used to model the time-to-event data. The time-to-event data is linked with longitudinal
responses through subject-specific random effects. The model is used to provide a subject-
specific measure of the latent trait trajectory over time. The proposed model uses a
nonparametric transformation function on longitudinal responses of different scales. The
proposed model avoids the restrictive multivariate normal assumption of the underlying
continuous latent responses. In addition, the modeling framework is also generic with
respect to the parametric distribution assumed for the latent trait trajectory, allowing
a flexible choice of the process of the trait. Our model allows for negative correlation
between multivariate outcomes through factor loadings, therefore, we do not need to
assume Gaussian distribution/process for the latent trait trajectory to allow for negative
correlation among outcomes. Our model parameters are estimated by maximizing the full-
likelihood so likelihood based standard errors can be used for inference and the estimates
are asymptotically efficient.
The proposed method is applied to measure the pain centrality trajectory of patients
undergoing hysterectomy as a treatment for pelvic pain with longitudinal pain-related re-
sponses measured prior to the surgery, one month after the surgery and three months after
the surgery. The method is compared with the ad-hoc 2011 Fibromyalgia (FM) Survey
Criteria instrument designed to characterize a similar construct. Difference of convex func-
tions algorithm (DCA) is used to estimate the nonparametric transformation functions of
the model. Covariate parameters and distributional parameters for latent variable are esti-
mated by maximizing the profile likelihood using the Broyden–Fletcher–Goldfarb–Shanno
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(BFGS) algorithm. The rest of the article is organized as follows. The proposed joint
model framework and likelihood function are presented in Section 4.2. The estimation
procedures are described in Section 4.3. The asymptotic properties are discussed in Sec-
tion 4.4. Section 4.5 shows the simulation study. In Section 4.6 we applied the proposed
joint longitudinal model to characterize latent pain centrality trajectories for pelvic pain
patients over the three month period. Section 4.7 concludes the proposed method and
discussion.
4.2 Joint Model Framework
The proposed joint model consists of three linked submodels: (1) a proportional odds
model for the longitudinal continuous, ordinal, and count measurements; (2) a propor-
tional odds model for the time-to-event data; (3) a multinomial logistic model for nominal
responses.
4.2.1 Proportional Odds Model for Longitudinal Continuous, Ordinal and
Count Responses
Suppose there are J distinct continuous, ordinal, or count outcomes measured for n
participants at K follow up times. Let yijk be the jth observed outcome for participant i
at time tk, where i = 1, · · · , n, j = 1, · · · , J , and k = 1, · · · , K. Therefore, for participant
i at time tk, we observe outcome vector yik = (yi1k, . . . , yiJk)
T with values in domain
space D = (D1, · · · , DJ)T respectively. Let Ui(t) be the latent trait function that is
shared by all observable outcomes at time t. Ui(t) represents the underlying latent trait
score for participant i at time t. The observed outcomes are assumed to be conditionally
independent given Ui(t) for all times. Let F¯ (x) = P (X > x) denotes the tail/survival
distribution of the variable x. We define the conditional tail/survival distribution function
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for Yijk as a semiparametric transformation model through a logistic link
F¯j(yijk | Ui(tk)) = 1
1 + U
αj
i (tk)γijHj(yijk)
, (4.1)
whereHj(y) is an arbitrary (nonparametrically specified) non-negative and non-decreasing
function of y that ranges from 0 to ∞. The covariate effect is γij = exp(ZTijβj), where
Zij is the covariate vector for participant i for the jth outcome, and βj is the vector
of regression coefficients. αj is the factor loading for the jth outcome. The conditional
probability mass/density function for Yijk is
P (Yijk = yijk | Ui(tk)) = 1
1 + Ui(tk)αjγijHj(y
−
ijk)
− 1
1 + Ui(tk)αjγijHj(yijk)
,
where y− = lim
∆→0
(y −∆).
Let yi = (yi1, · · · ,yiK)T be the outcome vector across time for participant i. Let
Zi = (Zi1, · · · ,ZiJ)T . Let Ui(t) = (Ui(t1), · · · , Ui(tK))T be the trajectory of latent trait
over time for participant i. The conditional likelihood of the multiple mixed longitudinal
outcomes for participant i is
LY (yi|Ui(t)) =
J∏
j=1
K∏
k=1
[
1
1 + Ui(tk)αjγijHj(y
−
ijk)
− 1
1 + Ui(tk)αjγijHj(yijk)
]
(4.2)
The variable tk is the time of measurement with t1 = 0 as the baseline. For identifiability,
Zij do not contain constant terms, α1 = 1 and γi1 = 1 for all i. The factor loading
αj determines the dependence between Yj and Y1. The latent trait function Ui(t) can
take a flexible functional form of t or can be a process over time. As an example, we
assume the latent trait function takes the form Ui(t) = U(t)e
ai+bit. The function U(t)
represents population average disease trajectory over time. The random variable ai and
bi represent subject-specific disease severity at baseline and disease progression rate, re-
spectively, relative to the population average. The function U(t) satisfies the constraints
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that U(0) = 1 and U(t) > 0 for all t. The shared random variables (ai, bi) follow a joint
distribution f(a, b|θi). Note that each subject may have subject-specific distributional
predictors θi that depend on subject-specific covariates Zi. For example, in Appendix C.1
and the real data application in Section 4.6, we consider f(a, b|θi) = f(a|θ1i, θ2i)f(b|η3),
where f(a|θ1i, θ2i) is a log-Gamma density function with shape θ1i = exp(η1Zi), and rate
θ2i = exp(η2Zi). f(b|η3) is a log-Gamma density function with both shape and rate being
η3. For the rest of the article, we denote the distribution of (ai, bi) as fab(ai, bi|η) where
η = (η1, η2, η3)
T .
4.2.2 Proportional Odds Model for Time-to-event Data
For the time-to-event data, we use a proportional odds survival model that shares
the subject-specific random variables (ai, bi) in (4.2). Assume for each participant i =
1, · · · , n, the censoring time C∗i is independent of true event time T ∗i , given covariate set
Zis. The observed event time is Ti = (T
∗
i ∧Ci) and Ci = (C∗i ∧ τ). Let δi = 1(Ti ≤ Ci) be
the censoring indicator. Here 1(·) is the indicator function, and τ denotes the time to the
end of the study. The domain space for Ti is (0, τ ]. Under the proportional odds survival
model, the conditional survival function for Ti is
F¯s(Ti|ai, bi) = 1
1 + ev0ai+v1biγisHs(Ti)
,
where v0 and v1 measure the association between the longitudinal sub-model and the
survival sub-model. Hs(t) is an unspecified non-negative and non-decreasing function in
[0, τ ] with Hs(0) = 0 and Hs(∞) = ∞. The conditional density function of having a
terminal event at time Ti is
fs(Ti|ai, bi) = e
v0ai+v1biγishs(Ti)
[1 + ev0ai+v1biγisHs(Ti)]2
,
where hs(t) = dHs(t)/dt.
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Therefore, the conditional likelihood for a participant i with observed data (Ti, δi, Zis)
is
Ls(Ti, δi|ai, bi) =
(
ev0ai+v1biγisdHs(Ti)
1 + ev0ai+v1biγisHs(Ti)
)δi ( 1
1 + ev0ai+v1biγisHs(Ti)
)
Let β = (β1, · · · , βJ)T be the regression coefficient matrix. Let α = (α1, · · · , αJ)T
be the vector of factor loadings. Let the functional parameter H = (H1, · · · , HJ , Hs) be
the set of transformation functions for the 1st to the Jth outcome and the survival data,
respectively. The observed data for subject i = 1, . . . , n consist of i.i.d. {Yi, Ti, δi,Zi, Zis}
observations. The complete data likelihood for the observed data is
L0(β,α,H|Y,Z, U(t), ai, bi) =
n∏
i=1
LY (yi|Ui(t))Ls(Ti, δi|ai, bi)
=
n∏
i=1
{
J∏
j=1
K∏
k=1
[
1
1 + Ui(tk)αjγijHj(y
−
ijk)
− 1
1 + Ui(tk)αjγijHj(yijk)
]
(
ev0ai+v1biγisdHs(Ti)
1 + ev0ai+v1biγisHs(Ti)
)δi ( 1
1 + ev0ai+v1biγisHs(Ti)
)}
,
and the complete data log-likelihood is
`0(β,α,H|Y,Z, U(t), ai, bi)
=
n∑
i=1
{
J∑
j=1
K∑
k=1
log
(
Ui(tk)
αjγijdHj(yijk)
[1 + Ui(tk)αjγijHj(y
−
ijk)][1 + Ui(tk)
αjγijHj(yijk)]
)
+δi log
(
ev0ai+v1biγisdHs(Ti)
1 + ev0ai+v1biγisHs(Ti)
)
− log[1 + ev0ai+v1biγisHs(Ti)]
}
=
n∑
i=1
J∑
j=1
K∑
k=1
{logUi(tk)αjγijdHj(yijk)− log[1 + Ui(tk)αjγijHj(y−ijk)][1 + Ui(tk)αjγijHj(yijk)]}
+
n∑
i=1
{δi(v0ai + v1bi + log γisdHs(Ti))− (1 + δi) log[1 + ev0ai+v1biγisHs(Ti)]}.
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Here we assume Hj is an outcome-specific step function that only jumps at the set of
observed values of yijk, i = 1, . . . , n, k = 1, · · · , K. We denote the jump of Hj at value x
as dHj(x). Hs is assumed to be a step function that only jumps at the observed event
times.
Let Ω = (α,β, η,v) be the set of model parameters, where v = (v0, v1) and η is
the parameter characterizes the distribution of the latent variable Ui(t) and (ai, bi). The
marginal likelihood for the observed data is the expectation of the complete data likelihood
over (ai, bi),
L(Ω,H|Y,Z) =
n∏
i=1
Eη
{
J∏
j=1
K∏
k=1
[
1
1 + Ui(tk)αjγijHj(y
−
ijk)
− 1
1 + Ui(tk)αjγijHj(yijk)
]
(
ev0ai+v1biγisdHs(Ti)
1 + ev0ai+v1biγisHs(Ti)
)δi ( 1
1 + ev0ai+v1biγisHs(Ti)
)}
. (4.3)
4.2.3 Multinomial Logistic Model for Nominal Responses
Our model has the flexibility to accommodate multinomial outcomes. For a M -
category multinomial observable outcome Yijk with an observed response category c, we
define the conditional probability mass function as
p(Yijk = c | Ui(tk)) =

Ui(tk)
αj θc
1+Ui(tk)
αj
∑M
m=2 θm
, c ≥ 1,
1
1+Ui(tk)
αj
∑M
m=2 θm
, c = 1,
where θm is the covariate effect for category m versus the reference category 1. Since the
multinomial part of the likelihood does not include infinite dimensional parameters, we
omit it for brevity in the following exposition.
Notice that since our model is a joint model of multiple outcomes, the model pa-
rameters and subject-specific latent variable can be estimated even if some outcomes are
missing.
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4.3 Estimation
4.3.1 Nonparametric Maximum Likelihood Estimation
(NPMLE)
The full parameter sets are finite-dimensional parameter vectors Ω = (α,β, η,v),
infinite-dimensional H = (H1(·), . . . , HJ(·), Hs(·)) and U(·). Denote {U} = (U(t1), · · · , U(tK))
and {dHj} as the vector of jumps for Hj at the observed values of the jth outcome. We
estimate Ω, {U} and {dHs}, {dHj}j=1,...,J jointly using the profile likelihood approach.
This is accomplished by applying an EM algorithm (Tsodikov (2003)) to obtain im-
plicit estimators {Uˆ(Ω)}, {dHˆs(Ω)} and {dHˆj(Ω)} that depend on Ω being held fixed,
when {U}, {dHs} and {dHj} are profiled out. To obtain stable MLEs and maintain
proper density functions for each outcome, we impose a zero-tail constraint on longitu-
dinal outcomes, namely, F¯j(yj(n) | Ui(t)) = 0, or equivalently, dHj(yj(n)) = ∞, where
yj(n) = max{yijk, i = 1, · · · , n, k = 1, · · · , K}, the maximum observed value for the jth
outcome over all participants and across all times.
Replacing {U(Ω)}, {dHs(Ω)} and {dHj(Ω)}j=1,...,J in the marginal log-likelihood we
obtain the profile log-likelihood `pr(Ω) = ` (Ω, {U(Ω)}, {dHs(Ω)}, {dHj(Ω)}j=1,...,J). To
obtain the conditional score function for dHj, we differentiate the log-likelihood with
respect to dHj(x)
U0,dHj(x) =
∂`0
∂dHj(x)
=
∑n
i=1
∑K
k=1 1(yijk = x)
dHj(x)
−
n∑
i=1
K∑
k=1
1(y−ijk ≥ x)Ui(tk)αjγij
1 + Ui(tk)αjγijHj(y
−
ijk)
−
n∑
i=1
K∑
k=1
1(yijk ≥ x)Ui(tk)αjγij
1 + Ui(tk)αjγijHj(yijk)
=
∑n
i=1
∑K
k=1 dNijk(x)
dHj(x)
−
n∑
i=1
K∑
k=1
1(y−ijk ≥ x)Ui(tk)αjγij
1 + Ui(tk)αjγijHj(y
−
ijk)
−
n∑
i=1
K∑
k=1
1(yijk ≥ x)Ui(tk)αjγij
1 + Ui(tk)αjγijHj(yijk)
.
where
∑n
i=1
∑K
k=1 dNijk(x) =
∑n
i=1
∑K
k=1 1(yijk = x) records the multiplicity of observa-
tions in the jth outcome having value x.
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Let Yis(t) = 1(Ti ≥ t) be the at-risk process for time-to-event data for subject i, and
Nis(t) = δi 1(Ti ≤ t) be the counting process that records the number of events that have
occurred by time t for subject i. On functional differentiation of the log-likelihood with
respect to dHs(x), we obtain the conditional score function for dHs
U0,dHs(x) =
∂`0
∂dHs(x)
=
∑n
i=1 dNis(x)
dHs(x)
−
n∑
i=1
Yis(x)(1 + δi)e
v0ai+v1biγis
1 + ev0ai+v1biγisHs(Ti)
The conditional score function for {U} can be obtained by functionally differentiating the
log-likelihood with respect to U(x):
U0,U(x) = ∂`0
∂U(x)
=
∑n
i=1
∑J
j=1 αj 1(Hj(yijx) 6=∞)
U(x)
−
n∑
i=1
J∑
j=1
αjU(x)
αj−1eαj(ai+bix)γijHj(y−ijx)
1 + U
αj
i (x)γijHj(y
−
ijx)
−
n∑
i=1
J∑
j=1
1(Hj(yijx) 6=∞)αjU(x)αj−1eαj(ai+bix)γijHj(yijx)
1 + U
αj
i (x)γijHj(yijx)
Define the conditional expectation operator E [f‖g] = E[f ·g]E[g] . We use the EM-DCA
algorithm to estimate the NPMLE. The derivation of the EM algorithm and the condi-
tional expectation operator E [·‖L0] that is used in the rest of the article are presented
in Appendix B.2. The EM algorithm involves iteratively update model parameters by
maximizing the conditional expectation of the complete data likelihood E [`0‖L0]. The
model parameters are updated by maximizing E [`0‖L0]. This can be achieved by set-
ting the derivative of E [`0‖L0] with respect to model parameters to 0. Specifically, we
calculate the conditional expectation of the conditional score function given the observed
data, latent variable ai, bi and the model parameters at the kth iteration. For the follow-
ing derivation of the EM algorithm, we use the expression E
[
U0
∥∥∥L(m)0 ] to represent the
conditional expectation of the conditional score function given the observed data, latent
variable ai, bi and the model parameters at the mth iteration. Note that E [U0‖L0] is the
marginal score function as derived in Appendix B.2.
The E-step involves taking conditional expectation E [·‖L0] of the conditional score
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functions over ai and bi. At the m
th iteration,
E
[
U0,dHj(x)
∥∥∥L(m)0 ] = E
[
U0,dHj(x)L(m)0
]
E
[
L
(m)
0
]
=
∑n
i=1
∑K
k=1 dNijk(x)
dH
(m+1)
j (x)
−
n∑
i=1
E
[
K∑
k=1
1(y−ijk ≥ x)γijUαji (tk)
1 + U
αj
i (tk)γijH
(m+1)
j (y
−
ijk)
∥∥∥∥∥L(m)0
]
−
n∑
i=1
E
[
K∑
k=1
1(yijk ≥ x)γijUαji (tk)
1 + U
αj
i (tk)γijH
(m+1)
j (yijk)
∥∥∥∥∥L(m)0
]
, (4.4)
E
[
U0,dHs(x)
∥∥∥L(m)0 ] = ∑ni=1 dNis(x)
dH
(m+1)
s (x)
−
n∑
i=1
E
[
Yis(x)(1 + δi)γise
v0ai+v1bi
1 + ev0ai+v1biγisH
(m+1)
s (Ti)
∥∥∥∥∥L(m)0
]
, (4.5)
E
[
U0,U(x)
∥∥∥L(m)0 ]
=
∑n
i=1
∑J
j=1 αj 1(Hj(yijx) 6=∞)
U (m+1)(x)
−
n∑
i=1
J∑
j=1
E
[
αjU
(m+1)(x)αj−1eαj(ai+bix)γijHj(y−ijx)
1 + U
(m+1)
i (x)
αjγijHj(y
−
ijx)
∥∥∥∥∥L(m)0
]
−
n∑
i=1
J∑
j=1
E
[
1(Hj(yijx) 6=∞)αjU (m+1)(x)αj−1eαj(ai+bix)γijHj(yijx)
1 + U
(m+1)
i (x)
αjγijHj(yijx)
∥∥∥∥∥L(m)0
]
, (4.6)
where L
(m)
0 indicates that the complete data likelihood L0 is parameterized by the mth
iteration copy of the parameters {U}, {dHs}, {dHj}j=1,··· ,J .
The complete data log-likelihood `0 can be represented as a difference between two
concave functions of {dHj} for each j, holding all other variables fixed. Consequently, the
conditional score equation U0,dHj(x) has a representation of a difference between deriva-
tives of two concave functions. Since the imputation operator E [f‖g] is a linear opera-
tor, it does not alter convexity properties. Therefore, the unconditional score function
E
[
U0,dHj(x)
∥∥∥L(m)0 ] is also a difference between derivatives of two concave functions. Sim-
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ilarly, `0 can be represented as a difference between two concave functions of {dHs},
holding all other variables fixed. And `0 can be represented as a difference between two
concave functions of {U}, holding all other variables fixed. Therefore, the unconditional
score functions E
[
U0,dHs(x)
∥∥∥L(m)0 ] and E [U0,U(x)∥∥∥L(m)0 ] each is a difference between the
derivatives of two concave functions.
For the M-step, we employ the difference of convex functions algorithm (DCA) to
iteratively maximize log-likelihood with respect to {dHj}, {dHs}, and {U}. DCA was
first introduced by Pham Dinh Tao in its preliminary form in 1985. DCA is a version
of MM-algorithm (Lange et al. (2000)) that has been extensively developed since 1994
by Le Thi Hoai An and Pham Dinh Tao for nonconvex optimization problems (Tao and
An (1997, 1998); An and Tao (2005)). DCA is particularly efficient when the target
function to be minimized/maximized can be represented as a difference between two
convex/concave functions. Equations (4.4), (4.5) and (4.6) are a set of self-consistency
equations that can be solved iteratively. Solving the conditional expectation of the score
equations (4.4), (4.5) and (4.6) equal to zero, respectively, and employing DCA, we obtain
Breslow-type estimators for dHj(x), dHs(x), and an updating equation for U(x), at the
(m+ 1)th iteration
dH
(m+1)
j (x)
=
∑n
i=1
∑K
k=1 dNijk(x)∑n
i=1 E
[∑K
k=1
1(y−ijk≥x)γijU
(m)
i (tk)
αj
1+U
(m)
i (tk)
αj γijH
(m)
j (y
−
ij)
∥∥∥∥L(m)0 ]+∑ni=1 E [∑Kk=1 1(yijk≥x)γijU(m)i (tk)αj1+U(m)i (tk)αj γijH(m)j (yijk)
∥∥∥∥L(m)0 ] ,
(4.7)
dH(m+1)s (x) =
∑n
i=1 dNis(x)∑n
i=1 E
[
Yis(x)(1+δi)γisev0ai+v1bi
1+ev0ai+v1biγisH
(m)
s (Ti)
∥∥∥L(m)0 ] , (4.8)
81
U (m+1)(x)
=
∑n
i=1
∑J
j=1 αj 1(Hj(yijx) 6=∞)∑n
i=1
∑J
j=1 E
[
αjU (m)(x)
αj−1eαj(ai+bix)γijH
(m)
j (y
−
ijx)
1+U
(m)
i (x)
αjγijH
(m)
j (y
−
ijx)
− 1(Hj(yijx)6=∞)αjU (m)(x)
αj−1eαj(ai+bix)γijH
(m)
j (yijx)
1+U
(m)
i (x)
αjγijH
(m)
j (yijx)
∥∥∥∥L(m)0 ]
(4.9)
Iterations proceed until the following convergence criteria are satisfied: ‖dH(m+1)j (x)−
dH
(m)
j (x)‖2 < , ‖dH(m+1)s (x)− dH(m)s (x)‖2 <  and ‖U (m+1)(x)−U (m)(x)‖2 <  for some
small  > 0.
The conditional expectations E
[
·
∥∥∥L(m)0 ] in (4.7), (4.8) and (4.9) were computed
by Laplace approximation (Laplace (1986)). The derivation of the EM algorithm along
with DCA and Laplace approximation is shown in Appendix C.1.
4.3.2 Estimation Procedure
The estimation procedure consists of two nested loops. The inner loop maximizes
{dHj(Ω)}j=1,...,J , {dHs(Ω)} and {U}, given Ω. The outer loop then maximizes the profile
log-likelihood over Ω. Specifically, we proceed with the following procedure for estimation.
Inner loop. Maximize {dHj(Ω)}j=1,...,J , {dHs(Ω)} and {U}, given Ω:
(1) Set m = 0. For each of the J outcomes, initialize {dHj} as the Breslow
estimates dHˆ
(0)
j (x) =
∑n
i=1
∑K
k=1 dNijk(x)∑n
i=1
∑K
k=1 1(yijk≥x)γij
. For the time-to-event outcome, ini-
tialize {dHs} as the Breslow estimates dHˆ(0)s (x) =
∑n
i=1 dNis(x)∑n
i=1 Yis(x)γis
. In addition,
Uˆ (0)(t) = 1 for all t = t1, · · · , tK .
(2) Given fixed Ω, calculate dHˆ
(m+1)
j (x) using the Breslow-type estimator (4.7) for
all j = 1, · · · , J ; calculate dHˆ(m+1)s (x) using the Breslow-type estimator (4.8);
and calculate U (m+1)(x) using the equation (4.8).
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(3) Keep updating dHˆ
(m+1)
j (x), dHˆ
(m+1)
s (x) and Uˆ (m+1)(x) as in previous step until
all the convergence criteria are satisfied:∥∥∥dHˆ(m+1)j (·)− dHˆ(m)j (·)∥∥∥
2
<  for all j = 1, . . . , J ,∥∥∥dHˆ(m+1)s (·)− dHˆ(m)s (·)∥∥∥
2
< , and
∥∥∥Uˆ (m+1)(·)− Uˆ (m)(·)∥∥∥
2
<  for some small
 > 0.
Outer loop. Maximize the profile likelihood `pr(Ω) = `
(
Ω, {Uˆ(Ω)}, {dHˆs(Ω)}, {dHˆj(Ω)}j=1,...,J
)
over Ω:
(1) Set r = 0. Set αˆ(0) = 1, βˆ(0) = 0, vˆ(0) = 1, ηˆ(0) = (0, 0, 1)T to start.
(2) Find αˆ(r+1), βˆ(r+1), vˆ(r+1) and ηˆ(r+1) by taking one step towards maximizing
the profile likelihood with respect to α,β,v and η using an optimization rou-
tine (e.g., BFGS). Note that when the parametric multinomial component is
present, it is added to the profile log-likelihood, and the vector of parameters
include the multinomial logistics parameter matrix.
(3) While executing (2), update dHˆ
(r+1)
j = dHˆj(Ω
(r+1)), for j = 1, · · · , J ,
dHˆ
(r+1)
s = dHˆs(Ω
(r+1)) and Uˆ (r+1) = Uˆ(Ω(r+1)) using steps in the inner loop.
(4) Repeat steps (2) and (3) until convergence
∥∥∥Ωˆ(r+1) − Ωˆ(r)∥∥∥
2
< 10.
Note that the convergence tolerance for the inner loop has to be stricter than for the outer
loop.
4.4 Asymptotic Properties
The proposed NPMLE are shown to be consistent and asymptotically normal by mak-
ing use of the empirical process (Murphy (1995), Zeng et al. (2005), Zeng and Lin (2007),
Zeng and Lin (2010)). The following regularity conditions are required to establish asymp-
totic properties of NPMLE.
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1. Hs(·) is a strictly increasing and continuously differentiable function. If the jth
outcome is continuous, the true function H0j(·) of Hj(·), is strictly increasing and
continuously differentiable. The true value of parameter set Ω0 = (β0, α0, η0,v0) ,
H0 = (H01, · · · ,H0J ,H0s) and U0(t) fall in the interior of a compact convex set H.
2. For the time-to-event outcome, there exists a positive constant ν0 such that P (C
∗
i ≥
τ |z) ≥ ν0 almost surely.
3. The number of non-missing outcomes for subject i, denoted as mi, is bounded by
some positive integer m0 and P (mi ≥ 2) > 0 with probability 1.
4. All the covariate set Zij are bounded. Further, if there exist a constant vector c
such that [1, ZTis,Z
T
ij]c = 0 almost surely, then c = 0.
5. If
U(tk)
αj = U0(tk)
α0j , j = 1, · · · , J, k = 1, · · · , K
and
∫ ∫
ev0a+v1b+
∑K
k=1 α1(a+btk)fab(a, b|η)dadb =
∫ ∫
ev
0
0ai+v
0
1bi+
∑K
k=1 α01(a+btk)fab(a, b|η0)dadb
then αj = α0j, v0 = v
0
0, v1 = v
0
1, η = η0 and U(tk) = U0(tk) for all j = 1, · · · , J, k =
1, · · · , K.
6. The score operator for (Ω, U,H) is Fre´chet differentiable at (Ω0, U0,H0) with a
continuously invertible derivative −I0. The hessian matrix In evaluated at the
true values of Ω, U , and H is positive definite, and converges in probability to a
deterministic and invertible operator I0.
The following theorems present the consistency and weak convergence for the pro-
posed NPMLE Ωˆ =
(
βˆ, αˆ, ηˆ, vˆ
)
, Hˆ = (Hˆ1, · · · , HˆJ , Hˆs) and U with details given in the
84
Appendix Section C.2.
Theorem IV.1. Let Ω0 = (β0, α0, η0,v0), U0(t) and H0(y) = (H01(y1), · · · , H0J(yJ), H0s(t))
be the true values of Ωˆ =
(
βˆ, αˆ, ηˆ, vˆ
)
, Uˆ(t) and Hˆ(y) = (Hˆ1(y1), · · · , HˆJ(yJ), Hˆs(t)), re-
spectively. Under regularity conditions, ||Ωˆ− Ω0|| → 0, ||Uˆ − U0|| → 0, supt∈[0,τ ] |Hˆs(t)−
H0s(t)| → 0 and
∑J
j=1 supyj∈Dj |Hˆj(yj)−H0j(yj)| → 0 almost surely.
Theorem IV.2. Assuming regularity conditions hold, n1/2{Ωˆ−Ω0, Uˆ(t)−U0(t), Hˆ(y)−
H0(y)} converges weakly to a zero-mean Gaussian process in Rd × RK × l∞(
∏J+1
j=1 Qj),
where Qj = {h(y) : ‖h‖BV [Dj ] ≤ 1} for j = 1, · · · , J , QJ+1 = {h(t) : ‖h‖BV [0,τ ] ≤ 1}, d is
the dimension of Ω, and ‖h‖BV [Dj ] denotes the total variation of h(·) in Dj. Furthermore,
Ωˆ and Uˆ are asymptotically efficient.
Consider a linear functional of the NPMLE Ωˆ, Uˆ and Hˆ
n1/2
{
vT (Ωˆ− Ω0, Uˆ − U0) +
J∑
j=1
∫
wjd(Hˆj −H0j) +
∫
wJ+1d(Hˆs −H0s)
}
, (4.10)
where v is real vector, wj is the vector consisting of the values of wj(·) evaluated at the
observed outcome values corresponding to the jumps of for Hˆj, and {dHˆj} is the vector
of jump sizes at the observed outcome values, for j = 1, · · · , J respectively. For each of
the j outcomes, wj(y) is in BV [Dj]; wJ+1(t) is in BV [0, τ ].
Theorem IV.3. Under regularity conditions, the linear function (4.10) converges weakly
to a zero-mean Gaussian process with variance-covariance matrix
(vT ,wT1 , · · · ,wTJ+1)I−10 (vT ,wT1 , · · · ,wTJ+1)T which can be consistently estimated by
n(vT ,wT1 , · · · ,wTJ+1)I−1n (vT ,wT1 , · · · ,wTJ+1)T , where In is the negative Hessian matrix of
the observed log-likelihood function with respect to Ωˆ, Uˆ and the jump sizes of (Hˆ1, · · · , HˆJ , Hˆs).
If we are primarily interested in Ω, the profile likelihood method (Murphy and Van der
Vaart (2000)) can be used. Let lpr(Ω) = `n(Ω, Uˆ(Ω), Hˆ(Ω)|Y,Z) be the profile log-
likelihood function for Ω.
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Theorem IV.4. Assuming the regularity conditions hold, for εn = Op(n
−1/2) and any
vector v, −{lpr(Ωˆ + εnv)−2lpr(Ωˆ) + lpr(Ωˆ− εnv)}/nε2n converges in probability to vTΣ−1v,
where Σ is the asymptotic covariance matrix of
√
n(Ωˆ− Ω0).
The profile likelihood lpr(Ω) can be calculated via the EM-DCA algorithm by holding Ω
fixed. The negative second-order numerical difference of the profile log-likelihood function
at Ω is used to estimate the inverse covariance matrix. Specifically, the (i, j)th element
of the inverse covariance matrix can be consistently estimated by
−{lpr(Ωˆ + εnei + εnej)− lpr(Ωˆ + εnei − εnej)− lpr(Ωˆ− εnei + εnej) + lpr(Ωˆ)}/ε2n
where ei and ej are the i
th and jth canonical basis vectors respectively. Theorem IV.4
can be verified by closely following the lines of Zeng and Lin (2010) Section 9 and Murphy
and Van der Vaart (2000).
4.5 Simulation Study
A Monte Carlo simulation study was conducted to examine the finite-sample perfor-
mance of the parameter estimates obtained by the proposed model.
For each time point t = 0, 1, 2, 3, we generated two continuous outcome Y2, Y6, and four
ordinal outcomes Y1, Y3, Y4 and Y5, each with five levels, from the conditional cumulative
probability function. The continuous outcome was generated using inverse CDF transform
sampling. The ordinal outcomes were generated by random sampling with level-specific
probability.
The simulation settings are as follows. The true population average disease trajectory
is specified as U(t) = exp(0.5t). The shared latent variable ai was generated from a
log-Gamma distribution with subject-specific shape eη1Zi3 and rate eη2Zi3 where the true
parameter values are specified as η1 = 1 and η2 = 1.7. The shared latent variable bi was
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generated from a log-Gamma(η3, η3) distribution with the true η3 = 2. We consider three
covariates: Zi1 ∼ N(0, 1), Zi2 ∼ Binom(0.5) and Zi3 ∼ Binom(0.5). The true Hj(y) = 1
2
y2
for j = 2, 6 and the true Hj(y) =
1
4
y2 for j = 1, 3, 4, 5. The covariate effect for each
outcome is of the following forms: γi1 = 1, γi2 = e
β2Zi2 , γi3 = e
β3Zi3 , γi4 = e
β4Zi1 , γi5 =
eβ5Zi2 , γi6 = e
β6Zi3 , where the true parameters are β2 = 1, β3 = −0.5, β4 = −1, β5 = 1 and
β6 = 0.5. The true factor loading parameters are α1 = 1, α2 = 0.8, α3 = 0.6, α4 = 1, α5 =
1 and α6 = 1.
A single simulated dataset consists of longitudinal outcomes and corresponding co-
variates as {Yijk, Zij} for i = 1, · · · , n, j = 1, · · · , 6, k = 1, · · · , 4 with time points at
t1 = 0, t2 = 1, t3 = 2, t4 = 3. We examined the performance of estimation for the pro-
posed model under the sample size of n = 100 and n = 200; each was replicated 500
times. Standard errors were obtained from the numerically evaluated Hessian matrix at
the solution.
The results of the simulation study are summarized in Table 4.1. The proposed estima-
tion and inference procedures perform well with diminishing bias as sample sizes increases,
and coverage probability at 95% nominal level. With the larger sample size, we see better
agreement between empirical standard deviation (ESD) and asymptotic average standard
errors (ASE). This suggests that the asymptotic approximation of the covariance matrix
from the profile likelihood is reasonable for the sample size of n = 100 or larger.
4.6 Real Data Analysis: Pain Centrality Trajectories on Pelvic
Pain Patients
The proposed longitudinal joint modeling approach was applied to measure pain cen-
trality trait trajectory of patients undergoing hysterectomy as a treatment for pelvic
pain. The proposed model allows us to estimate the population pain centrality trajectory
over time for pelvic pain patients and further allows us to explain the heterogeneity of
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Table 4.1: Simulation results from the proposed longitudinal joint model. β1 to β6 are
regression coefficients representing the covariate effects on the outcomes Y1 to Y6, respec-
tively. α1 to α6 are factor loadings for the outcome Y1 to Y6, respectively; η1, η2 are
regression coefficient effects on the log-Gamma distribution shape and rate parameters
for the shared latent variable ai; η3 is the shape and rate parameter of the log-Gamma
distribution for the shared latent variable bi. All the outcomes Y1 to Y6 are generated at
time points t = 0, 1, 2, 3. The results are based on 500 simulated datasets with sample
size of n = 100 and n = 200.
n Outcome Type parameter Truth Avg. est. ESD ASE 95% CP
100 Y1 ordinal β1 0
Y2 continuous β2 1 1.01 0.20 0.20 0.94
Y3 ordinal β3 -0.5 -0.52 0.20 0.20 0.95
Y4 ordinal β4 -1 -1.01 0.13 0.13 0.95
Y5 ordinal β5 1 1.02 0.24 0.23 0.94
Y6 continuous β6 0.5 0.51 0.21 0.21 0.95
Y1 ordinal α1 1
Y2 continuous α2 0.8 0.80 0.09 0.09 0.94
Y3 ordinal α3 0.6 0.61 0.09 0.09 0.95
Y4 ordinal α4 1 1.00 0.12 0.12 0.95
Y5 ordinal α5 1 1.01 0.13 0.12 0.94
Y6 continuous α6 1 1.00 0.12 0.11 0.94
ai shape η1 1 1.14 0.50 0.46 0.97
latent variable rate η2 1.7 1.85 0.59 0.56 0.97
bi shape/rate η3 2 2.05 0.44 0.43 0.95
200 Y1 ordinal β1 0
Y2 continuous β2 1 1.01 0.14 0.14 0.96
Y3 ordinal β3 -0.5 -0.50 0.15 0.14 0.94
Y4 ordinal β4 -1 -1.01 0.09 0.09 0.96
Y5 ordinal β5 1 1.01 0.15 0.16 0.96
Y6 continuous β6 0.5 0.50 0.15 0.15 0.95
Y1 ordinal α1 1
Y2 continuous α2 0.8 0.80 0.07 0.07 0.95
Y3 ordinal α3 0.6 0.60 0.06 0.06 0.94
Y4 ordinal α4 1 1.00 0.09 0.09 0.95
Y5 ordinal α5 1 1.01 0.09 0.09 0.95
Y6 continuous α6 1 1.00 0.08 0.08 0.96
ai shape η1 1 1.06 0.30 0.29 0.97
latent variable rate η2 1.7 1.76 0.38 0.35 0.95
bi shape/rate η3 2 2.05 0.32 0.30 0.95
Avg. est.: average of Monte Carlo estimates of the true parameter values over the 500 simulations
ESD: empirical standard deviation based on Monte Carlo estimates
ASE: average of numerically estimated standard errors
95% CP: 95% coverage probability
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patients’ longitudinal outcomes by estimating patient-specific pain centrality disease pro-
gression measure over time. The proposed joint shared variable model uses ad-hoc 2011
Fibromyalgia (FM) Survey Criteria (designed to characterize a similar latent construct)
as the baseline instrument (Y1), and extracts information from three other pain centrality
relevant outcomes.
The study sample consists of n = 160 female pelvic pain patients. We consider four
longitudinal responses of mixed scales collected prior to hysterectomy, at one month after
hysterectomy, and at three months after hysterectomy. Fibromyalgia (FM) Survey Cri-
teria score was included as the baseline instrument (Y1). Opioid use (OME), BPI pain
severity score, and BPI surgical pain score are the other three pain centrality relevant
outcomes included in the model.
The distribution of each outcome is presented in Figure 4.1. All of them are right-
skewed, however, the degree of skewness is different among different outcomes. Notice
that 90% of the longitudinal opioid use measurements are 0. One patient had extremely
heavy opioid use of 120 at baseline and one month after hysterectomy, and the usage
increased to 135 three months after hysterectomy. Our model is robust to outliers across
all times because of nonparametric transformation of the observable outcomes. While
analysis results from traditional latent variable models with pre-specified link may be
dominated by influential outlier trajectories.
We include age centered at 47 years old as a covariate for all the responses in our
model. The unit for age is per 20 years. The subject-specific latent trait at baseline, ai, is
assumed to follow a log-Gamma
(
eη1Agei , eη2Agei
)
distribution. The subject-specific disease
progression rate bi is assumed to follow a log-Gamma(η3, η3) distribution. The estimation
results of the proposed longitudinal joint latent trait model are shown in Table 4.2.
From the estimation results, we see that younger people feel more overall pain in this
sample. In addition, age has significant effects on the rate parameters of the baseline
latent trait distribution. The factor loadings are all close to 1, implying the FM score,
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Figure 4.1: Distribution of longitudinal pain responses: Fibromyalgia (FM) Survey Cri-
teria score, Opioid use, BPI pain severity score, and BPI surgical pain score. All of them
are right-skewed but with different degrees of skewness. Notice that 90% of the opioid use
measurements are 0. One patient has extremely heavy opioid use over time: 120 prior to
and at one month after hysterectomy, and 135 at three month after hysterectomy
opioid usage, BPI pain severity and BPI surgical pain contribute approximately equally
to the construct of latent trait trajectory.
The model predicted subject-specific latent variable log(Ui(t)) represents how pain-
uncentralized a person is at time t, with − log(Ui(t)) representing pain centrality at time
t. To see the relationship between the model-based pain centrality score and pain re-
lated responses in the model, Figure 4.2 shows a set of scatter plots of model-based pain
centrality score predictions versus Fibromyalgia Survey Criteria (first row), opioid use
(second row), BPI overall pain severity (third row), and BPI surgical pain (fourth row)
at the baseline, at one month after hysterectomy, and at three months after hysterec-
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Table 4.2: Parameter estimates, factor loadings, standard error and p-value from analysis
of n = 160 female pelvic pain patients with responses measured prior to hysterectomy,
one month after hysterectomy, and three months after hysterectomy. The unit for age is
per 20 years. Age is centered at 47 years old.
Response Covariate Param Est Standard Error p
Fibromyalgia survey criteria Age 0
Opioid use Age −0.514 0.356 0.149
BPI pain severity Age −0.737 0.249 0.003
BPI surgical pain Age 0.054 0.291 0.853
Response Factor loading Standard Error p
Fibromyalgia survey criteria 1
Opioid use 0.897 0.153 < 0.0001
BPI pain severity 1.182 0.131 < 0.0001
BPI surgical pain 1.055 0.139 < 0.0001
Latent trait distribution parameter Covariate Param Est Standard Error p
η1 Age 0.020 0.299 0.947
η2 Age −0.828 0.401 0.039
η3 2.934 0.716
tomy. The model-based pain centrality score is positively correlated with Fibromyalgia
Survey Criteria, opioid use, BPI overall pain severity, and BPI surgical pain across all
time points. For people with low centrality and low pain, there is still a nice resolution to
the positive correlation between model-based centrality and all four pain responses across
all time points.
Figure 4.3 shows a set of scatter plots of Fibromyalgia Survey Criteria versus the
model-based pain centrality score (first row), opioid use (second row), BPI overall pain
severity (third row), and BPI surgical pain (fourth row) at the baseline, at one month
after hysterectomy, and at three months after hysterectomy. The Fibromyalgia Survey
Criteria is positively correlated with the model-based pain centrality score, opioid use,
BPI overall pain severity, and BPI surgical pain across all time points, but the correlation
with the observed phenotype outcomes is not as strong compared to the mode-based pain
centrality. Compared to the Fibromyalgia Survey Criteria, the model-based centrality
score in general is better aligned with BPI overall pain severity and BPI surgical pain.
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Figure 4.2: Scatterplots of the model-based pain centrality score − log(Ui(t)) vs. Fi-
bromyalgia Survey Criteria (first row), opioid use (second row), BPI overall pain severity
(third row), and BPI surgical pain (fourth row) at the baseline, one month after hysterec-
tomy, and three months after hysterectomy.
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From both Figure 4.2 and Figure 4.3, we see that there is generally more variability
and less correlation at one month after hysterectomy between centrality and pain related
responses, as compared to other time points. This is probably because of the noise induced
by transient acute pain effects soon after the surgery.
Figure 4.4 shows the trajectory of the model-based pain centrality score − log(Ui(t))
over time grouped by quartiles of the predicted subject-specific baseline score −ai. Pa-
tients were grouped into four equal sized clusters based on the predicted 1st quartile (Q1),
the median (Q2) and the 3rd quartile (Q2) of baseline scores −ai. Groups are labeled
based on baseline score as follows. ”High”: −ai ≥ Q3; ”Medium High”: Q2 ≤ −ai < Q3;
”Medium Low”: Q1 ≤ −ai < Q2; ”Low”: −ai < Q1. The black triangle points represent
the sample mean of the predicted measure at each time point. From Figure 4.4 we can
see that on average pain centrality decreases over time. However, there is large variability
in the pain centrality trajectory for people who are more central at baseline.
Figure 4.5 shows the trajectory of the Fibromyalgia Survey Criteria (FM) over time
grouped by quartiles of the baseline FM. We can see that for baseline ”High”, ”Medium
High”, and ”Medium Low” groups, the FM decreases over time on average, which is
consistent with the model-based centrality score. However, for the ”Low” baseline group,
on average the FM goes up at one month and decreases at three month after hysterectomy,
while the mode-based centrality score decreases all the way for the ”Low” group. This may
imply that model-based centrality is more sensitive to sub-clinical centrality compared to
FM. This is expected because FM is designed for the diagnosis of fibromyalgia where
substantial widespread pain is a classic symptom. Similar to model-based centrality,
we also see greater variability in the FM trajectory for people who have high FM at
baseline. Even though Figure 4.4 and Figure 4.5 convey similar messages over time, the
FM trajectory in Figure 4.5 is a lot noisier than the model-based trajectory in Figure
4.2, implying the model-based centrality trajectory summarizes the longitudinal pain
information more precisely compared to the FM score.
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Figure 4.3: Scatterplots of Fibromyalgia Survey Criteria versus model-based pain central-
ity score (first row), opioid use (second row), BPI overall pain severity (third row), and
BPI surgical pain (fourth row) at the baseline, one month after hysterectomy, and three
months after hysterectomy.
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Figure 4.4: Model-based pain centrality trajectory − log(Ui(t)) by baseline score −ai.
Patients were grouped into four equal sized clusters based on the 1st quartile (Q1), median
(Q2) and the 3rd quartile (Q2) of baseline scores−ai. Groups are labeled based on baseline
score as follows: ”High”: −ai ≥ Q3; ”Medium High”: Q2 ≤ −ai < Q3; ”Medium Low”:
Q1 ≤ −ai < Q2; ”Low”: −ai < Q1. The black triangle points represent the sample mean
at each time point.
4.7 Discussion
In this article, we proposed a flexible joint model framework for multiple longitudinal
outcomes of mixed scales and time-to-event data, incorporating shared latent trait trajec-
tory. A logistic link is used to accommodate nonparametrically transformed continuous,
ordinal, count, multinomial outcomes. A proportional odds survival model is used to
model the survival data. We provided an example of using the random effects to link be-
tween the survival outcome and the longitudinal responses of mixed types. However, our
joint modeling framework is flexible in the association structure between longitudinal and
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Figure 4.5: Fibromyalgia Survey Criteria (FM) trajectory by baseline FM score. Patients
were grouped into four equal sized clusters based on the 1st quartile (Q1), median (Q2)
and the 3rd quartile (Q2) of baseline FM. Groups are labeled based on baseline FM score
(FM0) as follows: ”High”: FM0 ≥ Q3; ”Medium High”: Q2 ≤ FM0 < Q3; ”Medium
Low”: Q1 ≤ FM0 < Q2; ”Low”: FM0 < Q1. The black triangle points represent the
sample mean at each time point.
survival outcomes. Hickey et al. (2016) and Rizopoulos (2012) provided a comprehensive
discussion of different association structures that can be potentially incorporated into our
model. In addition, the proposed joint model has the flexibility to extend to multiple
correlated event times data or a competing risk data.
The resulting parametric and nonparametric estimators are n−1/2 consistent and asymp-
totically normal. The form of the subject-specific latent trait trajectory Ui(t) enjoys a
flexible nonparametric specification. We provided an example of using random effects
of time to describe the trajectory. However, the latent trait trajectory can be modeled
as a stochastic process. One advantage of a joint model is that our model is robust to
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unbalanced longitudinal data and we can estimate subject-specific latent trait trajectory
even when some of the outcomes are missing.
We have devised numerically efficient and stable estimation and inference procedures
based on the maximum likelihood, EM algorithm, DCA algorithm, and classical optimiza-
tion procedures applied to a finite dimensional profile likelihood. These methods allowed
us to conduct a simulation study and to study the dynamic latent trait of pain centrality
in patients undergoing hysterectomy. We developed a model-based measurement of the
latent trait as a subject-specific function predicted using the model, given the multivariate
longitudinal phenotype observed on the subject. Compared to the ad-hoc Fibromyalgia
score proposed earlier to characterize pain centrality, our model-based measure of the
latent trait is better correlated with pain responses, and is more sensitive in less central
patients who experience less pain.
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CHAPTER V
Conclusion
Latent variable models have been extensively employed to study the unobservable
subject-specific trait and to account for the unobserved heterogeneity between subjects.
Existing cure models are limited to modeling static cure status. Most of the latent trait
models that accommodate multivariate responses of different scales either were developed
under Gaussian framework or require explicitly specified link within exponential family.
In this dissertation, we constructed a dynamic cure model that allowed the cure status
to change over time. We also proposed a flexible shared latent variable model to ac-
commodate nonparametrically transformed continuous, ordinal, count, multinomial and
time-to-event outcomes, under cross-sectional and longitudinal settings. The proposed
share latent variable models do not rely on Gaussian assumption and is generic regard-
ing the distribution of the latent variable. The methods proposed in this dissertation
represents a contribution to statistical methodology useful for latent variable models,
specifically the relaxation of parametric assumptions in statistical models.
Regarding the dynamic cure modeling framework, we modeled the conditional hazard
function for terminal event as a change-point function driven by the latent event of cure
as an illustrative example. In general, any stochastic hazard process U(t) that has an
absorbing boundary of 0 leads to a cure model. The proposed model framework has the
flexibility to incorporate a wide variety of dynamic cure models. We model the time to
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cure and time to failure with a proportional hazard model. Other link functions can be
naturally incorporated. Notice that if the time to cure model is itself a cure model, the
baseline hazard for cure H2 is bounded, and the cure event may not happen. Predicting
something that is fully unobserved, such as the time to cure, should be treated with
caution because the model typically has less power for parameters associated with latent
components. However, the model-based predictions represent a useful tool to generate
hypotheses on the latent effects and to guide further confirmatory studies pursuing more
explicit measurements.
The shared latent variable models developed in this dissertation provide a flexible sta-
tistical framework to joint modeling nonparametrically transformed continuous, ordinal,
count, multinomial and time-to-event responses. As an example, we consider only one
latent factor in our model. However, our model can be extended to allow for multiple fac-
tors. Extra care should be exercised regarding model identifiability and factor selections.
Under the longitudinal setting, we provided an example of using the random effects to link
between the survival outcome and the longitudinal responses of mixed types. However,
our joint modeling framework is flexible in the association structure between longitudinal
and survival outcomes. In addition, the proposed joint model has the flexibility to extend
to multiple correlated event times data or a competing risk data. In addition, the form of
the subject-specific latent trait trajectory Ui(t) enjoys a flexible nonparametric specifica-
tion. We provided an example of using random effects of time to describe the trajectory.
However, the latent trait trajectory can be modeled as a stochastic process. One advan-
tage of a joint model is that our model is robust to unbalanced longitudinal data and we
can estimate subject-specific latent trait trajectory even when some of the outcomes are
missing. Application to hysterectomy patient data indicated that the proposed method
can offer an improved model-based measurement of the latent trait that better utilizes the
information encoded in the multivariate multi-scale observed phenotype. Compared to
the ad-hoc Fibromyalgia score proposed earlier to characterize pain centrality, our model-
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based measure of the latent trait is better correlated with pain responses, and is more
sensitive in less central patients who experience less pain.
Although we illustrated the proposed models using examples in cancer and pain re-
searches, these models can potentially be adapted to a wide spectrum of problems. Pre-
cise measurement of subject-specific latent trait that account for population heterogeneity
certainly play an important role in precision medicine. The methods in this dissertation
enables us to characterize the effect of dynamic factor on latent cure process, to extract
useful information from a variety of observable responses, to explain the unobserved het-
erogeneity, to make prediction and react to potential future trait progression. We hope
that this dissertation contributes to statistical methods for cure models and has broader
relevance in the statistical literature on latent variable models.
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APPENDIX A
A Semiparametric Joint Survival Model with A
Time-Dependent Cure Process
A.1 Joint and Marginal Distributions of Proposed Model
Based on the proposed model hazard functions (2.3) and (2.4), we can show the
following model quantities:
1. The marginal density function and survival function of time to cure Tu:
fTu(tu) = η(tu)h2(tu)e
− ∫ tu0 η(x)dH2(x)
STu(tu) = e
− ∫ tu0 η(x)dH2(x)
2. The conditional density function and conditional survival function of time to failure
T given Tu:
f(t | Tu) = 1(Tu > t)θ(t)h1(t)e−
∫ t
0 θ(x)dH1(x)
S(t | Tu) = e−
∫ t
0 1(Tu>x)θ(x)dH1(x)
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3. The joint density function of time to failure and time to cure (T, Tu):
fT,Tu(t, tu) = f(t | Tu)fTu(tu)
= 1(Tu > t)θ(t)η(tu)h1(t)h2(tu)e
− ∫ t0 θ(x)dH1(x)e− ∫ tu0 η(x)dH2(x)
4. The marginal density and survival function of time to failure T :
f(t) = E {f(t | Tu)}
=
∞∫
t
θ(t)h1(t)e
− ∫ t0 θ(x)dH1(x)η(tu)e− ∫ tu0 η(x)dH2(x)dH2(tu)
= θ(t)h1(t)e
− ∫ t0 θ(x)dH1(x)e− ∫ t0 η(x)dH2(x)
S(t) = E {S(t | Tu)}
=
∞∫
t
η(tu)e
− ∫ t0 θ(x)dH1(x)e− ∫ tu0 η(x)dH2(x)dH2(tu)+
t∫
0
η(tu)e
− ∫ tu0 θ(x)dH1(x)e− ∫ tu0 η(x)dH2(x)dH2(tu)
= e−
∫ t
0 θ(x)dH1(x)e−
∫ t
0 η(x)dH2(x)+
t∫
0
η(tu)e
− ∫ tu0 θ(x)dH1(x)e− ∫ tu0 η(x)dH2(x)dH2(tu)
A.2 Prediction of Survival Function for The Onset of Cure
From prediction perspective, we are interested in the conditional survival function of
the onset of cure given observed information. The prediction is given to those who do
not experience the failure event (δ = 0). Given observed data (X, δ = 0) and estimates
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of η, θ, {dH1}, and {dH2}, the survival function of time to cure Tu can be derived as
STu(tu|X, δ = 0) =
∫∞
tu
L0(s)η(s)e
− ∫ s0 η(y)dH2(y)dH2(s)∫∞
0
L0(s)η(s)e
− ∫ s0 η(y)dH2(y)dH2(s) , (S.1)
where L0 is the complete data likelihood (2.9) assuming Tu is known.
Consider a subject who is censored at time X. Note the denominator of (S.1) is the
expectation of the conditional survival function (2.5) with respect to Tu. Therefore, the
denominator of (S.1) is the marginal survival function (2.7). The numerator of (S.1) can
be derived under two conditions below:
1. As tu ≤ X,
∞∫
tu
L0(s)η(s)e
− ∫ s0 η(y)dH2(y)dH2(s)
=
∞∫
X
η(s)e−
∫X
0 θ(y)dH1(y)e−
∫ s
0 η(y)dH2(y)dH2(s) +
X∫
tu
η(s)e−
∫ s
0 θ(y)dH1(y)e−
∫ s
0 η(y)dH2(y)dH2(s)
=e−
∫X
0 θ(y)dH1(y)e−
∫X
0 η(y)dH2(y) +
X∫
tu
η(s)e−
∫ s
0 θ(y)dH1(y)e−
∫ s
0 η(y)dH2(y)dH2(s)
2. As tu > X,
∞∫
tu
L0(s)η(s)e
− ∫ s0 η(y)dH2(y)dH2(s) = e− ∫X0 θ(y)dH1(y)e− ∫ tu0 η(y)dH2(y)
Combing the results in (a) and (b), we obtain the survival function for the onset of cure
Tu given a censored observation at time X as
STu(tu|X, δ = 0) =
e−
∫X
0 θ(y)dH1(y)e−
∫X∨tu
0 η(y)dH2(y) +
∫ X∨tu
tu
η(s)e−
∫ s
0 θ(y)dH1(y)e−
∫ s
0 η(y)dH2(y)dH2(s)
e−
∫X
0 θ(y)dH1(y)e−
∫X
0 η(y)dH2(y) +
∫ X
0
η(s)e−
∫ s
0 θ(y)dH1(y)e−
∫ s
0 η(y)dH2(y)dH2(s)
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A.3 Functional Derivatives
Consider a functional J(f), where f = f(x) is a function from a certain class. Define
a Fre´chet differential δs (variation of the functional) taken in the direction of a specific
function g(x | s) = 1(x > s), a unit-jump function at time x = s, where s is treated as a
parameter. Consider a one-dimensional submodel f + g that perturbs f in the direction
g by the amount of a real number . A necessary condition for J to be maximized at f is
that δsJ = 0 uniformly over s, where δs is defined as
δsJ(f, g) =
∂J(f + g)
∂
∣∣∣∣
=0, g=1(·>s)
. (S.2)
Suppose now that J
(
f¯(t)
)
=
∫ t
0
ϕ (f(x)) df(x) is a functional that depends on the
past trajectory of the function f and ϕ(y) is a differentiable function. The operator δs
differentiates over the local behavior of f at the point s, and is zero if the perturbation of
f does not occur at this location. When differentiating over the vector Ω = (β,H1, H2)
T
, we will use the differential operator ∆sJ(Ω) = (
∂J
∂β
, δsJ
(
H¯1
)
, δsJ
(
H¯2
)
), whose last
element is a function of s, and δs is with respect to H1 or H2. For the specific models
of this paper, differentiating functions and expectations of a linear functional of the form
J
(
f¯(t)
)
=
∫ t
0
ϕ (f(x)) df(x) is of interest. Applying (S.2), we have
δsJ
(
f¯(t)
)
=
∂J
(
f¯(t)
)
∂f(s)
=
t∫
0
ϕ′ (f(x)) df(x) ∂f + g
∂
∣∣∣∣
=0,g=1(x>s)
+
t∫
0
ϕ (f(x)) d
∂f + g
∂
∣∣∣∣
=0,g=1(x>s)
=
t∫
0
ϕ′ (f(x)) df(x)1(x > s) +
t∫
0
ϕ (f(x)) d1(x > s)
= 1(x > s)
 t∫
0
ϕ′ (f(x)) df(x) + ϕ (f(s))
 , s > 0
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This definition of the functional derivative corresponds to taking the derivative with
respect to a jump in H at timepoint t when H is a step function. Throughout the paper
we assume that integration and differentiation are exchangeable, and this can be verified
directly for all relevant functionals of the paper. Expression (S.2) is valid whether or not f
is a continuous or step function. In the case of step-function, s is restricted to jump points
of f to make g in the same class. Then the local functional derivative δsJ =
∂J
∂dH(s)
for
any point of jump s, which is the traditional differentiation over the jump sizes typically
used to derive Nonparametric Maximum Likelihood estimates from the log-likelihood.
This observation endows the differentiation with the meaning of δs =
∂
∂dH(s)
in the
continuous case as well.
A.4 EM Algorithm
We use the methods of EM algorithm in Tsodikov (2003) to estimate the infinite
dimensional baseline hazard function ({dH1(β)}, {dH2(β)}). Consider a single observation
data (X, δ), it’s contribution to the joint likelihood of time to failure and time to cure can
be expressed as
L0 ({dH1}, {dH2} | X, δ, Tu) f(Tu) =
[1(Tu > X)θ(X)dH1(X)]
δe−
∫X
0 1(Tu>s)θ(s)dH1(s)η(Tu)dH2(Tu)e
− ∫ Tu0 η(x)dH2(x) (S.3)
The rest of this section is organized as follows. For baseline hazard function of failure
{dH1}, we first drive the E step for the censored and failed cases respectively, then we
derive the M step to maximize the likelihood with respect to {dH1}, which results in a
closed-form expression similar to the weighted Breslow-type estimators (Chen (2009)).
The same steps were applied to the derivation of EM algorithm for baseline hazard func-
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tion of cure {dH2}. We introduce the following notations
G
(k)
1i (u, v) = e
− ∫ u0 θi(y)dH(k)1 (y)e− ∫ v0 ηi(y)dH(k)2 (y)
G
(k)
2i (u, v) =
v∫
u
ηi(x)e
− ∫ x0 θi(y)dH(k)1 (y)e− ∫ x0 ηi(y)dH(k)2 (y)dH(k)2 (x)
p
(k)
i (s) =
[
G
(k)
1i (Xi, Xi) +G
(k)
2i (s
+, Xi)
G
(k)
1i (Xi, Xi) +G
(k)
2i (0, Xi)
]1−δi
,
Ψ
(k)
i (s) = Yi(s)
[
G
(k)
1i (Xi, Xi)−G(k)1i (s, s) +G(k)2i (s,Xi)
G
(k)
1i (Xi, Xi) +G
(k)
2i (0, Xi)
]1−δi
,
µ
(k)
i (s) =
[
Yi(s)G
(k)
1i (s, s) + (1− Yi(s))G(k)1i (Xi, s)
G
(k)
1i (Xi, Xi) +G
(k)
2i (0, Xi)
]1−δi [
(1− Yi(s)) G
(k)
1i (Xi, s)
G
(k)
1i (Xi, Xi)
]δi
A.4.1 EM algorithm for {dH1}
Applying the functional derivative definition (S.2) to the joint log likelihood (S.3) with
respect to dH1(s), we obtain the conditional score function for dH1(s) as
U0,dH1(s) = δs logL0({dH1}, {dH2} | Tu) + δs log f(Tu)
=
δ1(X = s)
dH1(s)
− θ(s)1(Tu > s)1(X ≥ s)
=
dN(s)
dH1(s)
− Y (s)θ(s)1(Tu > s)
1. E step
Consider an observation censored at time X and δ = 0. The likelihood contribution
conditional on Tu is L0 = e
− ∫X0 1(Tu>y)θ(y)dH1(y). The unconditional score is
UdH1(s) = E
[
U0,dH1(s)
∥∥∥L(k)0 ] = −Y (s)θ(s)E
[
1(Tu > s)L
(k)
0
]
E
[
L
(k)
0
]
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Since E operator only involve parameters from kth iteration but not from (k + 1)th
iteration, we keep the iteration index for (k + 1)th iteration as needed, and drop
iteration index (k) for brevity. Therefore, in the rest of EM algorithm section,
any dH1 and dH2 without an iteration index implies the k
th iteration. Note the
denominator E
[
L
(k)
0
]
is the marginal survival function (2.7). The numerator of the
unconditional score is
E
[
1(Tu > s)L
(k)
0
]
= E
[
1(Tu > s)e
− ∫X0 1(Tu>y)θ(y)dH1(y)]
=
∞∫
s+
e−1(X<tu)
∫X
0 θ(y)dH1(y)−1(X≥tu)
∫ tu
0 θ(y)dH1(y)η(tu)e
− ∫ tu0 η(y)dH2(y)dH2(tu)
=
∞∫
X+
η(tu)e
− ∫X0 θ(y)dH1(y)e− ∫ tu0 η(y)dH2(y)dH2(tu)+
X∫
s+
η(tu)e
− ∫ tu0 θ(y)dH1(y)e− ∫ tu0 η(y)dH2(y)dH2(tu)
= e−
∫X
0 θ(y)dH1(y)e−
∫X
0 η(y)dH2(y)+
X∫
s+
η(tu)e
− ∫ tu0 θ(y)dH1(y)e− ∫ tu0 η(y)dH2(y)dH2(tu)
= G
(k)
1 (X,X) +G
(k)
2 (s
+, X)
Therefore, the contribution of an observation censored at time X to the uncondi-
tional score is
UdH1(s) = −Y (s)θ(s)
G
(k)
1 (X,X) +G
(k)
2 (s
+, X)
G
(k)
1 (X,X) +G
(k)
2 (0, X)
(S.4)
Now we consider an observation failed at time X and δ = 1. The likelihood con-
tribution conditional on Tu is L0 = 1(Tu > X)θ(X)dH1(X)e
− ∫X0 θ(y)dH1(y). The
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unconditional score is
UdH1(s) = E
[
U0,dH1(s)
∥∥∥L(k)0 ] = dN(s)
dH
(k+1)
1 (s)
− Y (s)θ(s)
E
[
1(Tu > s)L
(k)
0
]
E
[
L
(k)
0
]
Note the denominator E
[
L
(k)
0
]
is the marginal density function (2.8). The numer-
ator of the unconditional score is
Y (s)E
[
1(Tu > s)L
(k)
0
]
= Y (s)E
[
1(Tu > s)1(Tu > X)θ(X)dH1(X)e
− ∫X0 θ(y)dH1(y)]
=
∞∫
s+
Y (s)1(tu > X)θ(X)dH1(X)e
− ∫X0 θ(y)dH1(y)η(tu)e− ∫ tu0 η(y)dH2(y)dH2(tu)
= Y (s)
∞∫
X+
θ(X)dH1(X)e
− ∫X0 θ(y)dH1(y)η(tu)e− ∫ tu0 η(y)dH2(y)dH2(tu)
= Y (s)θ(X)dH1(X)e
− ∫X0 θ(y)dH1(y)e− ∫X0 η(y)dH2(y)
The contribution of an observation failed at time X to the unconditional score is
UdH1(s) =
dN(s)
dH
(k+1)
1 (s)
− Y (s)θ(s) (S.5)
Combing the above results (S.4) and (S.5), we obtain the marginal score function
for dH1(s) as
UdH1(s) =
dN(s)
dH
(k+1)
1 (s)
− Y (s)θ(s)
[
G
(k)
1 (X,X) +G
(k)
2 (s
+, X)
G
(k)
1 (X,X) +G
(k)
2 (0, X)
]1−δ
=
dN(s)
dH
(k+1)
1 (s)
− Y (s)θ(s)p(k)i (s)
2. M step
Suppose there are n independent observations with data (Xi, δi) for i = 1 · · ·n. The
estimator for dH
(k+1)
1 (s) can be obtained by solving
∑n
i=1 UdH1(s) = 0. The solution
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results in a Breslow-type estimator
dH
(k+1)
1 (s) =
∑n
i=1 dNi(s)∑n
i=1 Yi(s)θi(s)p
(k)
i (s)
This constitutes a self-consistent equation that can be solved iteratively (Tsodikov
(2003)).
A.4.2 EM algorithm for {dH2}
Again, we consider a single observation with data (X, δ). To derive the EM algorithm
for dH2, we first apply the functional derivative definition (S.2) to the joint log likelihood
(S.3) with respect to dH2(s) to obtain the conditional score function for dH2(s) as
U0,dH2(s) = δs logL0({dH1}, {dH2} | Tu) + δs log f(Tu)
=
1(Tu = s)
dH2(s)
− η(s)1(Tu ≥ s)
1. E step
The unconditional score for dH2 is the expectation of the conditional score function
with respect to Tu:
UdH2(s) = E
[
U0,dH2(s)
∥∥∥L(k)0 ] = 1
dH
(k+1)
2
E
[
1(Tu = s)L
(k)
0
]
E
[
L
(k)
0
] − η(s)E
[
1(Tu ≥ s)L(k)0
]
E
[
L
(k)
0
]
(S.6)
Consider an observation censored at time X and δ = 0. The likelihood contribution
conditional on Tu is L0 = e
− ∫X0 1(Tu>y)θ(y)dH1(y). The denominator E [L(k)0 ] is the
marginal survival function (2.7). One of the numerator E
[
1(Tu = s)L
(k)
0
]
can be
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derived as
E
[
1(Tu = s)L
(k)
0
]
= E
[
1(Tu = s)e
− ∫X0 1(Tu>y)θ(y)dH1(y)]
=
∞∫
0
1(tu = s)e
−1(X<tu)
∫X
0 θ(y)dH1(y)−1(X≥tu)
∫ tu
0 θ(y)dH1(y)η(tu)e
− ∫ tu0 η(y)dH2(y)dH2(tu)
=
X∫
0
1(tu = s)η(tu)e
− ∫ tu0 θ(y)dH1(y)e− ∫ tu0 η(y)dH2(y)dH2(tu)
+
∞∫
X
1(tu = s)η(tu)e
− ∫X0 θ(y)dH1(y)e− ∫ tu0 η(y)dH2(y)dH2(tu)
= 1(X ≥ s)η(s)e−
∫ s
0 θ(y)dH1(y)e−
∫ s
0 η(y)dH2(y)dH
(k)
2 (s)
+ 1(X < s)η(s)e−
∫X
0 θ(y)dH1(y)e−
∫ s
0 η(y)dH2(y)dH
(k)
2 (s)
= η(s)dH
(k)
2 (s)
[
Y (s)G
(k)
1 (s, s) + (1− Y (s))G(k)1 (X, s)
]
Therefore, the first term in (S.6) can be written as
1
dH
(k+1)
2
E
[
1(Tu = s)L
(k)
0
]
E
[
L
(k)
0
] = dH(k)2 (s)
dH
(k+1)
2 (s)
η(s)
[
Y (s)G
(k)
1 (s, s) + (1− Y (s))G(k)1 (X, s)
]
G
(k)
1 (X,X) +G
(k)
2 (0, X)
Next, we calculate the numerator expression of the second term E
[
1(Tu ≥ s)L(k)0
]
under two cases, X ≥ s and X < s, respectively.
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(a) X ≥ s;Y (s) = 1
E
[
1(Tu ≥ s)L(k)0
]
=
∞∫
s
e−1(X<tu)
∫X
0 θ(y)dH1(y)−1(X≥tu)
∫ tu
0 θ(y)dH1(y)η(tu)e
− ∫ tu0 η(y)dH2(y)dH2(tu)
=
∞∫
X+
e−
∫X
0 θ(y)dH1(y)η(tu)e
− ∫ tu0 η(y)dH2(y)dH2(tu)
+
X∫
s
η(tu)e
− ∫ tu0 θ(y)dH1(y)e− ∫ tu0 η(y)dH2(y)dH2(tu)
= e−
∫X
0 θ(y)dH1(y)e−
∫X
0 η(y)dH2(y) +
X∫
s
η(tu)e
− ∫ tu0 θ(y)dH1(y)e− ∫ tu0 η(y)dH2(y)dH2(tu)
= G
(k)
1 (X,X) +G
(k)
2 (s,X)
(b) X < s;Y (s) = 0
E
[
1(Tu ≥ s)L(k)0
]
=
=
∞∫
s
e−1(X<tu)
∫X
0 θ(y)dH1(y)−1(X≥tu)
∫ tu
0 θ(y)dH1(y)η(tu)e
− ∫ tu0 η(y)dH2(y)dH2(tu)
=
∞∫
s
e−
∫X
0 θ(y)dH1(y)η(tu)e
− ∫ tu0 η(y)dH2(y)dH2(tu)
= e−
∫X
0 θ(y)dH1(y)e−
∫ s
0 η(y)dH2(y)
= G
(k)
1 (X, s)
Combine the results (i) and (ii), we obtain the expression for the second term in
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(S.6) as
E
[
1(Tu ≥ s)L(k)0
]
E
[
L
(k)
0
] = Y (s)
[
G
(k)
1 (X,X) +G
(k)
2 (s,X)
]
+ (1− Y (s))G(k)1 (X, s)
G
(k)
1 (X,X) +G
(k)
2 (0, X)
Therefore, the contribution of a censored observation at time X to the unconditional
score for dH2 can be written as
UdH2(s) =
dH
(k)
2 (s)
dH
(k+1)
2 (s)
η(s)
[
Y (s)G
(k)
1 (s, s) + (1− Y (s))G(k)1 (X, s)
]
G
(k)
1 (X,X) +G
(k)
2 (0, X)
− η(s)
Y (s)
[
G
(k)
1 (X,X) +G
(k)
2 (s,X)
]
+ (1− Y (s))G(k)1 (X, s)
G
(k)
1 (X,X) +G
(k)
2 (0, X)
= −η(s)Y (s)G
(k)
1 (X,X)−G(k)1 (s, s) +G(k)2 (s,X)
G
(k)
1 (X,X) +G
(k)
2 (0, X)
+
(
dH
(k)
2 (s)
dH
(k+1)
2 (s)
− 1
)
η(s)
Y (s)G
(k)
1 (s, s) + (1− Y (s))G(k)1 (X, s)
G
(k)
1 (X,X) +G
(k)
2 (0, X)
(S.7)
Now we consider an observation failed at time X and δ = 1. The likelihood con-
tribution conditional on Tu is L0 = 1(Tu > X)θ(X)dH1(X)e
− ∫X0 θ(y)dH1(y), so the
denominator of (S.6), E
[
L
(k)
0
]
, is the marginal density function (2.8). The term
E
[
1(Tu = s)L
(k)
0
]
can be derived as
E
[
1(Tu = s)L
(k)
0
]
= E
[
1(Tu = s)1(Tu > X)θ(X)dH1(X)e
− ∫X0 θ(y)dH1(y)]
=
∞∫
0
1(tu = s)1(tu > X)θ(X)dH1(X)e
− ∫X0 θ(y)dH1(y)η(tu)e− ∫ tu0 η(y)dH2(y)dH2(tu)
= 1(X < s)θ(X)dH1(X)e
− ∫X0 θ(y)dH1(y)η(s)e− ∫ s0 η(y)dH2(y)dH2(s)
= (1− Y (s))θ(X)dH1(X)η(s)dH(k)2 (s)G(k)1 (X, s)
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The first term in (S.6) can be written as
1
dH
(k+1)
2
E
[
1(Tu = s)L
(k)
0
]
E
[
L
(k)
0
] = (1− Y (s))η(s) dH(k)2 (s)
dH
(k+1)
2 (s)
G
(k)
1 (X, s)
G
(k)
1 (X,X)
Next, we calculate the expression of the term E
[
1(Tu ≥ s)L(k)0
]
under two cases,
X ≥ s and X < s, respectively.
(a) X ≥ s;Y (s) = 1
E
[
1(Tu ≥ s)L(k)0
]
=
=
∞∫
s
1(tu ≥ s)1(tu > X)θ(X)dH1(X)e−
∫X
0 θ(y)dH1(y)η(tu)e
− ∫ tu0 η(y)dH2(y)dH2(tu)
=
∞∫
X+
θ(X)dH1(X)e
− ∫X0 θ(y)dH1(y)η(tu)e− ∫ tu0 η(y)dH2(y)dH2(tu)
= θ(X)dH1(X)e
− ∫X0 θ(y)dH1(y)e− ∫X0 η(y)dH2(y)
= θ(X)dH1(X)G
(k)
1 (X,X)
(b) X < s;Y (s) = 0
E
[
1(Tu ≥ s)L(k)0
]
=
=
∞∫
s
1(tu ≥ s)1(tu > X)θ(X)dH1(X)e−
∫X
0 θ(y)dH1(y)η(tu)e
− ∫ tu0 η(y)dH2(y)dH2(tu)
=
∞∫
s
θ(X)dH1(X)e
− ∫X0 θ(y)dH1(y)η(tu)e− ∫ tu0 η(y)dH2(y)dH2(tu)
= θ(X)dH1(X)e
− ∫X0 θ(y)dH1(y)e− ∫ s0 η(y)dH2(y)
= θ(X)dH1(X)G
(k)
1 (X, s)
Combine the above results (i) and (ii), we obtain the expression for the second term
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in (S.6) as
E
[
1(Tu ≥ s)L(k)0
]
E
[
L
(k)
0
] = Y (s) + (1− Y (s)) G(k)1 (X, s)
G
(k)
1 (X,X)
Therefore, the contribution of an observation failed at time X to the unconditional
score for dH2 can be written as
UdH2(s) =
dH
(k)
2 (s)
dH
(k+1)
2 (s)
η(s)(1− Y (s))G(k)1 (X, s)
G
(k)
1 (X,X)
− η(s)Y (s)− η(s)(1− Y (s))G
(k)
1 (X, s)
G
(k)
1 (X,X)
= −η(s)Y (s) +
(
dH
(k)
2 (s)
dH
(k+1)
2 (s)
− 1
)
η(s)
(1− Y (s))G(k)1 (X, s)
G
(k)
1 (X,X)
(S.8)
Combing expressions (S.7) and (S.8), we obtain the unconditional score function for
dH2(s) as
UdH2(s) = −Y (s)η(s)
[
G
(k)
1 (X,X)−G(k)1 (s, s) +G(k)2 (s,X)
G
(k)
1 (X,X) +G
(k)
2 (0, X)
]1−δ
+(
dH
(k)
2 (s)
dH
(k+1)
2 (s)
− 1
)
η(s)
[
Y (s)G
(k)
1 (s, s) + (1− Y (s))G(k)1 (X, s)
G
(k)
1 (X,X) +G
(k)
2 (0, X)
]1−δ [
(1− Y (s))G(k)1 (X, s)
G
(k)
1 (X,X)
]δ
= −η(s)Ψ(k)(s) +
(
dH
(k)
2 (s)
dH
(k+1)
2 (s)
− 1
)
η(s)µ(k)(s)
2. M step
Suppose there are n independent observations with data (Xi, δi) for i = 1 · · ·n. The
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estimator for dH
(k+1)
2 (s) can be obtained by solving
∑n
i=1 UdH2(s) = 0. We have
dH
(k+1)
2 (s) =
[∑n
i=1 ηi(s)µ
(k)
i (s)
]
dH
(k)
2 (s)∑n
i=1 ηi(s)
[
µ
(k)
i (s) + Ψ
(k)
i (s)
]
The above equation solves for dH2(s) iteratively until convergence. We obtain a
consistent estimate of dH2 at convergence (Tsodikov (2003)).
A.5 Property of Martingale Transform
Let V (s) =
∫ τ
0
ε(t, s; β,H1, H2)dM(t), where ε is a predictable function such that it
does not depend on s when t < s. Consider the increment of V (s) over s
dV (t) =
τ∫
0
ε(t, s+ ds)dM(t)− ε(t, s)dM(t) =
τ∫
0
dsε(t, s)dM(t), (S.9)
where dsε(t, s) is the partial derivative of ε(t, s) with respect to s. Since M(s) is a
martingale process adapted to filtration Fs−, we know E{dM(t)|Fs−} = 1(t < s)dM(t).
Taking an expectation conditional of (S.9) on filtration,
E{dV (s)|Fs−} =
τ∫
0
E{dsε(t, s)dtdM(t)|Fs−}
=
τ∫
0
dsε(t, s)E{dM(t)|Fs−} =
s∫
0
dsε(t, s)dM(t)
Since ε(t, s) by definition is a predictable function such that it does not depend on s for
t < s, so dsε(t, s) = 0 when t < s. We have E{dV (t)|Fs−} = 0. Therefore, V (t) is a
martingale.
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A.6 Asymptotic Properties
In this section we provide the technical details to present the consistency and weak con-
vergence properties for the proposed NPMLE weak convergence for the proposed NPMLE
Ωˆ =
(
βˆ, {dHˆ1}, {dHˆ2}
)
.
Let ‖ · ‖l∞[0,τ ] denote the supremum norm in [0, τ ], and ‖w‖BV [0,τ ] the total variation
of w(t) in [0, τ ]. Define Q = {w(t) : ‖w‖BV [0,τ ] ≤ 1}. Hˆ(t) =
(
Hˆ1(t), Hˆ2(t)
)
may be
regarded as bounded linear functional in l∞[Q] × l∞[Q], and
{
βˆ − β0, Hˆ(t)−H0(t)
}
a
random element in the metric space Rp × l∞(Q) × l∞(Q), where p is the dimension of
β0. We denote H as the compact convex set in the metric space Rp × l∞(Q) × l∞(Q)
where Ω0 ∈ H. By Fleming and Harrington (1991) (p289-p290), the following regularity
conditions are required to establish asymptotic properties of NPMLE.
(1) The true Hk, k = 1, 2, is strictly increasing and continuously differentiable. The true
value of parameter set Ω = (β,H1, H2) falls in the interior of the compact convex
set H.
(2) The covariate process zk(t), k = 1, 2, are left continuous with total bounded vari-
ation (BV) within [0, τ ], with probability one. Also, zk(t), k = 1, 2 are linearly
independent in the sense that, if there exist a(t) and c such that a(t) + cTz(t) = 0
with probability one, then a(t) = 0 and c = 0.
(3) With probability one, E(Y (τ)|z1(t), z2(t)) > 0, P (δ = 0, T = τ |z1(t), z2(t)) > 0.
The at risk set Y (t) will not shrink to empty.
(4) The score operator for Ω is Fre´chet differentiable at Ω0 with a continuously invertible
derivative −I0. The hessian matrix In evaluated at the true values of H and β
is positive definite, and converges in probability to a deterministic and invertible
operator I0.
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A.6.1 Proof of Proposition II.1
To establish consistency of NPMLE of Ω, i.e., ‖Hˆ1(t) − H1(t)0‖l∞(Q) p→ 0, ‖Hˆ2(t) −
H2(t)
0‖l∞(Q) p→ 0 and |βˆ − β0| p→ 0, we assume the above regularity conditions (1)-(4)
hold. In addition, we need to verify the following two conditions hold:
(a) identifiability condition:The model is identifiable in the sense that Λ = Λ0 uniformly
over Ω implies Ω = Ω0. Then for any sequence Ωn ∈ H, the compact convex set in the
metric space Rp × l∞(Q)× l∞(Q), lim infn→∞ `(Ωn) ≥ `(Ω0) implies ‖Ωn −Ω0‖ p→ 0.
(b) uniform convergence condition: for any Ω ∈ H we have uniform convergence, i.e.,
sup
Ω∈H
|`n(Ω)− `(Ω)| p→ 0.
Since `n(Ωˆ) = supΩ∈H `n(Ω) + op(1), based on Theorem 2.12 in Kosorok (2008), given
that the regularity conditions (1)-(4), identifiability condition and uniform convergence
condition hold, we have the consistency of NPMLE: ‖Ωˆ− Ω0‖ p→ 0.
We verify these conditions in the following steps:
To verify the identifiability condition, we need to make use of the large sample limit of
the likelihood. Let F (t) be the crude cumulative density function of failure in the presence
of censoring, and R(t) be the crude survival function in the presence of censoring. The true
function of F (t) and R(t) are denoted as F0(t) and R0(t). The model hazard function is a
function of Ω and can be denoted as dΛ(t) = γ
(
t; β,H1(t), H2(t)
)
dH1(t) = γ(t; Ω)dH1(t).
Notice the fact that dF (t) = R(t)dΛ(t). Denote the true value of Ω as Ω0. The true
likelihood as a function of Ω can be written as
`(Ω,Ω0) = E
τ∫
0
[
log dΛ(t)dF 0(t)−R0(t)dΛ(t)] ,
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where the expectation is taken with respect to the covariate process z(t) = (z1(t), z2(t)).
Consider the negative ”true” Kullback-Leibler distance, i.e.,
D = `(Ω,Ω0)− `(Ω0,Ω0),
The distance can be written as
D = E
τ∫
0
(
log
dΛ(t)
dΛ0(t)
− dΛ(t)
dΛ0(t)
+ 1
)
dF 0(t)
Consider a non-positive convex function φ(x) = log x − x + 1. The function φ(x) has a
unique maximizer at x = 1, and max
x
φ(x) = φ(1) = 0. Notice D can be written as
D = E
τ∫
0
φ
(
dΛ(t)
dΛ0(t)
)
dF 0(t)
Therefore, D has a unique maximum when dΛ(t) = dΛ0(t) uniformly over Ω. Under an
identifiable model this means D has a unique maximum at Ω0.
Since maximizing D is equivalent to maximizing likelihood `(Ω,Ω0), and D has a
unique maximum, therefore, Ω0 = argmaxΩ∈H`(Ω) is unique. We assume the model
`(Ω,Ω0) is identifiable in the sense that Λ = Λ0 uniformly over Ω implies Ω = Ω0 uniformly.
Furthermore, since Λ is assumed to be a continuous and differentiable functional of H,
so is the likelihood function `(Ω). Based on Lemma 14.3 of Kosorok (2008), we have
lim infn→∞ `(Ωn) ≥ `(Ω0), i.e., the identifiability condition holds.
To verify the uniform convergence condition, we need to make use of the uniform law
of large numbers for the empirical process. If the regularity condition (1) holds, Ω is in
the class of functions of bounded variation with integrable envelope, and so the hazard
function H1(t) and H2(t) are bounded. Therefore, H is in a Glivenko-Cantelli class whose
ε-entropy with bracketing number is bounded by A/ε, where A is a constant. Since the
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functionals Λ and `(Ω) are assumed continuous and the envelope of Ω is integrable, the
integrand in `(Ω) is also Glivenko-Cantelli by the preservation theorems. Therefore, we
may apply the uniform law of large numbers for the empirical process to the sequence Dn,
the limited sample counterpart of D as
Dn = `n(Ω,Ω
0)− `n(Ω0,Ω0),
where
`n(Ω,Ω
0) = n−1
n∑
i=1
τ∫
0
{[log γi(t; Ω) + log dHt]dNi(t)− Yi(t)γi(t; Ω)dH1(t)}
such that
sup
Ω∈H
|Dn(Ω)−D(Ω)| p→ 0
sup
Ω∈H
|`n(Ω)− `(Ω)| p→ 0.
Therefore the uniform convergence condition holds.
A.6.2 Proof of Proposition II.2
Theorem II.2 can be proved by the martingale theory applied to the score functions
(2.12), (2.13) and (2.14). We know the proposed NPMLE Ωˆ solves the score equation
U(Ω) = 0 where U(Ω) = (Uβ, UH1(s), UH2(s))
T is the score functions for parameter set Ω.
Let Ω0 be the set of true parameters. Since U(Ω0) are martingales, by the martingale cen-
tral limit theory n−1/2U(Ω0) converges weakly to V (Ω) = (Vβ, VH1(s), VH2(s))
T , where Vβ is
a zero-mean normal random variable and VH1(s), VH2(s) are zero-mean Gaussian processes.
The variance-covariance function of (Vβ, VH1(s), VH2(s)) can be derived below.
The predictable variation process for the score process n−1/2UHk(s), k = 1, 2, (equations
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(2.12) and (2.13)) is
n−1
n∑
i=1
τ∫
0
ε2ki(t, s; β,H1, H2)Yi(t)γi
(
t; β,H1(t), H2(t)
)
dH1(t),
for k = 1, 2, respectively.
An n → ∞, the martingale score process n−1/2UHk(s), k = 1, 2, converges weakly to a
zero-mean Gaussian process VHk(s), k = 1, 2 with covariance function
σ2Hk(s, u; β
0, H01 , H
0
2 ) =
ξ∫
0
εk(t, s; β,H
0
1 , H
0
2 )εk(t, u; β,H
0
1 , H
0
2 )P (T ≥ t)γi
(
t; β,H1(t), H2(t)
)
dH01 (t),
for s, u ∈ [0, τ ].
Similarly, as n → ∞, the martingale score process n−1/2Uβ converges weakly to a
zero-mean Gaussian process Vβ with covariance
σ2β(β
0) =
τ∫
0
γ˙2i,β
(
t; β0, H1(t), H2(t)
)
γi
(
t; β0, H1(t), H2(t)
) P (T ≥ t)dH1(t)
As n→∞, n−1/2U(H0k(t), β0), for some t and k = 1, 2, is a martingale and converges
to a zero-mean Gaussian process with deterministic covariance function
σ2Hk,β(s; β0, H
0
1 , H
0
2 ) =
τ∫
0
εk(t, s; β0, H
0
1 , H
0
2 )γ˙i
(
t; β,H1(t), H2(t)
)
P (T ≥ t)dH01 (t).
Let the normalized likelihood `/n converges in probability to `0 and U0 =
(
∂`0
∂β
, ∂`
0
∂dH(t)
)T
,
dH(t) = (dH1(t), dH2(t)). Introduce an integral equation operator with respect to (Ωˆ−Ω0)
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as follow
I0(t, s) = ∂U
0
∂Ω
= −
 ∂2`0∂β∂βT ∂2`0∂β∂dH(s)
∂2`0
∂dH(t)∂βT
∂2`0
∂dH(t)∂dH(s)

Ω=Ω0
,
where Ω0 = (β0, H0t ). The operator I0 acts on an arbitrary vector-function element
Ωs = (β, dH(s))
T as follow
I0(t, s)Ωs = −
 ∂2`0∂β∂βT β + ∂2`0∂β∂dH(s)dH(s)
∂2`0
∂dH(t)∂βT
β + ∂
2`0
∂dH(t)∂dH(s)
dH(s)

Ω=Ω0
Expand the score Ut(Ωˆ) at the true value of parameter set Ω
0, we have
n1/2Ut(Ωˆ) = V (t)− n−1/2I0(t, s)(Ωˆ− Ω) + op(1)
Since Ut(Ωˆ) = 0, we have
n−1/2I0(t, s)(Ωˆ− Ω) = V (t) + op(1) (S.10)
Assume that the Fredholm operator expressed by the kernel I0 of the Fredholm integral
equation (S.10) of the first kind is square integrable, and that the equation I0Ω = 0 has
only the trivial solution Ω = 0. By Theorem 3.3.1 of Van Der Vaart and Wellner (1996),
equation (S.10) has the unique solution, and there exists the inverse information operator
I−10 (t, s) such that
n1/2(Ωˆ− Ω0) = n−1/2(I0)−1V (t) + op(1)
By differentiating the equation E[U(Ω0)] = 0 with respect to Ω at the true parameter
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value Ω0 we obtain the variance of the normalized score Gaussian process V (t)
I0(t, s) = −
 ∂`0∂β ∂`0∂βT ∂`0∂β ∂`0∂dH(s)
∂`0
∂dH(t)
∂`0
∂βT
∂`0
∂dH(t)
∂`0
∂dH(s)

Ω0
,
which is equivalent to the likelihood second derivatives I0. Andersen et al. (1993) showed
that for a differentiable functional F (Ω), by functional delta method, n1/2{F (Ωˆ)−F (Ω)}
converges weakly to a zero-mean Gaussian process with variance-covariance function
F˙ (Ω)T (I0)−1F˙ (Ω), where F˙ (Ω) = ∂F
∂Ω
. Apply the above functional delta method to (2.21),
and replacing I0 by its consistent estimate n−1In, we obtain the asymptotic properties
stated in Theorem II.2.
A.6.3 Proof of Proposition II.3
In this section, we show that the covariance matrix for β obtained from the profile
likelihood `pr(β) = `
(
β, dHˆ(β) = (dHˆ1(β), dHˆ2(β))
)
converges to the β submatrix of the
covariance matrix obtained from the full likelihood at the true model.
Denote the elements of information matrix from the full likelihood at the true model
as
I0(t, s) = ∂U
0
∂Ω
= −
 ∂2`0∂β∂βT ∂2`0∂β∂dH(s)
∂2`0
∂dH(t)∂βT
∂2`0
∂dH(t)∂dH(s)

Ω=Ω0
=
 Iββ IβH
IHβ IHH

Apply the general four blocks matrix inverse formula to the above information matrix, we
have the variance covariance matrix for Ω at the true model as
I−10 (t, s) =
 Q−1 −Q−1IβHI−1HH
−I−1HHIHβQ−1 I−1HH + I−1HHIHβQ−1IβHI−1HH
 ,
where Q = Iββ − IβHI−1HHIHβ.
123
We first show that the second derivative of the likelihood with respect to dH is a
consistent estimator of the true information submatrix IHH .
Denote dΛ(t) = γ
(
t; β,H1(t), H2(t)
)
dH1(t), the second partial derivative of the like-
lihood with respect to dH can be written as
∂`2
∂dH(s)dH(y)
=
1
n
n∑
i=1
τ∫
s
{
∂2 log dΛi(x)
∂dH(s)dH(y)
dNi(x)− ∂
2dΛi(x)
∂dH(s)dH(y)
Yi(x)
}
=
1
n
n∑
i=1
τ∫
s
{
∂2 log dΛi(x)
∂dH(s)dH(y)
dNi(x)− ∂
2 log dΛi(x)
∂dH(s)dH(y)
dΛi(x)Yi(x)− 1
∂dΛi(x)
∂dΛi(x)
∂dH(s)
∂dΛi(x)
∂dH(y)
Yi(x)
}
=
1
n
n∑
i=1
τ∫
s
{
∂2 log dΛi(x)
∂dH(s)dH(y)
dMi(x)− ∂ log dΛi(x)
∂dH(s)
∂ log dΛi(x)
∂dH(y)
Yi(x)dΛi(x)
}
Note that by martingale central limit theory, the process 1
n
∑n
i=1
∫ τ
s
∂2 log dΛi(x)
∂dH(s)dH(y)
dMi(x)
converges to a zero-mean Gaussian process. Therefore,
− ∂`
2
∂dH(s)dH(y)
=
1
n
n∑
i=1
τ∫
s
∂ log dΛi(x)
∂dH(s)
∂ log dΛi(x)
∂dH(y)
Yi(x)dΛi(x) + op(1)
Notice that by the weak law of large number, 1
n
∑n
i=1
∫ τ
s
∂ log dΛi(x)
∂dH(s)
∂ log dΛi(x)
∂dH(y)
Yi(x)dΛi(x)
is the consistent estimator of predictable variation process for the score function UH(s).
Therefore, − ∂`2
∂dH(s)dH(y)
is in fact a consistent estimator of the true information submatrix
IHH . From now on, we denote − ∂`2∂dH(s)dH(y) as IˆHH .
Next, we will show that the covariance matrix for β obtained from the profile likelihood
converges to Q−1, the true covariance matrix of β obtained from the full likelihood at
the true model. The first-order partial derivatives of the baseline hazard functions with
respect to β is a Jacobian matrix JHβ =
∂dHˆ(β)
∂β
. The profile score function for β can be
derived as
Uprβ =
d`pr
dβ
=
∂`
∂dH(s)
∣∣∣∣
dHˆ
∂dHˆ(s)
∂β
+
∂`pr
∂β
=
∂`pr
∂β
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Since dHˆ solves the profile score equation ∂`
∂dH(s)
= 0, so we have ∂`
∂dH(s)
∣∣∣
dHˆ
= 0.
The profile Hessian matrix can be derived as
Iprββ =−
d2`pr
dβdβT
=− ∂
∂dH(y)
(
∂`pr
∂dH(s)
∣∣∣∣
dHˆ
∂dHˆ(s)
∂β
)
∂dHˆ(y)
∂βT
− ∂
∂βT
(
∂`
∂dH(s)
∣∣∣∣
dHˆ
∂dHˆ(s)
∂β
)
− ∂
∂dH(y)
(
∂`
∂β
)∣∣∣∣
dHˆ
∂dHˆ(y)
∂βT
− ∂
2`
∂β∂βT
= − ∂
2`
∂dH(s)∂dH(y)
∣∣∣∣
dHˆ
∂dHˆ(s)
∂β
∂dHˆ(y)
∂βT
− ∂`
∂dH(s)
∣∣∣∣
dHˆ
∂2dHˆ(s)
∂β∂dH(y)
∂dHˆ(y)
∂βT
− ∂
2`
∂dH(s)∂βT
∣∣∣∣
dHˆ
∂dHˆ(s)
∂β
− ∂`
∂dH(s)
∣∣∣∣
dHˆ
∂2dHˆ(s)
∂β∂βT
− ∂
2`
∂β∂dH(y)
∣∣∣∣
dHˆ
∂dHˆ(y)
∂βT
− ∂
2`
∂β∂βT
=JβH IˆHHJHβ − 0 + JβH IˆHβ − 0 + IˆβHJHβ + Iˆββ
=JβH IˆHHJHβ + JβH IˆHβ + IˆβHJHβ + Iˆββ (S.11)
To express the Jacobian in terms of I, we make use of the fact that ∂`pr
∂dH(s)
= 0. We have
0 =
d
dβ
(
∂`pr
∂dH(s)
)
=
∂2`
∂dH(s)∂βT
∣∣∣∣
dHˆ
+
∂2`
∂dH(s)∂dH(y)
∣∣∣∣
dHˆ
∂dHˆ(y)
∂β
= −IˆHβ − IˆHHJHβ
JHβ = −Iˆ−1HH IˆHβ (S.12)
Replace the Jacobian matrix in (S.11) with the expression (S.12), we obtain the profile
Hessian matrix for β as
Iprββ = Iˆββ − IˆβH Iˆ−1HH IˆHβ
Assuming the regularity conditions hold, by the weak law of large number,
Iˆββ − IˆβH Iˆ−1HH IˆHβ
p→ Iββ + IβHI−1HHIHβ = Q
Ipr−1ββ
p→ Q−1
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The covariance matrix for β obtained from the full likelihood at true model, Q−1, can be
consistently estimated by the profile likelihood covariance operator Ipr−1ββ .
A.7 Observed Information Matrix
The observed information matrix In for the parameter set Ωˆ = (βˆ, { ˆdH1}, { ˆdH2}) can
be obtained explicitly by taking derivative of the negative score functions. For brevity, we
denote dHk(tj) = dHkj for k = 1, 2 and γi
(
t; β,H1(t), H2(t)
)
= γi (t; Ωt). We introduce
the following notation for k = 1, 2, l = 1, 2 and for the failure time t∗ ∈ (t1, . . . , tJ):
γi,Hk,Hl(t; Ωt) = Yi(t∗)
∂γ˙i,Hk (t; Ωt)
∂dHl∗
γi,β,β(t; Ωt) =
∂γ˙i,β (t; Ωt)
∂β
γi,β,Hl(t; Ωt) = Yi(t∗)
∂γ˙i,β (t; Ωt)
∂dHl∗
The explicit form of observed information matrix can be expressed as follow, for j 6= l:
IdH1jdH1j =
n∑
i=1

dNi(tj)
dH21j
+ Yi(tj)
γ˙i,H1 (tj; Ωtj) +
τ∫
t+j
γi,H1,H1 (t; Ωt) dH1(t)

−
n∑
i=1
Yi(tj)
τ∫
t+j
[
γi,H1,H1 (t; Ωt)
γi (t; Ωt)
− γ
⊗2
i,H1
(t; Ωt)
γ2i (t; Ωt)
]
dNi(t)
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IdH1jdH1l =
n∑
i=1
Yi(tj)
γ˙i,H1 (tj; Ωtj)1(tl < tj) +
τ∫
t+j ∨t+l
γi,H1,H1 (t; Ωt) dH1(t)
−
n∑
i=1
Yi(tj)
τ∫
t+j ∨t+l
[
γi,H1,H1 (t; Ωt)
γi (t; Ωt)
− γ
⊗2
i,H1
(t; Ωt)
γ2i (t; Ωt)
]
dNi(t)
IdH2jdH2j =
n∑
i=1
Yi(tj)
τ∫
t+j
γi,H2,H2 (t; Ωt) dH1(t)−
n∑
i=1
Yi(tj)
τ∫
t+j
[
γi,H2,H2 (t; Ωt)
γi (t; Ωt)
− γ
⊗2
i,H2
(t; Ωt)
γ2i (t; Ωt)
]
dNi(t)
IdH2jdH2l =
n∑
i=1
Yi(tj)
τ∫
t+j ∨t+l
γi,H2,H2 (t; Ωt) dH1(t)−
n∑
i=1
Yi(tj)
τ∫
t+j ∨t+l
[
γi,H2,H2 (t; Ωt)
γi (t; Ωt)
− γ
⊗2
i,H2
(t; Ωt)
γ2i (t; Ωt)
]
dNi(t)
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IdH1jdH2l =
n∑
i=1
Yi(tj)
γ˙i,H2 (tj; Ωtj)1(tl < tj) +
τ∫
t+j ∨t+l
γi,H1,H2 (t; Ωt) dH1(t)
−
n∑
i=1
Yi(tj)
τ∫
t+j ∨t+l
[
γi,H1,H2 (t; Ωt)
γi (t; Ωt)
− γi,H1 (t; Ωt) γi,H2 (t; Ωt)
γ2i (t; Ωt)
]
dNi(t)
IβdH1j =
n∑
i=1
Yi(tj)
γi,β(tj; Ωtj) +
τ∫
t+j
γi,β,H1 (t; Ωt) dH1(t)
−
n∑
i=1
Yi(tj)
τ∫
t+j
[
γi,β,H1 (t; Ωt)
γi (t; Ωt)
− γi,β (t; Ωt) γi,H1 (t; Ωt)
γ2i (t; Ωt)
]
dNi(t)
IβdH2j =
n∑
i=1
Yi(tj)
τ∫
t+j
γi,β,H2 (t; Ωt) dH1(t)−
n∑
i=1
Yi(tj)
τ∫
t+j
[
γi,β,H2 (t; Ωt)
γi (t; Ωt)
− γi,β (t; Ωt) γi,H2 (t; Ωt)
γ2i (t; Ωt)
]
dNi(t)
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Iββ =
n∑
i=1
Yi(tj)
τ∫
t+j
γi,β,β (t; Ωt) dH1(t)−
n∑
i=1
Yi(tj)
τ∫
t+j
[
γi,β,β (t; Ωt)
γi (t; Ωt)
− γ
⊗2
i,β (t; Ωt)
γ2i (t; Ωt)
]
dNi(t)
A.8 Gompertz Survival Model for Death from Other Causes
In Section 2.8, we consider the practical concept of cure. Modeling practical concept
of cure requires modeling residual survival for other causes from the age of prostate cancer
diagnosis. Denote Toc as the time to death from other causes from birth and Soc(t|Z) as
the survival function of Toc. Then the residual survival for other causes is
P (Toc > t+ a|Toc > a,Z) = P (Toc > t+ a|Z)
P (Toc > a|Z) =
Soc(t+ a|Z)
Soc(a|Z) = Soc(t|a, Z)
where a is the age at prostate cancer diagnosis. Without loss of generality, assume Z is
a null set. Assume age at prostate cancer diagnosis is proportional hazard covariate for
Soc(t|a).
• Under cox model framework,
Soc(t+ a)
Soc(a)
= e−[H(t+a)−H(a)], and Soc(t|a) = e−H∗(t)eβa
H(t+ a)−H(a) = H∗(t)eβa ∀a, t
• Take a = 0, the above implies H(t) = H∗(t) ∀t. Therefore we have
H(t+ a)−H(a) = H(t)eβa (A.1)
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• Solve equation (A.1) by differential equation:
H ′(a) = H ′(0)eβa
H(t) = C · (eβt − 1)
where C is a positive constant. Recognize that H(t) is a Gompertz cumulative
hazard function (characterization of Gompertz distribution).
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Table A.1: Characteristics of studied patients
One primary only Secondary cancer patients
(N=189,264) (N=11,730)
Characteristic mean (SD) or n (%)
First primary cancer
(prostate)
Age at diagnosis (yr) 66 (9.4) 69 (8.3)
Stage Localized/Regional 183,338 (96.9) 11,489 (97.9)
Distant 5,926 (3.1) 241 (2.1)
Grade* I/II 100,173 (52.9) 7,149 (60.9)
III/IV 89,091 (47.1) 4,581 (39.1)
Secondary cancer
Age at diagnosis (yr) 72 (8.3)
Stage Localized 5,626 (48.0)
Regional 2,783 (23.7)
Distant 3,321 (28.3)
Median follow-up time (months) 56 72
No. patients died of prostate cancer 8,028 (4.2) 488 (4.2)
Secondary cancer stage
Localized 180
Regional 113
Distant 195
Median follow-up time to secondary
cancer (months)
Secondary cancer stage
Localized 34
Regional 36
Distant 38
*Grade I: Well differentiated
Grade II: Moderately differentiated
Grade III: Poorly differentiated
Grade IV: Undifferentiated; anaplastic
131
Table A.2: Characteristics of secondary cancer patients
Characteristic n (%)
Median follow-up time to secondary cancer (months)
Localized 34
Regional 36
Distant 38
Median follow-up time from
secondary cancer diagnosis to death (months)
Localized 33
Regional 19
Distant 8
No. patients died of prostate cancer
Localized 180
Regional 113
Distant 195
No. patients died of other causes
Localized 1,375 (24.4∗)
Regional 1,330 (48.8)
Distant 2,256 (67.9)
*Percentage denominator: total number of death among localized secondary cancer patients
Table A.3: Frequency table of causes of death for secondary cancer patients n (%∗)
Cause of death Alive Prostate cancer Other causes Total
Secondary cancer stage
Localized 4,071 (72.4) 180 (3.2) 1,375 (24.4) 5,626 (100)
Regional 1,340 (48.1) 113 (4.1) 1,330 (48.8) 2,783 (100)
Distant 870 (26.2) 195 (6.9) 2,256 (67.9) 3,321 (100)
*row percentage
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APPENDIX B
A Semiparametric Latent Trait Model for Multiple
Mixed Continuous, Categorical, and Time-to-event
Outcomes
B.1 Proportional Odds Ratio
From the survival function (3.5), we can see that βj is the proportional odds ratio for
one unit increase in Zj on Yj, given U .
P (Yj≤yj |U,Zj=zj+1)
P (Yj>yj |U,Zj=zj+1)
P (Yj≤yj |U,Zj=zj)
P (Yj>yj |U,Zj=zj)
=
Uαje(zj+1)βjHj(yj)
UαjezjβjHj(yj)
= eβj
B.2 EM Algorithm
The EM algorithm is an efficient iterative procedure to compute the maximum like-
lihood estimate in the presence of missing data. Each iteration of the EM algorithm
consists of the E-step and the M-step. In the E-step, the missing data are estimated by
the conditional expectation given the observed data and the model parameters at the
current iteration. In the M-step, the likelihood function is maximized by substituting the
missing data with conditional expectation obtained in the E-step. Convergence is assured
since the algorithm is guaranteed to increase the likelihood at each iteration.
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Let Y be the observed data and U be the missing data. The complete data likelihood
is L0(θ) = f(Y, U |θ) where θ is the model parameter. Denote the complete data log-
likelihood as `0(θ) = logL0(θ). The conditional score function can be obtained by taking
derivative of the complete data log-likelihood U0 = ∂`0(θ)∂θ . Introduce the conditional
expectation operator E [f‖g] = E[f ·g]E[g] . The E-M algorithm at the kth iteration consists of
the following E-step and M-step:
1. E-step:
Determine the conditional expectation given observed data Y ,
Q(θ|θ(k)) = EU |Y,θ(k) [`0(θ)] =
∫
`0(θ)f(u|Y, θ(k))du =
∫
`0(θ)
f(u, Y |θ(k))
f(Y |θ(k)) du
=
∫
`0(θ)f(Y, u|θ(k))du
f(Y |θ(k)) =
∫
`0(θ)f(Y, u|θ(k))du∫
f(Y, u|θ(k))du =
E[`0(θ) · L0(θ(k))]
E[L0(θ(k))]
= E
[
`0(θ)
∥∥∥L(k)0 ]
(B.1)
where L
(k)
0 = L0(θ
(k)).
2. M-step:
Update θ by the value that maximizes (B.1) with respect to θ.
θ(k+1) = arg max
θ
Q(θ|θ(k))
This can be achieved by taking derivative of (B.1) and setting the resulting equation
to zero,
∂Q(θ|θ(k))
∂θ
= E
[
∂`0(θ)
∂θ
∥∥∥∥L(k)0 ] = E [U0(θ)∥∥∥L(k)0 ] = 0 (B.2)
And E
[
U0(θ(k+1))
∥∥∥L(k)0 ] = 0.
Notice that E [U0(θ)‖L0] is the marginal score function for θ. We can see this by
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writing out the marginal score function,
U(θ) = ∂`(θ)
∂θ
=
∂ logE[L0(θ)]
∂θ
=
∂E[L0(θ)]
∂θ
E[L0(θ)]
=
E
[
∂L0(θ)
∂θ
]
E[L0(θ)]
=
E
[
∂`0(θ)
∂θ
· L0(θ)
]
E[L0(θ)]
= E [`0(θ)‖L0]
Therefore, the M-step maximizes the conditional expectation of the conditional score
function given the observed data and the model parameter at the current iteration.
For the following derivation of the EM-DCA algorithm, we adopt the expression
(B.2) to represent the E-step and M-step in the algorithm.
B.3 EM-DCA Algorithm
We use the methods of EM algorithm in Tsodikov (2003) and the difference of convex
functions algorithm (DCA) to iteratively estimate the infinite dimensional transforma-
tion functions (H1(Ω), . . . , Hm(Ω)). Consider n independent subjects with m distinct
outcomes. For subject i = 1, . . . , n, we observe the covariate vectors (Zi1, . . . , Zim) corre-
sponding to a vector of outcomes (Yi1, . . . , Yim) and censoring indicators (δi1, · · · , δim). As
an example, we assume the shared latent variable for the ith subject Ui ∼ Gamma(ai, bi),
where ai = exp(η1Zi) and bi = exp(η2Zi). The full parameter sets consist of parameter
vectors Ω = (α, β, η) and infinite-dimensional H = (H1(·), . . . , Hm(·)). The joint like-
lihood of the observed data (Y, Z) and the shared latent variable U can be expressed
as
L0(Ω, H|Y, Z, U)f(U ; η)
=
n∏
i=1
m∏
j=1
[
1
1 + U
αj
i γijHj(y
−
ij)
− 1
1 + U
αj
i γijHj(yij)
]δij [
1
1 + U
αj
i γijHj(yij)
]1−δij baii
Γ(ai)
Uai−1i e
−biUi
(B.3)
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Taking the log of (B.3),we obtain the joint log likelihood
`0(Ω, H|Y, Z, U) + log f(U ; η)
=
n∑
i=1
{
m∑
j=1
[
δij log
(
U
αj
i γijdHj(yij)
[1 + U
αj
i γijHj(y
−
ij)][1 + U
αj
i γijHj(yij)]
)
+ (1− δij) log
(
1
1 + U
αj
i γiHj(yij)
)]
+
baii
Γ(ai)
+ (ai − 1) log(Ui)− biUi
}
=
n∑
i=1
{
m∑
j=1
δij logU
αj
i γijdHj(yij)−
m∑
j=1
δij log[1 + U
αj
i γijHj(y
−
ij)]−
m∑
j=1
log[1 + U
αj
i γijHj(yij)]
+ log
baii
Γ(ai)
+ (ai − 1) log(Ui)− biUi
}
. (B.4)
1. Difference of convex algorithm (DCA)
DCA is a version of the Minorize-Maximization(MM) algorithm that iteratively
optimizes an objective function that can be expressed as the difference of concave
functions. Consider two concave functions f(x) and g(x). The objective function
to be maximized is f(x)− g(x). By the subgradient inequality of concave function,
g(x) ≤ g(x∗) +∇g(x∗)(x− x∗)
f(x)− g(x) ≥ f(x)− (g(x∗) +∇g(x∗)(x− x∗))
Notice that the objective function (B.4) is a difference between two concave functions
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of H. We construct the surrogate function as
S(dHj, dH
(k)
j )
=
n∑
i=1
{
m∑
j=1
δij logU
αj
i γijdHj(yij)−
m∑
j=1
δij log[1 + U
αj
i γijHj(y
−
ij)]−
m∑
j=1
log[1 + U
αj
i γijHj(yij)]
+ log
baii
Γ(ai)
+ (ai − 1) log(Ui)− biUi
}
(B.5)
− (dHj(yij)− dH(k)j (yij))
[
n∑
i=1
δij 1(y
−
ij ≥ s)Uαji γij
1 + U
αj
i γijH
(k)
j (y
−
ij)
−
n∑
i=1
1(yij ≥ s)Uαji γij
1 + U
αj
i γijH
(k)
j (yij)
]
(B.6)
The surrogate function (B.5) satisfies S(dH(k), dH(k)) = `0(dH
(k)) + log f(U) and
S(dH, dH(k)) ≤ `0(dH) + log f(U). By MM algorithm theory, the next iteration
dH(k+1) that maximizes S(dH, dH(k)) in M-step will improve the likelihood.
Instead of maximizing imputed joint log likelihood, we employ DCA and maximize
imputed surrogate function (B.5). Applying the functional derivative to the surro-
gate function (B.5) with respect to dHj(s), we obtain the conditional score function
for dHj(s) as
U0,dHj(s) = δsS(dH, dH(k))
=
∑n
i=1 δij 1(yij = s)
dHj(yij)
−
n∑
i=1
δij 1(y
−
ij ≥ s)Uαji γij
1 + U
αj
i γijH
(k)
j (y
−
ij)
−
n∑
i=1
1(yij ≥ s)Uαji γij
1 + U
αj
i γijH
(k)
j (yij)
=
∑n
i=1 dNij(s)
dHj(yij)
−
n∑
i=1
δij 1(y
−
ij ≥ s)Uαji γij
1 + U
αj
i γijH
(k)
j (y
−
ij)
−
n∑
i=1
1(yij ≥ s)Uαji γij
1 + U
αj
i γijH
(k)
j (yij)
(B.7)
where
∑n
i=1 dNij(s) =
∑n
i=1 δij 1(yij = s) records the number of observations in
outcome Yj are of value s.
2. E step
Based on Appendix B.2, the marginal score function can be represented by the
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conditional expectation operator as below
UdHj(s) = E
[
U0,dHj(s)
∥∥∥L(k)0 ]
=
∑n
i=1 dNij(s)
dHj(s)
−
n∑
i=1
δij 1(y
−
ij ≥ s)γijE
[
U
αj
i
1 + U
αj
i γijH
(k)
j (y
−
ij)
∥∥∥∥∥L(k)0
]
−
n∑
i=1
1(yij ≥ s)γijE
[
U
αj
i
1 + U
αj
i γijH
(k)
j (yij)
∥∥∥∥∥L(k)0
]
.
The conditional expectation E
[
U
αj
i
1+U
αj
i γijH
(k)
j (y
−
ij)
∥∥∥∥L(k)0 ] and E [ Uαji1+Uαji γijH(k)j (yij)
∥∥∥∥L(k)0 ]
are obtained by Laplace approximation (Laplace (1986)).
Let u = ev. The conditional expectation E
[
U
αj
i
1+U
αj
i γijH
(k)
j (yij)
∥∥∥∥L(k)0 ] can be written as
E
[
U
αj
i
1 + U
αj
i γijHj(yij)
∥∥∥∥L0] = E [ eviαj1 + eviαjγijHj(yij)
∥∥∥∥L0]
=
∫∞
−∞
evαj
1+evαj γijHj(yij)
∏m
j=1
(
1
1+evαj γijHj(y
−
ij)
− 1
1+evαj γijHj(yij)
)δij (
1
1+evαj γijHj(yij)
)1−δij baii
Γ(ai)
evai−bie
v
dv
∫∞
−∞
∏m
j=1
(
1
1+evαj γijHj(y
−
ij)
− 1
1+evαj γijHj(yij)
)δij (
1
1+evαj γijHj(yij)
)1−δij baii
Γ(ai)
evai−bievdv
(B.8)
The numerator and the denominator of (B.8) can be approximated by Laplace’s
method. We obtain
E
[
U
αj
i
1 + U
αj
i γijHj(yij)
∥∥∥∥L0] ≈ e
vˆiαj
1+evˆiαj γijHj(yij)
b
ai
i
Γ(ai)
emf(vˆi)
√
2pi
m|f ′′(vˆi)|
b
ai
i
Γ(ai)
emf(vˆi)
√
2pi
m|f ′′(vˆi)|
=
evˆiαj
1 + evˆiαjγijHj(yij)
=
Uˆi
αj
1 + Uˆi
αj
γijHj(yij)
where
f(v) =
1
m
{
vai − biev
+
m∑
j=1
[
δij log
(
1
1 + evαjγijHj(y
−
ij)
− 1
1 + evαjγijHj(yij)
)
+ (1− δij)
(
1
1 + evαjγijHj(yij)
)]
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Here vˆi is assumed not an endpoint of the interval of integration and is the global
maximum of f(v) for the ith subject. That is, f ′(vˆi) = 0.
Similar approximation method is applied to the term E
[
U
αj
i
1+U
αj
i γijH
(k)
j (y
−
ij)
∥∥∥∥L(k)0 ] ≈
Uˆi
αj
1+Uˆi
αj γijHj(y
−
ij)
.
3. M step
The estimator for dH
(k+1)
j (s) that maximize E
(
S(dH, dH(k))
∥∥∥L(k)0 ) can be obtained
by solving UdHj(s) = 0. The solution results in a Breslow-type estimator
dH
(k+1)
j (s)
=
∑n
i=1 dNij(s)∑n
i=1 δij 1(y
−
ij ≥ s)γijE
[
U
αj
i
1+U
αj
i γijH
(k)
j (y
−
ij)
∥∥∥∥L(k)0 ]+∑ni=1 1(yij ≥ s)γijE [ Uαji1+Uαji γijH(k)k (yij)∥∥∥L(k)0 ]
(B.9)
This constitutes a self-consistent equation that can be solved iteratively (Tsodikov
(2003)).
Note that the conditional expectation operator E
[
·
∥∥∥L(k)0 ] is linear and does not
alter convexity properties. Hence, iterations based on (B.9) will also constitute an
MM algorithm monotonically improves the likelihood.
B.4 Asymptotic Properties
B.4.1 Proof of Theorem III.1
For each of i = 1, · · · , nth independent subject, we observed
{Yi1, . . . , Yim, δi1, . . . , δim, Zi1, . . . , Zim}. Note that for non-survival outcomes, all event
indicator δij are one. The contribution to the marginal likelihood can be obtained by
taking the expectation of complete data likelihood. We can write the observed data
likelihood function as:
Ln(Ω, H|Y,Z) =
m∏
i=1
E

m∏
j=1
(
1
1 + U
αj
i γijHj(yij)
)1−δij ( Uαji γijdHj(yij)
[1 + U
αj
i γijHj(y
−
ij)][1 + U
αj
i γijHj(yij)]
)δij .
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And the observed data log-likelihood:
`n(Ω, H|Y, Z)
=
n∑
i=1
logE

m∏
j=1
(
1
1 + U
αj
i γijHj(yij)
)1−δij ( Uαji γijdHj(yij)
[1 + U
αj
i γijHj(y
−
ij)][1 + U
αj
i γijHj(yij)]
)δij
(B.10)
To prove theorem 1, we show that any convergent sub-sequence of (Ωˆn, Hˆn) must
converge to (Ω0, H0). Since Ωˆn and Hˆn belong to a compact set, we can assume that
Ωˆn → Ω∗ and Hˆn(·) converges point-wise to a monotone function H∗(·) within its domain
D. We will show that Ω∗ = Ω0 and H∗(y) = H0(y) for all y within the domain.
The observed data log-likelihood (B.10) can be written as
`n(Ω, H|Y,Z)
=
n∑
i=1
logE

m∏
j=1
(
1
1 + U
αj
i γijHj(yij)
)1−δij ( Uαji γij
[1 + U
αj
i γijHj(y
−
ij)][1 + U
αj
i γijHj(yij)]
)δij
m∏
j=1
dHj(yij)
δij
=
n∑
i=1
logE

m∏
j=1
(
1
1 + U
αj
i γijHj(yij)
)1−δij ( Uαji γij
[1 + U
αj
i γijHj(y
−
ij)][1 + U
αj
i γijHj(yij)]
)δij
+
n∑
i=1
m∑
j=1
δij log(dHj(yij))
By differentiating `(Ω, H) with respect to dHk(s),
∂`n
∂dHk(s)
=
∑n
i=1 δik 1(yik = s)
dHk(s)
−
n∑
i=1
E[R1i(Ω, H)R2i(s,Ω, H)]
E[R1i(Ω, H)]
=
∑n
i=1 dNik(s)
dHk(s)
−
n∑
i=1
∫
R1i(Ω, H, u)R2i(s,Ω, H, u)f(u; η)du∫
R1i(Ω, H, u)f(u; η)du
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where
R1i(Ω, H, u) =
m∏
j=1
(
1
1 + U
αj
i γijHj(yij)
)1−δij ( Uαji γij
[1 + U
αj
i γijHj(y
−
ij)][1 + U
αj
i γijHj(yij)]
)δij
R2i(s,Ω, H, u) =
(1 + δik)1(yik ≥ s)Uαki γik
1 + Uαki γikHk(yik)
Setting the derivative to zero, we obtain the equation
∑n
i=1 dNik(s)
dHk(s)
=
n∑
i=1
∫
R1i(Ω, H, u)R2i(s,Ω, H, u)f(u; η)du∫
R1i(Ω, H, u)f(u; η)du
Therefore, we see that dHˆk satisfies the equation
∑n
i=1 dNik(s)
dHˆk(s)
=
n∑
i=1
∫
R1i(Ωˆ, Hˆ, u)R2i(s, Ωˆ, Hˆ, u)f(u; ηˆ)du∫
R1i(Ωˆ, Hˆ, u)f(u; ηˆ)du
(B.11)
Construct a function H˜ by imitating Hˆ and we will show H˜ uniformly converges to
H0. Define H˜ as a step function with jumps only at the yij for which δij = 1 and dH˜k
satisfies the equation
∑n
i=1 dNik(s)
dH˜k(s)
=
n∑
i=1
∫
R1i(Ω0, H0, u)R2i(s,Ω0, H0, u)f(u; η0)du∫
R1i(Ω0, H0, u)f(u; η0)du
(B.12)
By definition, H˜k(s) =
∑n
i=1 1(yik ≤ s)dH˜k(yik). By Glivenko-Cantelli theorem, H˜k(s)
converges almost surely to E{1(yik ≤ s)fYk(s)/µ(yik)}, where
µ(s) = E
{∫
R1i(Ω0, H0, u)R2i(s,Ω0, H0, u)f(u; η0)du∫
R1i(Ω0, H0, u)f(u; η0)du
}
= E
{
E
[
(1 + δik)1(yik ≥ s)Uα0ki γ0ik
1 + Uα0ki γ
0
ikH0k(yik)
∣∣∣∣R1i(Ω0, H0, u)]} ,
fYk(s) = E[dNik(s)] = E[δik 1(yik = s)]
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Denote Sc(·|Z) the survival function of censoring time C given Z.
E
{
(1 + δik)1(yik ≥ s)Uα0ki γ0ik
1 + Uα0ki γ
0
ikH0k(yik)
∣∣∣∣R1i(Ω0, H0, u)}
=E
2
∞∫
s
Uα0ki γ
0
ik
1 + Uα0ki γ
0
ikH0k(y)
Uα0ki γ
0
ikh0k(y)
[1 + Uα0ki γ
0
ikH0k(y)]
2
Sc(y|Zik)dy
∣∣∣∣∣∣R1i(Ω0, H0, u)

−E

∞∫
s
Uα0ki γ
0
ik
1 + Uα0ki γ
0
ikH0k(y)
1
1 + Uα0ki γ
0
ikH0k(y)
dSc(y|Zik)
∣∣∣∣∣∣R1i(Ω0, H0, u)

=E
{
Sc(s|Zik)Uα0ki γ0ik
[1 + Uα0ki γ
0
ikH0k(s)]
2
∣∣∣∣R1i(Ω0, H0, u)}
where the second equality follows from integration by part. Therefore we have
E
{
1(yik ≤ s)fYik(s)
µ(yik)
}
= E
E
 s∫
0
Sc(y|Zik)Uα0ki γ0ikh0k(y)
µ(y)[1 + Uα0ki γ
0
ikH0k(y)]
2
dy
∣∣∣∣∣∣R1i(Ω0, H0, u)

=
s∫
0
h0k(y)dy = H0k(s)
Therefore, H˜k(s) converges uniformly to H0k(s) in its specific domain Dk. By plugging in
(B.11) into `n(Ωˆ, Hˆ), we obtain
`n(Ωˆ, Hˆ)
=
n∑
i=1
logE

m∏
j=1
(
1
1 + U
αˆj
i γˆijHˆj(yij)
)1−δij (
U
αˆj
i γˆij
[1 + U
αˆj
i γˆijHˆj(y
−
ij)][1 + U
αˆj
i γˆijHˆj(yij)]
)δij
+
n∑
i=1
m∑
j=1
δij log(dHˆj(yij))
=
n∑
i=1
log
∫
R1i(Ωˆ, Hˆ, u)f(u; ηˆ)du+
n∑
i=1
m∑
j=1
δij log
(
n∑
k=1
dNkj(yij)
)
−
n∑
i=1
m∑
j=1
δij log
(
n∑
k=1
∫
R1k(Ωˆ, Hˆ, u)R2k(yij, Ωˆ, Hˆ, u)f(u; ηˆ)du∫
R1k(Ωˆ, Hˆ, u)f(u; ηˆ)du
)
.
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Likewise, plug in (B.12) into `n(Ω0, H˜), we obtain
`n(Ω0, H˜)) =
n∑
i=1
log
∫
R1i(Ω0, H˜, u)f(u; η0)du+
n∑
i=1
m∑
j=1
δij log
(
n∑
k=1
dNkj(yij)
)
−
n∑
i=1
m∑
j=1
δij log
(
n∑
k=1
∫
R1k(Ω0, H˜, u)R2k(yij,Ω0, H˜, u)f(u; η0)du∫
R1k(Ω0, H˜, u)f(u; η0)du
)
.
Define
R3i(s,Ω, H) =
∫
R1i(Ω, H, u)R2i(s,Ω, H, u)f(u; η)du∫
R1i(Ω, H, u)f(u; η)du
.
We see that Hˆk(y) is continuous with respect to H˜k(y) and
Hˆk(y) =
∫ ∑n
i=1R3i(s,Ω0, H0)∑n
i=1 R3i(s, Ωˆ, Hˆ)
dH˜k(s)
for k = 1, · · · ,m.
If the kth outcome is continuous or time-to-event, by taking limits on both sides of the
above equation, we see that H∗k(y) is continuous with respect to H0k(y) so that H
∗
k(y) is
differentiable with respect to y. In addition, dHˆ(y)/dH˜(y) converges to dH∗(y)/dH0(y)
uniformly in y.
Since (Ωˆ, Hˆ) are NPMLEs for `n(Ω, H), we know `n(Ωˆ, Hˆ) − `n(Ω, H) ≥ 0 for any
Ω, H. We have
0 ≤ n−1{`n(Ωˆ, Hˆ)− `n(Ω0, H˜)}
=n−1
n∑
i=1
log
∫
R1i(Ωˆ, Hˆ, u)f(u; ηˆ)du− n−1
n∑
i=1
log
∫
R1i(Ω0, H˜, u)f(u; η0)du
+ n−1
n∑
i=1
m∑
j=1
δij log
dHˆj(yij)
dH˜j(yij)
(B.13)
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As n→∞ in (B.13), we have
0 ≤ `(Ω∗, H∗)− `(Ω0, H0) (B.14)
= E
[
log
∫
R1i(Ω
∗, H∗, u)f(u; η∗)du
∏m
j=1 dH
∗
j (yij)
δij∫
R1i(Ω0, H0, u)f(u; η0)du
∏m
j=1 dH0j(yij)
δij
]
is the negative Kullback-Leibler information. By definition, (Ω0, H0) maximizes `(Ω, H),
therefore, (B.14) has a unique maximum when
m∏
j=1
dH∗j (yij)
δij
∫
R1i(Ω
∗, H∗, u)f(u; η∗)du =
m∏
j=1
dH0j(yij)
δij
∫
R1i(Ω0, H0, u)f(u; η0)du
(B.15)
uniformly over (Ω, H). Under an identifiable model this means (B.14) has a unique
maximum at (Ω0, H0). Since maximizing (B.14) is equivalent to maximizing likelihood
`(Ω∗, H∗), and (B.14) has a unique maximum, therefore, (Ω0, H0) = argmax(Ω,H)∈H`(Ω, H)
is unique. Write out (B.15)
∫ m∏
j=1
[U
α∗j
i γ
∗
ijdH
∗
j (yij)]
δij
[1 + U
α∗j
i γ
∗
ijH
∗
j (yij)]
1+δij
f(u; η∗)du =
∫ m∏
j=1
[U
α0j
i γ
0
ijdH0j(yij)]
δij
[1 + U
α0j
i γ
0
ijH0j(yij)]
1+δij
f(u; η0)du
(B.16)
We will show (B.16) implies that Ω∗ = Ω0 and H∗ = H0. For an integer q such that
1 ≤ q ≤ m. Let δij = 1, yij = 0 in (B.16) for j = 1, · · · , q. For j = q + 1, · · · ,m we
perform the following: if δij = 0, replace yij with τj (upper bound of Dj); if δij = 1, we
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integrate yij in its domain. Applying the above actions to (B.16), we obtain
∫ q∏
j=1
{
U
α∗j
i γ
∗
ijdH
∗
j (0)
} m∏
j=q+1
{
U
α∗j
i γ
∗
ijH
∗
j (τj)
1 + U
α∗j
i γ
∗
ijH
∗
j (τj)
}δij {
1
1 + U
α∗j
i γ
∗
ijH
∗
j (τj)
}1−δij
f(u; η∗)du
=
∫ q∏
j=1
{
U
α0j
i γ
0
ijdH0j(0)
} m∏
j=q+1
{
U
α0j
i γ
0
ijH0j(τj)
1 + U
α0j
i γ
0
ijH0j(τj)
}δij {
1
1 + U
α0j
i γ
0
ijH0j(τj)
}1−δij
f(u; η0)du
(B.17)
Since {δij : j = q + 1, · · · ,m} are arbitrary, we sum the two sides of (B.17) over all
possible combinations of {δij : j = q + 1, · · · ,m} and we get
∫ q∏
j=1
{
uα
∗
jγ∗ijdH
∗
j (0)
}
f(u; η∗)du =
∫ q∏
j=1
{
uα0jγ0ijdH0j(0)
}
f(u; η0)du
Thus,
q∏
j=1
dH∗j (0)γ
∗
ij
∫ { q∏
j=1
uα
∗
j
}
f(u; η∗)du =
q∏
j=1
dH0j(0)γ
0
ij
∫ { q∏
j=1
uα0j
}
f(u; η0)du
Regularity condition (1) implies that dH∗j (0) > 0 for any j. Take q = 1, we have
dH∗1 (0)γ
∗
i1
∫
uα
∗
1f(u; η∗)du = dH01(0)γ0i1
∫
uα01f(u; η0)du
log dH∗1 (0) + Z
T
i1β
∗ + log
∫
uα
∗
1f(u; η∗)du = log dH01(0) + ZTi1β0 + log
∫
uα01f(u; η0)du
log
dH∗1 (0)
dH01(0)
+ ZTi1(β
∗ − β0) + log
∫
uα
∗
1f(u; η∗)du∫
uα01f(u; η0)du
= 0 (B.18)
Since outcome index q is interchangeable between outcomes, so equation (B.18) applies
to any q. According to condition (4) and (5), equation (B.18) implies α∗ = α0, β∗ = β0,
η∗ = η0 and dH∗(0) = dH0(0).
Next we show that H∗j = H0j for all = 1, · · · ,m. We let δi1 = 1 in (B.16) and integrate
yi1 from 0 to s. In addition, for j = 2, · · · ,m, if δij = 0, we replace Yij with τj; if δij = 1,
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we integrate yij from 0 to τj. Then we sum the resulting equations over all possible
{δij : j = 2, · · · ,m} to obtain
∫ {
uα
∗
1γ∗i1H
∗
1 (s)
1 + uα
∗
1γ∗i1H
∗
1 (s)
}
f(u; η∗)du =
∫ {
uα01γ0i1H01(s)
1 + uα01γ0i1H01(s)
}
f(u; η0)du
The two sides of the above equation are strictly monotone in H∗1 (s) and H01(s), respec-
tively. Therefore, we have H∗1 (s) = H01(s). Since the outcome index is arbitrary, the
above result also applies to j = 2, · · · ,m. We have H∗(s) = H0(s).
We conclude that ||Ωˆ − Ω0|| → 0, and ||Hˆ(s) −H0(s)|| → 0 for all s ∈ D. Thus, we
established uniform convergence
∑m
k=1 supyk∈Dk |Hˆk(yk)−H0k(yk)| → 0.
B.4.2 Proof of Theorem III.2
Consider the set
H = {(v, w1, · · · , wm) : v ∈ RdΩ , wk(·) is a function on Dk;
|v| ≤ 1, ||wk||BV [Dk] ≤ 1, k = 1, · · · ,m}
where ||wk||BV [Dk] denotes the total variation of wk(·) in Dk, and dΩ is the dimension of
Ω. Define a sequence Sn(Ω, H)[v, w1, · · · , wm] mapping a neighborhood of (Ω0, H0) into
l∞(H) as follows:
Sn(Ω, H)[v, w1, · · · , wm] = d
d
n−1`n
Ω + v,Hk(y) +  y∫
−∞
wk(s)dHk(s), k = 1, · · · ,m
∣∣∣∣∣∣
=0
= An0[v] +
m∑
k=1
Ank[wk]
where Anp, p = 0, · · · ,m, are linear functionals on RdΩ and BV [Dk], respectively. Let ˙`Ω
and ˙`Hk(wk) be the score function for Ω and the score for Hk along the path Hk(y) +
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
∫
wk(s)dHk(s), then
An0[v] = Pn[vT ˙`Ω], Ank[wk] = Pn[ ˙`Hk(wk)], k = 1, · · · ,m
where Pn denotes the empirical measure based on n independent subjects.
Correspondingly we define the limit map S : (Ω, H)→ l∞(H) as
S(Ω, H)[v, w1, · · · , wm] = A0[v] +
m∑
k=1
Ak[wk],
where the linear functionals Ap, p = 0, · · · ,m, are the expectation of the empirical average
of Anp, p = 0, · · · ,m. By definition, Sn(Ωˆ, Hˆ) = 0 and S(Ω0, H0) = 0.
Since H is a Donsker class and the functionals Anp, p = 0, · · · ,m, are bounded Lip-
schitz functionals with respect to H, √n(Sn(Ω0, H0) − S(Ω0, H0)) converges to a tight
Gaussian process on l∞(H). The first condition in Theorem 2 of Murphy (1995) holds.
By regularity condition (6), the score operator S(Ω, H) is Fre´chet differentiable at Ω0
with a continuously invertible derivative −I0. The hessian matrix In evaluated at the
true values of H and Ω is positive definite, and converges in probability to a deterministic
and invertible operator I0. Thus the second condition in Theorem 2 of Murphy (1995)
holds. The derivative of S(Ω, H) at (Ω0, H0), denoted as −I0, is a map from the space
(Ω − Ω0, H − H0) to l∞(H). The fourth condition in Theorem 2 of Murphy (1995), the
approximation condition below can be verified along the lines of appendix in Murphy
(1995)
sup |(Sn − S)(Ωˆ, Hˆ)− (Sn − S)(Ω0, H0)|
= op
(
n−1/2 ∨
{
||Ωˆ− Ω0||+
m∑
k=1
sup |Hˆk(y)−H0k(y)|
})
.
In order to verify the third condition in Theorem 2 of Murphy (1995), we want to
show that −I0, denoted S˙0, is continuously invertible. S˙0 maps (Ω − Ω0, H − H0) to a
147
bounded functional on H. By Zeng et al. (2005), we will prove the invertibility of S˙0
by verifying that S˙0(Ω − Ω0, H − H0)[v, w1, · · · , wm] = 0 implies v = 0 and wk(y) = 0
uniformly, k = 1, · · · ,m.
For a small constant , choose Ω = Ω0 + v,Hk(y) = H0k(y) + 
∫ y
∞wk(s)dH0k(s).
Then,
0 = S˙0(Ω− Ω0, H −H0)[v, wk, k = 1, · · · ,m] = E
( ˙`
Ω[v] +
m∑
k=1
˙`Hk [wk]
)2
This means
˙`
Ω[v] +
m∑
k=1
˙`Hk [wk] = 0 (B.19)
Closely following the lines in Appendix of Zeng et al. (2005), we can see that the equation
(B.19) entails v = 0 and wk(·) = 0 uniformly. Therefore, the derivative of the score
operator at (Ω0, H0), denoted as −I0 is continuously invertible. By Theorem 2 of Murphy
(1995),
√
n
{
Ωˆ− Ω, Hˆ(·)− Hˆ0(·)
}
converges weakly to a zero-mean Gaussian process.
Furthermore,
√
nS˙0(Ω− Ω0, H −H0)[v, wk, k = 1, · · · ,m] =
√
n(Pn − P)
[
vT ˙`Ω +
m∑
k=1
˙`
Hk [wk]
]
+ op(1)
(B.20)
Thus, Ωˆ is semiparametrically efficient since Ωˆ is asymptotically linear estimator for Ω0,
and its influence function belong to the space spanned by the score function (Zeng et al.
(2005)).
B.4.3 Proof of Theorem III.3
Observe that
√
nS˙0(Ω − Ω0, H − H0)[v, wk, k = 1, · · · ,m] is the expectation of the
second derivative of the normalized log-likelihood along the direction (Ωˆ − Ω0, Hˆ − H0)
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and the direction
(
v,
∫
wdH0
)
. Therefore,
√
nS˙0(Ω−Ω0, H−H0)[v, wk, k = 1, · · · ,m] can
be approximated by
√
n(vT , w¯T )(In/n)
 Ωˆ− Ω0
dHˆ(s)− dH0(s)
 ,
where w¯ denotes the set of vectors {wk(s) : dNij(s) = 1}. On the other hand,
√
n(Pn − P)
[
vT ˙`Ω +
m∑
k=1
˙`
Hk [wk]
]
→d (vT , w¯T )(In/n)1/2G
where G is standard multivariate Gaussian. Therefore, equation (B.20) implies that
√
n(vT , w¯T )(In/n)
 Ωˆ− Ω0
dHˆ(s)− dH0(s)
→d (vT , w¯T )(In/n)1/2G
√
n(vT , w¯T )
 Ωˆ− Ω0
dHˆ(s)− dH0(s)
→d (vT , w¯T )(In/n)−1/2G
Thus,
√
n
{
vT (Ωˆ− Ω0) +
∑m
k=1
∫
wkd(Hˆk −H0k)
}
converges to a zero mean Gaussian
process with with variance-covariance matrix n(vT , w¯T )I−10 (vT , w¯T )T .
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Table B.1: Pearson correlation between age and the six pain responses
Age
Fibromyalgia survey criteria −0.22
Opioid use −0.05
BPI pain severity −0.21
BPI surgical pain −0.29
HADS depression −0.16
HADS anxiety −0.24
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APPENDIX C
A Semiparametric Joint Latent Trait Model for
Multiple Mixed Longitudinal Continuous,
Categorical Outcomes and Time-to-event Data
C.1 EM-DCA Algorithm
We use the methods of EM algorithm in Tsodikov (2003) and the difference of convex
functions algorithm (DCA) to iteratively estimate the infinite dimensional transformation
functions (H1(Ω), . . . , HJ(Ω), Hs(Ω)) and U(Ω). Consider n independent subjects with
J distinct longitudinal outcomes. As an example, we assume the latent trait function
takes the form Ui(t) = U(t)e
ai+bit. The shared random variables (ai, bi) follow a joint
distribution f(a, b|θi) = f(a|θ1i, θ2i)f(b|η3) where f(a|θ1i, θ2i) is a log-Gamma density
function with shape θ1i = exp(η1Zi), and rate θ2i = exp(η2Zi). f(b|η3) is a log-Gamma
density function with both shape and rate being η3. The full joint likelihood of the
151
observed data (Y,X) and the shared latent variable Ui(t) can be expressed as
L0(Ω,H|Y,Z, U(t), ai, bi)
n∏
i=1
f(ai|θ1i, θ2i)f(bi|η3)
=
n∏
i=1
{
J∏
j=1
K∏
k=1
[
1
1 + Ui(tk)αjγijHj(y
−
ijk)
− 1
1 + Ui(tk)αjγijHj(yijk)
]
(
ev0ai+v1biγisdHs(Ti)
1 + ev0ai+v1biγisHs(Ti)
)δi ( 1
1 + ev0ai+v1biγisHs(Ti)
)
θθ1i2i
Γ(θ1i)
eaiθ1i−θ2ie
ai η
η3
3
Γ(η3)
ebiη3−η3e
bi
}
(C.1)
Taking the log of (C.1),we obtain the full joint log-likelihood
`0(Ω,H|Y,Z, U(t), ai, bi) +
n∑
i=1
log f(ai|θ1i, θ2i)f(bi|η3)
=
n∑
i=1

J∑
j=1
K∑
k=1
log
(
Ui(tk)
αjγijdHj(yijk)
[1 + Ui(tk)αjγijHj(y
−
ijk)][1 + Ui(tk)
αjγijHj(yijk)]
)
− log[1 + ev0ai+v1biγisHs(Ti)]
+δi log
(
ev0ai+v1biγisdHs(Ti)
1 + ev0ai+v1biγisHs(Ti)
)
+ log
(
θθ1i2i
Γ(θ1i)
eaiθ1i−θ2ie
ai η
η3
3
Γ(η3)
ebiη3−η3e
bi
)}
=
n∑
i=1

J∑
j=1
K∑
k=1
{logUi(tk)αjγijdHj(yijk)− log[1 + Ui(tk)αjγijHj(y−ijk)][1 + Ui(tk)αjγijHj(yijk)]}
+ δi(v0ai + v1bi + log γisdHs(Ti))− (1 + δi) log[1 + ev0ai+v1biγisHs(Ti)] + θ1i log θ2i − log Γ(θ1i)
+ aiθ1i − θ2ieai + η3 log η3 − log Γ(η3) + biη3 − η3ebi
}
. (C.2)
1. Difference of convex algorithm (DCA)
DCA is a version of the Minorize-Maximization(MM) algorithm that iteratively
optimizes an objective function that can be expressed as the difference of concave
functions. Consider two concave functions f(x) and g(x). The objective function
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to be maximized is f(x)− g(x). By the subgradient inequality of concave function,
g(x) ≤ g(x∗) +∇g(x∗)(x− x∗)
f(x)− g(x) ≥ f(x)− (g(x∗) +∇g(x∗)(x− x∗))
2. EM-DCA for {dHj}j=1,··· ,J
For each outcome j = 1, · · · , J , notice that the objective function (C.2) is a differ-
ence between two concave functions of dHj. We construct the surrogate function
as
S(dHj, dH
(m)
j )
=
n∑
i=1
{
J∑
j=1
K∑
k=1
{logUi(tk)αjγijdHj(yijk)− log[1 + Ui(tk)αjγijH(m)j (y−ijk)][1 + Ui(tk)αjγijH(m)j (yijk)]}
+ δi(v0ai + v1bi + log γisdHs(Ti))− (1 + δi) log[1 + ev0ai+v1biγisHs(Ti)] + θ1i log θ2i − log Γ(θ1i)
+ aiθ1i − θ2ieai + η3 log η3 − log Γ(η3) + biη3 − η3ebi
}
− (dHj(x)− dH(m)j (x))
[
n∑
i=1
K∑
k=1
1(y−ijk ≥ x)Ui(tk)αjγij
1 + Ui(tk)αjγijH
(m)
j (y
−
ijk)
+
n∑
i=1
K∑
k=1
1(yijk ≥ x)Ui(tk)αjγij
1 + Ui(tk)αjγijH
(m)
j (yijk)
]
(C.3)
The surrogate function (C.3) satisfies S(dH
(m)
j , dH
(m)
j ) = `0(dH
(m)
j ) + log f(a, b)
and
S(dHj, dH
(m)
j ) ≤ `0(dHj) + log f(a, b). By MM algorithm theory, the next iteration
dH
(m+1)
j that maximizes S(dHj, dH
(m)
j ) in M-step will improve the likelihood.
Instead of maximizing imputed joint log-likelihood, we employ DCA and maximize
imputed surrogate function (C.3). Applying the functional derivative to the surro-
gate function (C.3) with respect to dHj(x), we obtain the conditional score function
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for dHj(x) as
U0,dHj(x) = δxS(dHj, dH(m)j )
=
∑n
i=1
∑K
k=1 dNijk(x)
dHj(x)
−
n∑
i=1
K∑
k=1
1(y−ijk ≥ x)Ui(tk)αjγij
1 + Ui(tk)αjγijH
(m)
j (y
−
ijk)
−
n∑
i=1
K∑
k=1
1(yijk ≥ x)Ui(tk)αjγij
1 + Ui(tk)αjγijH
(m)
j (yijk)
(C.4)
where
∑n
i=1
∑K
k=1 dNijk(x) =
∑n
i=1
∑K
k=1 1(yijk = x) records the number of obser-
vations in the jth outcome are of value x.
• E step
Taking expectation of (C.4), we obtain the marginal score function
UdHj(x) = E
[
U0,dHj(x)
∥∥∥L(k)0 ]
=
∑n
i=1
∑K
k=1 dNijk(x)
dHj(x)
−
n∑
i=1
E
[
K∑
k=1
1(y−ijk ≥ x)γijU(tk)eαj(ai+bitk)
1 + Ui(tk)αjγijH
(m)
j (y
−
ijk)
∥∥∥∥∥L(m)0
]
−
n∑
i=1
E
[
K∑
k=1
1(yijk ≥ x)γijU(tk)eαj(ai+bitk)
1 + Ui(tk)αjγijH
(m)
j (yijk)
∥∥∥∥∥L(m)0
]
.
The imputation terms E
[∑K
k=1
1(y−ijk≥x)γijU(tk)eαj(ai+bitk)
1+Ui(tk)
αj γijH
(m)
j (y
−
ijk)
∥∥∥∥L(m)0 ] and
E
[∑K
k=1
1(yijk≥x)γijU(tk)eαj(ai+bitk)
1+Ui(tk)
αj γijH
(m)
j (yijk)
∥∥∥∥L(m)0 ] are obtained by multivariate Laplace
approximation (Laplace (1986)).
Specifically,
E
[
K∑
k=1
1(yijk ≥ x)γijU(tk)eαj(ai+bitk)
1 + Ui(tk)αjγijH
(m)
j (yijk)
∥∥∥∥∥L0
]
=
∫∞
−∞
∫∞
−∞
(∑K
k=1
1(yijk≥x)γijU(tk)eαj(a+btk)
1+U(tk)e
αj(a+btk)γijH
(m)
j (yijk)
)
L0
θ
θ1i
2i
Γ(θ1i)
eaθ1i−θ2ie
a η
η3
3
Γ(η3)
ebη3−η3e
b
dadb∫∞
−∞
∫∞
−∞ L0
θ
θ1i
2i
Γ(θ1i)
eaθ1i−θ2iea η
η3
3
Γ(η3)
ebη3−η3ebdadb
(C.5)
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where
L0 =
n∏
i=1
{
J∏
j=1
K∏
k=1
[
1
1 + Ui(tk)αjγijHj(y
−
ijk)
− 1
1 + Ui(tk)αjγijHj(yijk)
]
(
ev0ai+v1biγisdHs(Ti)
1 + ev0ai+v1biγisHs(Ti)
)δi ( 1
1 + ev0ai+v1biγisHs(Ti)
)}
The numerator and the denominator of (C.5) can be approximated by multi-
variate Laplace’s method. We obtain
E
[
K∑
k=1
1(yijk ≥ x)γijU(tk)eαj(ai+bitk)
1 + Ui(tk)αjγijH
(m)
j (yijk)
∥∥∥∥∥L0
]
≈
(∑K
k=1
1(yijk≥x)γijU(tk)eαj(aˆi+bˆitk)
1+U(tk)e
αj(aˆi+bˆitk)γijH
(m)
j (yijk)
)
θ
θ1i
2i
Γ(θ1i)
η
η3
3
Γ(η3)
ef(aˆi,bˆi)2pi| −H(f)(aˆi, bˆi)|−1/2
θ
θ1i
2i
Γ(θ1i)
η
η3
3
Γ(η3)
ef(aˆi,bˆi)2pi| −H(f)(aˆi, bˆi)|−1/2
=
K∑
k=1
1(yijk ≥ x)γijU(tk)eαj(aˆi+bˆitk)
1 + U(tk)eαj(aˆi+bˆitk)γijH
(m)
j (yijk)
where
f(a, b) =
{
aθ1i − θ2iea + bη3 − η3eb
+
J∑
j=1
K∑
k=1
log
[
1
1 + Ui(tk)αjγijHj(y
−
ijk)
− 1
1 + Ui(tk)αjγijHj(yijk)
]
+ log
(
ev0ai+v1biγisdHs(Ti)
1 + ev0ai+v1biγisHs(Ti)
)δi ( 1
1 + ev0ai+v1biγisHs(Ti)
)}
(C.6)
and H(f)(aˆi, bˆi) is the hessian matrix of f(a, b) evaluated at (aˆi, bˆi); | · | denotes
matrix determinant.
Here (aˆi, bˆi) are assumed not at the boundary of the interval of integration and
are the global maximum of f(a, b) for the ith subject. That is, ∇f(aˆi, bˆi) = 0.
Similar approximation method is applied to the term
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E
[∑K
k=1
1(y−ijk≥x)γijU(tk)eαj(ai+bitk)
1+Ui(tk)
αj γijH
(m)
j (y
−
ijk)
∥∥∥∥L(m)0 ] ≈∑Kk=1 1(yijk≥x)γijU(tk)eαj(aˆi+bˆitk)1+U(tk)eαj(aˆi+bˆitk)γijH(m)j (y−ijk) .
• M step
The estimator for dH
(m+1)
j (x) that maximizes E
(
S(dHj, dH
(m)
j )
∥∥∥L(m)0 ) can
be obtained by solving UdHj(x) = 0. The solution results in a Breslow-type
estimator
dH
(m+1)
j (x)
=
∑n
i=1
∑K
k=1 dNijk(x)∑n
i=1 E
[∑K
k=1
1(y−ijk≥x)γijU (m)i (tk)αj
1+U
(m)
i (tk)
αjγijH
(m)
j (y
−
ij)
∥∥∥∥L(m)0 ]+∑ni=1 E [∑Kk=1 1(yijk≥x)γijU (m)i (tk)αj1+U (m)i (tk)αjγijH(m)j (yijk)
∥∥∥∥L(m)0 ]
(C.7)
This constitutes a self-consistent equation that can be solved iteratively (Tsodikov
(2003)). Note that the imputation operator E
[
·
∥∥∥L(m)0 ] is linear and does
not alter convexity properties. Hence, iterations based on (C.7) will also con-
stitute an MM algorithm monotonically improves the likelihood.
3. EM-DCA for {dHs}
For the time-to-event outcome, the objective function (C.2) is a difference between
two concave functions of dHs. We construct the surrogate function as
S(dHs, dH
(m)
s )
=
n∑
i=1

J∑
j=1
K∑
k=1
{logUi(tk)αjγijdHj(yijk)− log[1 + Ui(tk)αjγijHj(y−ijk)][1 + Ui(tk)αjγijHj(yijk)]}
+ δi(v0ai + v1bi + log γisdHs(Ti))− (1 + δi) log[1 + ev0ai+v1biγisH(m)s (Ti)] + θ1i log θ2i − log Γ(θ1i)
+ aiθ1i − θ2ieai + η3 log η3 − log Γ(η3) + biη3 − η3ebi
}
−
(
dHs(x)− dH(m)s (x)
) n∑
i=1
Yis(x)(1 + δi)e
v0ai+v1biγis
1 + ev0ai+v1biγisH
(m)
s (Ti)
(C.8)
The surrogate function (C.8) satisfies S(dH
(m)
s , dH
(m)
s ) = `0(dH
(m)
s ) + log f(a, b)
and
S(dHs, dH
(m)
s ) ≤ `0(dHs) + log f(a, b). By MM algorithm theory, the next iteration
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dH
(m+1)
s that maximizes S(dHs, dH
(m)
s ) in M-step will improve the likelihood.
We employ DCA and maximize imputed surrogate function (C.8). Applying the
functional derivative to the surrogate function (C.8) with respect to dHs(x), we
obtain the conditional score function for dHs(x) as
U0,dHs(x) = δxS(dHs, dH(m)s ) =
∑n
i=1 dNis(x)
dHs(x)
−
n∑
i=1
Yis(x)(1 + δi)e
v0ai+v1biγis
1 + ev0ai+v1biγisH
(m)
s (Ti)
(C.9)
• E step
Taking expectation of (C.9), we obtain the marginal score function for dHs(x)
UdHs(x) = E
[
U0,dHs(x)
∥∥∥L(m)0 ] = ∑ni=1 dNis(x)dHs(x) −
n∑
i=1
E
[
Yis(x)(1 + δi)γise
v0ai+v1bi
1 + ev0ai+v1biγisH
(m)
s (Ti)
∥∥∥∥∥L(m)0
]
.
We use multivariate Laplace approximation for the conditional expectation
E
[
Yis(x)(1+δi)γise
v0ai+v1bi
1+ev0ai+v1biγisH
(m)
s (Ti)
∥∥∥L(m)0 ]. Specifically,
E
[
Yis(x)(1 + δi)γise
v0ai+v1bi
1 + ev0ai+v1biγisH
(m)
s (Ti)
∥∥∥∥∥L0
]
=
∫∞
−∞
∫∞
−∞
Yis(x)(1+δi)γise
v0ai+v1bi
1+ev0ai+v1biγisH
(m)
s (Ti)
L0
θ
θ1i
2i
Γ(θ1i)
eaθ1i−θ2ie
a η
η3
3
Γ(η3)
ebη3−η3e
b
dadb∫∞
−∞
∫∞
−∞ L0
θ
θ1i
2i
Γ(θ1i)
eaθ1i−θ2iea η
η3
3
Γ(η3)
ebη3−η3ebdadb
(C.10)
where L0 is shown as function (2).
Applying multivariate Laplace’s approximation to the numerator and the de-
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nominator of (C.10), we obtain
E
[
Yis(x)(1 + δi)γise
v0ai+v1bi
1 + ev0ai+v1biγisH
(m)
s (Ti)
∥∥∥∥∥L0
]
≈
Yis(x)(1+δi)γise
v0aˆi+v1 bˆi
1+ev0aˆi+v1 bˆiγisH
(m)
s (Ti)
θ
θ1i
2i
Γ(θ1i)
η
η3
3
Γ(η3)
ef(aˆi,bˆi)2pi| −H(f)(aˆi, bˆi)|−1/2
θ
θ1i
2i
Γ(θ1i)
η
η3
3
Γ(η3)
ef(aˆi,bˆi)2pi| −H(f)(aˆi, bˆi)|−1/2
=
Yis(x)(1 + δi)γise
v0aˆi+v1bˆi
1 + ev0aˆi+v1bˆiγisH
(m)
s (Ti)
where f(a, b) is the function (C.6) and ∇f(aˆi, bˆi) = 0.
• M step
The estimator for dH
(m+1)
s (x) that maximizes E
(
S(dHs, dH
(m)
s )
∥∥∥L(m)0 ) can
be obtained by solving UdHs(x) = 0. The solution results in a Breslow-type
estimator
dH(m+1)s (x) =
∑n
i=1 dNis(x)∑n
i=1 E
[
Yis(x)(1+δi)γisev0ai+v1bi
1+ev0ai+v1biγisH
(m)
s (Ti)
∥∥∥L(m)0 ]
which is a self-consistent equation that can be solved iteratively.
4. EM-DCA for {U}
Notice that the objective function (C.2) is a difference between two concave functions
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of U(t). Construct the surrogate function
S(U,U (m))
=
n∑
i=1

J∑
j=1
K∑
k=1
{logU(tk)eαj(ai+bitk)γijdHj(yijk)
− log[1 + U (m)(tk)eαj(ai+bitk)γijHj(y−ijk)][1 + U (m)(tk)eαj(ai+bitk)γijHj(yijk)]}
+ δi(v0ai + v1bi + log γisdHs(Ti))− (1 + δi) log[1 + ev0ai+v1biγisHs(Ti)] + θ1i log θ2i − log Γ(θ1i)
+ aiθ1i − θ2ieai + η3 log η3 − log Γ(η3) + biη3 − η3ebi
}
−
(
U(x)− U (m)(x)
) n∑
i=1
J∑
j=1
αjU
(m)(x)αj−1eαj(ai+bix)γijHj(y−ijx)
1 + U (m)(x)eαj(ai+bix)γijHj(y
−
ijx)
+
n∑
i=1
J∑
j=1
1(Hj(yijx) 6=∞)αjU (m)(x)αj−1eαj(ai+bix)γijHj(yijx)
1 + U (m)(x)eαj(ai+bix)γijHj(yijx)
 (C.11)
The surrogate function (C.11) satisfies S(U (m), U (m)) = `0(U
(m)) + log f(a, b) and
S(U,U (m)) ≤ `0(U)+log f(a, b). By MM algorithm theory, the next iteration U (m+1)
that maximizes S(U,U (m)) in M-step will improve the likelihood.
We employ DCA and maximize imputed surrogate function (C.11). Applying the
functional derivative to the surrogate function (C.11) with respect to U(x), we
obtain the conditional score function for U(x) as
U0,U(x) = ∂`0
∂U(x)
=
∑n
i=1
∑J
j=1 αj 1(Hj(yijx) 6=∞)
U(x)
−
n∑
i=1
J∑
j=1
αjU
(m)(x)αj−1eαj(ai+bix)γijHj(y−ijx)
1 + U (m)(x)eαj(ai+bix)γijHj(y
−
ijx)
−
n∑
i=1
J∑
j=1
1(Hj(yijx) 6=∞)αjU (m)(x)αj−1eαj(ai+bix)γijHj(yijx)
1 + U (m)(x)eαj(ai+bix)γijHj(yijx)
(C.12)
• E step
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Taking expectation of (C.12), we obtain the marginal score function for U(x):
UU(x) =
∑n
i=1
∑J
j=1 αj 1(Hj(yijx) 6=∞)
U(x)
−
n∑
i=1
J∑
j=1
E
[
αjU
(m)(x)αj−1eαj(ai+bix)γijHj(y−ijx)
1 + U
(m)
i (x)
αjγijHj(y
−
ijx)
∥∥∥∥∥L(m)0
]
−
n∑
i=1
J∑
j=1
E
[
1(Hj(yijx) 6=∞)αjU (m)(x)αj−1eαj(ai+bix)γijHj(yijx)
1 + U
(m)
i (x)
αjγijHj(yijx)
∥∥∥∥∥L(m)0
]
.
We use multivariate Laplace approximation for the imputed terms. Specifically,
E
[
αjU
(m)(x)αj−1eαj(ai+bix)γijHj(y−ijx)
1 + U
(m)
i (x)
αjγijHj(y
−
ijx)
∥∥∥∥∥L0
]
=
∫∞
−∞
∫∞
−∞
αjU
(m)(x)αj−1eαj(ai+bix)γijHj(y−ijx)
1+U
(m)
i (x)
αj γijHj(y
−
ijx)
L0
θ
θ1i
2i
Γ(θ1i)
eaθ1i−θ2ie
a η
η3
3
Γ(η3)
ebη3−η3e
b
dadb∫∞
−∞
∫∞
−∞ L0
θ
θ1i
2i
Γ(θ1i)
eaθ1i−θ2iea η
η3
3
Γ(η3)
ebη3−η3ebdadb
(C.13)
where L0 is the function (2).
Applying multivariate Laplace’s approximation to the numerator and the de-
nominator of (C.13), we obtain
E
[
αjU
(m)(x)αj−1eαj(ai+bix)γijHj(y−ijx)
1 + U
(m)
i (x)
αjγijHj(y
−
ijx)
∥∥∥∥∥L0
]
≈
αjU
(m)(x)αj−1eαj(aˆi+bˆix)γijHj(y−ijx)
1+U(m)(x)αj eαj(aˆi+bˆix)γijHj(y
−
ijx)
θ
θ1i
2i
Γ(θ1i)
η
η3
3
Γ(η3)
ef(aˆi,bˆi)2pi| −H(f)(aˆi, bˆi)|−1/2
θ
θ1i
2i
Γ(θ1i)
η
η3
3
Γ(η3)
ef(aˆi,bˆi)2pi| −H(f)(aˆi, bˆi)|−1/2
=
αjU
(m)(x)αj−1eαj(aˆi+bˆix)γijHj(y−ijx)
1 + U (m)(x)αjeαj(aˆi+bˆix)γijHj(y
−
ijx)
where f(a, b) is the function (C.6) and ∇f(aˆi, bˆi) = 0.
• M step
The estimator for U(x) that maximizes E
(
S(U,U (m))
∥∥∥L(m)0 ) can be obtained
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by solving UU(x) = 0. The solution results in a Breslow-type estimator
U (m+1)(x) =
∑n
i=1
∑J
j=1 αj 1(Hj(yijx) 6=∞)∑n
i=1
∑J
j=1 E
[
Θ
(m)
1ij
∥∥∥L(m)0 ]− E [Θ(m)2ij ∥∥∥L(m)0 ]
where
Θ
(m)
1ij =
αjU
(m)(x)αj−1eαj(ai+bix)γijH
(m)
j (y
−
ijx)
1 + U
(m)
i (x)
αjγijH
(m)
j (y
−
ijx)
Θ
(m)
2ij =
1(Hj(yijx) 6=∞)αjU (m)(x)αj−1eαj(ai+bix)γijH(m)j (yijx)
1 + U
(m)
i (x)
αjγijH
(m)
j (yijx)
The above updating equation for U(x) is a self-consistent equation that can be
solved iteratively.
C.2 Asymptotic Properties
C.2.1 Proof of Theorem IV.1
To prove theorem IV.1, we show that any convergent sub-sequence of (Ωˆn, Uˆn, Hˆn)
must converge to (Ω0, U0,H0). Since Ωˆn, Uˆn and Hˆn belong to a compact set, we can
assume that Ωˆn → Ω∗, Uˆn(t) → U∗(t) and Hˆn(·) converges point-wise to a monotone
function H∗(·) within its domain D. We will show that Ω∗ = Ω0, U∗(t) = U0(t) and
H∗(y) = H0(y) for all y within the domain.
The marginal loglikelihood (4.3) can be written as
161
`n(Ω,H|Y,Z)
=
n∑
i=1
logE
{
J∏
j=1
K∏
k=1
eαj(ai+bitk)γij
[1 + Ui(tk)αjγijHj(y
−
ijk)][1 + Ui(tk)
αjγijHj(yijk)]
(ev0ai+v1biγis)
δi
[1 + ev0ai+v1biγisHs(Ti)]1+δi
}
·
J∏
j=1
K∏
k=1
U(tk)
αjdHj(yijk)dHs(Ti)
δi
=
n∑
i=1
logE
{
J∏
j=1
K∏
k=1
eαj(ai+bitk)γij
[1 + Ui(tk)αjγijHj(y
−
ijk)][1 + Ui(tk)
αjγijHj(yijk)]
(ev0ai+v1biγis)
δi
[1 + ev0ai+v1biγisHs(Ti)]1+δi
}
+
n∑
i=1
J∑
j=1
K∑
k=1
αj logU(tk) +
n∑
i=1
J∑
j=1
K∑
k=1
log dHj(yijk) +
n∑
i=1
δi log dHs(Ti).
By differentiating `n with respect to dHs(x),
∂`n
∂dHs(x)
=
∑n
i=1 δi 1(Ti = x)
dHs(x)
−
n∑
i=1
E[R1i(Ω, U,H)Rsi(x,Ω, U,H)]
E[R1i(Ω, U,H)]
=
∑n
i=1 dNi(x)
dHs(x)
−
n∑
i=1
∫ ∫
R1i(Ω, U,H, a, b)Rsi(x,Ω, H, a, b)fab(a, b|η)dadb∫ ∫
R1i(Ω, H, U, a, b)fab(a, b|η)dadb
where
R1i(Ω, U,H, a, b)
=
J∏
j=1
K∏
k=1
eαj(ai+bitk)γij
[1 + Ui(tk)αjγijHj(y
−
ijk)][1 + Ui(tk)
αjγijHj(yijk)]
(ev0ai+v1biγis)
δi
[1 + ev0ai+v1biγisHs(Ti)]1+δi
Rsi(x,Ω, U,H, a, b) =
(1 + δi)1(Ti ≥ x)ev0ai+v1biγis
1 + ev0ai+v1biγisHs(Ti)
Setting the derivative to zero, we obtain the equation
∑n
i=1 dNi(x)
dHs(x)
=
n∑
i=1
∫ ∫
R1i(Ω, U,H, a, b)Rsi(x,Ω, U,H, a, b)fab(a, b|η)dadb∫ ∫
R1i(Ω, U,H, a, b)fab(a, b|η)dadb
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Therefore, we see that dHˆs satisfies the equation
∑n
i=1 dNi(x)
dHˆs(x)
=
n∑
i=1
∫ ∫
R1i(Ωˆ, Uˆ , Hˆ, a, b)Rsi(x, Ωˆ, Uˆ , Hˆ, a, b)f(a, b|ηˆ)dadb∫ ∫
R1i(Ωˆ, Uˆ , Hˆ, a, b)fab(a, b|ηˆ)dadb
(C.14)
Construct a function H˜s by imitating Hˆs and we will show H˜s uniformly converges to
H0s. Define H˜0 as a step function with jumps only at the Ti for which δi = 1 and dH˜s
satisfies the equation
∑n
i=1 dNi(x)
dH˜s(x)
=
n∑
i=1
∫ ∫
R1i(Ω0, U0, H0, a, b)Rsi(x,Ω0, U0, H0, a, b)fab(a, b|η0)dadb∫ ∫
R1i(Ω0, U0, H0, a, b)f(a, b|η0)dadb (C.15)
By definition, H˜s(x) =
∑n
i=1 1(Ti ≤ x)dH˜s(Ti). By Glivenko-Cantelli theorem, H˜s(x)
converges almost surely to E{1(Ti ≤ x)fT (x)/µ(Ti)}, where
µ(x) = E
{∫ ∫
R1i(Ω0, U0, H0, a, b)Rsi(s,Ω0, U0, H0, a, b)fab(a, b|η0)dadb∫ ∫
R1i(Ω0, U0, H0, a, b)fab(a, b|η0)dadb
}
= E
{
E
[
(1 + δi)1(Ti ≥ x)ev0ai+v1biγ0is
1 + ev0ai+v1biγ0isH0s(Ti)
∣∣∣∣R1i(Ω0, U0, H0, a, b)]} ,
fT (x) = E[dNi(x)] = E[δi 1(Ti = x)]
Denote Sc(·|Z) the survival function of censoring time C given Z.
E
{
(1 + δi)1(Ti ≥ x)ev0ai+v1biγ0is
1 + ev0ai+v1biγ0isH0s(Ti)
∣∣∣∣R1i(Ω0, U0, H0, a, b)}
=E
2
∞∫
x
ev0ai+v1biγ0is
1 + ev0ai+v1biγ0isHs(t)
ev0ai+v1biγ0ish0s(t)
[1 + ev0ai+v1biγ0isH0s(t)]
2
Sc(t|Zis)dt
∣∣∣∣∣∣R1i(Ω0, U0, H0, a, b)

−E

∞∫
x
ev0ai+v1biγ0is
1 + ev0ai+v1biγ0isH0s(t)
1
1 + ev0ai+v1biγ0isH0s(t)
dSc(t|Zis)
∣∣∣∣∣∣R1i(Ω0, U0, H0, a, b)

=E
{
Sc(x|Zis)ev0ai+v1biγ0is
[1 + ev0ai+v1biγ0isH0s(x)]
2
∣∣∣∣R1i(Ω0, U0, H0, a, b)}
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where the second equality follows from integration by part. Therefore we have
E
{
1(Ti ≤ x)fT (x)
µ(Ti)
}
= E
E
 x∫
0
Sc(t|Zik)ev0ai+v1biγ0ish0k(t)
µ(t)[1 + ev0ai+v1biγ0isH0k(t)]
2
dt
∣∣∣∣∣∣R1i(Ω0, U0, H0, a, b)

=
x∫
0
h0s(t)dt = H0s(x)
Therefore, H˜s(x) converges uniformly to H0s(x) in [0, τ ].
Next, differentiating `n with respect to dHj(x),
∂`n
∂dHj(x)
=
∑n
i=1
∑K
k=1 1(yijk = x)
dHj(x)
−
n∑
i=1
E[R1i(Ω, U,H)R2i(x,Ω, U,H)]
E[R1i(Ω, U,H)]
=
∑n
i=1
∑K
k=1 1(yijk = x)
dHj(x)
−
n∑
i=1
∫ ∫
R1i(Ω, U,H, a, b)R2i(x,Ω, U,H, a, b)fab(a, b|η)dadb∫ ∫
R1i(Ω, U,H, a, b)fab(a, b|η)dadb
where
R2i(x,Ω, U,H, a, b) =
K∑
k=1
21(yijk ≥ x)Uαji (tk)γij
1 + U
αj
i (tk)γijHj(yijk)
Setting the derivative to zero, we obtain the equation
∑n
i=1
∑K
k=1 1(yijk = x)
dHj(x)
=
n∑
i=1
∫ ∫
R1i(Ω, U,H, a, b)R2i(x,Ω, U,H, a, b)fab(a, b|η)dadb∫ ∫
R1i(Ω, U,H, a, b)fab(a, b|η)dadb
Therefore, we see that dHˆj satisfies the equation
∑n
i=1
∑K
k=1 1(yijk = x)
dHˆj(x)
=
n∑
i=1
∫ ∫
R1i(Ω, U,H, a, b)R2i(x,Ω, U,H, a, b)fab(a, b|η)dadb∫ ∫
R1i(Ω, U,H, a, b)fab(a, b|η)dadb
(C.16)
Construct a function H˜j by imitating Hˆj and we will show H˜j uniformly converges to
H0j. Define H˜j as a step function with jumps at the yijk, i = 1, · · · , n, k = 1, · · · , K and
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dH˜j satisfies the equation
∑n
i=1
∑K
k=1 1(yijk = x)
dH˜j(x)
=
n∑
i=1
∫ ∫
R1i(Ω0, U0, H0, a, b)R2i(x,Ω0, U0, H0, a, b)fab(a, b|η0)dadb∫ ∫
R1i(Ω0, U0, H0, a, b)fab(a, b|η0)dadb
(C.17)
By definition, H˜j(x) =
∑n
i=1
∑K
k=1 1(yijk ≤ x)dH˜j(yijk). By Glivenko-Cantelli theo-
rem, H˜j(x) converges almost surely to E
{∑K
k=1 1(yijk ≤ x)fYj(x)/µ(yijk)
}
, where
µ(x) = E
{∫ ∫
R1i(Ω0, U0, H0, a, b)R2i(x,Ω0, U0, H0, a, b)fab(a, b|η0)dadb∫ ∫
R1i(Ω0, U0, H0, a, b)fab(a, b|η0)dadb
}
= E
{
K∑
k=1
E
[
21(yijk ≥ x)Uα0ji (tk)γ0ik
1 + Uα0ki (tk)γ
0
ikH0k(yik)
∣∣∣∣R1i(Ω0, U0, H0, a, b)]
}
,
fYj(x) = E[1(yijk = x)]
Note that
E
{
21(yijk ≥ x)Uα0ji (tk)γ0ij
1 + U
α0j
i (tk)γ
0
ijH0j(yijk)
∣∣∣∣∣R1i(Ω0, U0, H0, a, b)
}
=E
2
∞∫
x
U
α0j
i (tk)γ
0
ij
1 + U
α0j
i (tk)γ
0
ijH0j(y)
U
α0j
i (tk)γ
0
ijh0j(y)
[1 + U
α0j
i γ
0
ijH0j(y)]
2
dy
∣∣∣∣∣∣R1i(Ω0, U0, H0, a, b)

=E
{
U
α0j
i (tk)γ
0
ij
[1 + U
α0j
i (tk)γ
0
ijH0j(x)]
2
∣∣∣∣∣R1i(Ω0, U0, H0, a, b)
}
Therefore we have
E
{
K∑
k=1
1(yijk ≤ x)fYj(x)
µ(yijk)
}
= E

K∑
k=1
E
 x∫
0
U
α0j
i γ
0
ijh0j(y)
µ(y)[1 + U
α0j
i γ
0
ijH0j(y)]
2
dy
∣∣∣∣∣∣R1i(Ω0, U0, H0, a, b)

=
x∫
0
h0j(y)dy = H0j(x)
Therefore, H˜j(x) converges uniformly to H0j(x) in its specific domain Dj.
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By plugging in (C.14) and (C.16) into `n(Ωˆ, Uˆ , Hˆ), we obtain
`n(Ωˆ, Uˆ , Hˆ)
=
n∑
i=1
logE
{
J∏
j=1
K∏
k=1
eαj(ai+bitk)γij
[1 + Ui(tk)αjγijHj(y
−
ijk)][1 + Ui(tk)
αjγijHj(yijk)]
(ev0ai+v1biγis)
δi
[1 + ev0ai+v1biγisHs(Ti)]1+δi
}
+
n∑
i=1
J∑
j=1
K∑
k=1
αj log Uˆ(tk) +
n∑
i=1
J∑
j=1
K∑
k=1
log dHˆj(yijk) +
n∑
i=1
δi log dHˆs(Ti)
=
n∑
i=1
log
∫ ∫
R1i(Ωˆ, Uˆ , Hˆ, a, b)fab(a, b|ηˆ)dadb+
n∑
i=1
J∑
j=1
K∑
k=1
log Uˆ(tk)
αˆj
+
n∑
i=1
δi log
(
n∑
l=1
dNls(Ti)
)
+
n∑
i=1
J∑
j=1
K∑
k=1
log
(
n∑
l=1
K∑
k=1
1(yljk = yijk)
)
−
n∑
i=1
δi log
(
n∑
i=1
∫ ∫
R1i(Ωˆ, Uˆ , Hˆ, a, b)Rsi(x, Ωˆ, Uˆ , Hˆ, a, b)f(a, b|ηˆ)dadb∫ ∫
R1i(Ωˆ, Uˆ , Hˆ, a, b)fab(a, b|ηˆ)dadb
)
−
n∑
i=1
J∑
j=1
K∑
k=1
log
(
n∑
i=1
∫ ∫
R1i(Ωˆ, Uˆ , Hˆ, a, b)R2i(x, Ωˆ, Uˆ , Hˆ, a, b)fab(a, b|ηˆ)dadb∫ ∫
R1i(Ωˆ, Uˆ , Hˆ, a, b)fab(a, b|ηˆ)dadb
)
.
Likewise, plug in (C.15) and (C.17) into `n(Ω0, U0, H˜), we obtain
`n(Ω0, U0, H˜)
=
n∑
i=1
log
∫ ∫
R1i(Ω0, U0, H˜, a, b)fab(a, b|η0)dadb+
n∑
i=1
J∑
j=1
K∑
k=1
logU0(tk)
α0j
+
n∑
i=1
δi log
(
n∑
l=1
dNls(Ti)
)
+
n∑
i=1
J∑
j=1
log
(
n∑
l=1
K∑
k=1
1(yljk = yijk)
)
−
n∑
i=1
δi log
(
n∑
i=1
∫ ∫
R1i((Ω0, U0, H0, a, b)Rsi(x, (Ω0, U0, H0, a, b, a, b)f(a, b|η0)dadb∫ ∫
R1i((Ω0, U0, H˜, a, b)fab(a, b|η0)dadb
)
−
n∑
i=1
J∑
j=1
K∑
k=1
log
(
n∑
i=1
∫ ∫
R1i((Ω0, U0, H˜, a, b)R2i(x, (Ω0, U0, H0, a, b)fab(a, b|η0)dadb∫ ∫
R1i((Ω0, U0, H0, a, b)fab(a, b|η0)dadb
)
.
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Define
Rssi(s,Ω, U,H) =
∫ ∫
R1i(Ω, U,H, a, b)Rsi(s,Ω, U,H, a, b)fab(a, b|η)dadb∫ ∫
R1i(Ω, U,H, a, b)fab(a, b|η)dadb ,
R3i(s,Ω, U,H) =
∫ ∫
R1i(Ω, U,H, a, b)R2i(s,Ω, U,H, a, b)fab(a, b|η)dadb∫ ∫
R1i(Ω, U,H, a, b)fab(a, b|η)dadb .
We see that Hˆj(y) is continuous with respect to H˜k(y) and Hˆs(t) is continuous with
respect to H˜s(t). In addition,
Hˆs(t) =
t∫
0
∑n
i=1Rssi(u,Ω0, U0, H0)∑n
i=1Rssi(u, Ωˆ, Uˆ , Hˆ)
dH˜s(u)
Hˆj(y) =
y∫ ∑n
i=1R3i(s,Ω0, U0, H0)∑n
i=1 R3i(s, Ωˆ, Uˆ , Hˆ)
dH˜j(s)
for j = 1, · · · , J .
If the jth outcome is continuous, by taking limits on both sides of the above equations,
we conclude that H∗j (y) is absolutely continuous with respect to H0j(y) so that H
∗
j (y) is
differentiable with respect to y. In addition, dHˆj(y)/dH˜j(y) converges to dH
∗
j (y)/dH0j(y)
uniformly in y. Similarly, we conclude that H∗s (t) is absolutely continuous with respect
to H0s(t) so that H
∗
s (t) is differentiable with respect to t. In addition, dHˆs(t)/dH˜s(t)
converges to dH∗s (t)/dH0s(t) uniformly in t.
Since (Ωˆ, Uˆ , Hˆ) are NPMLEs for `n(Ω, U,H), we know `n(Ωˆ, Uˆ , Hˆ)− `n(Ω, U,H) ≥ 0
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for any Ω, U,H. We have
0 ≤ n−1{`n(Ωˆ, Uˆ , Hˆ)− `n(Ω0, U0, H˜)}
=n−1
n∑
i=1
log
∫ ∫
R1i(Ωˆ, Uˆ , Hˆ, a, b)fab(a, b|ηˆ)dadb
− n−1
n∑
i=1
log
∫ ∫
R1i(Ω0, U0, H˜, a, b)f(a, b|η0)dadb
+
n∑
i=1
J∑
j=1
K∑
k=1
log
Uˆ(tk)
αˆj
U0(tk)α0j
+
n∑
i=1
J∑
j=1
K∑
k=1
log
dHˆj(yijk)
dH˜j(yijk)
+
n∑
i=1
δi log
dHˆs(Ti)
dH˜s(Ti)
. (C.18)
As n→∞ in (C.18), we have
0 ≤ `(Ω∗, U∗, H∗)− `(Ω0, U0, H0) (C.19)
= E
[
log
∫ ∫
R1i(Ω
∗, U∗, H∗, a, b)fab(a, b|η∗)dadb
∏J
j=1
∏K
k=1 U
∗(tk)α
∗
j
∏J
j=1
∏K
k=1 dH
∗
j (yijk)dH
∗
s (Ti)
δi∫ ∫
R1i(Ω0, U0, H0, a, b)fab(a, b|η0)dadb
∏J
j=1
∏K
k=1 U0(tk)
α0j
∏J
j=1
∏K
k=1 dH0j(yijk)dH0s(Ti)
δi
]
is the negative Kullback-Leibler information. By definition, (Ω0, U0, H0) maximizes
`(Ω, U,H), therefore, (C.19) has a unique maximum when
∫ ∫
R1i(Ω
∗, U∗, H∗, a, b)fab(a, b|η∗)dadb
J∏
j=1
K∏
k=1
U∗(tk)α
∗
j
J∏
j=1
K∏
k=1
dH∗j (yijk)dH
∗
s (Ti)
δi
=
∫ ∫
R1i(Ω0, U0, H0, a, b)fab(a, b|η0)dadb
J∏
j=1
K∏
k=1
U0(tk)
α0j
J∏
j=1
K∏
k=1
dH0j(yijk)dH0s(Ti)
δi
(C.20)
uniformly over (Ω, U,H). Under an identifiable model this means (C.19) has a unique
maximum at (Ω0, U0, H0). Since maximizing (C.19) is equivalent to maximizing likelihood
`(Ω∗, U∗, H∗), and (C.19) has a unique maximum, therefore, (Ω0, U0, H0) = argmax(Ω,U,H)∈H`(Ω, U,H)
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is unique. Write out (C.20)
∫ ∫ J∏
j=1
K∏
k=1
U∗(tk)α
∗
j eα
∗
j (ai+bitk)γ∗ijdH
∗
j (yijk)
[1 + U∗(tk)α
∗
j eα
∗
j (ai+bitk)γ∗ijH
∗
j (yijk)]
2
(ev
∗
0ai+v
∗
1biγ∗isdH
∗
s (Ti))
δi
[1 + ev
∗
0ai+v
∗
1biγ∗isH∗s (Ti)]1+δi
fab(a, b|η∗)dadb
=
∫ ∫ J∏
j=1
K∏
k=1
U0(tk)
α0jeα0j(ai+bitk)γ0ijdH0j(yijk)
[1 + U0(tk)α0jeα0j(ai+bitk)γ0ijH0j(yijk)]
2
(ev
0
0ai+v
0
1biγ0isdH0s(Ti))
δi
[1 + ev
0
0ai+v
0
1biγ0isH0s(Ti)]
1+δi
fab(a, b|η0)dadb
(C.21)
We will show (C.21) implies that Ω∗ = Ω0, U∗ = U0 and H∗ = H0. For an integer q such
that 1 ≤ q ≤ J , let yijk = 0 in (C.21) for j = 1, · · · , q. For j = q + 1, · · · , J , we integrate
yijk out in its domain. For the survival outcome, let δi = 1, Ti = 0. Applying the above
actions to (C.21), we obtain
∫ ∫
ev
∗
0ai+v
∗
1biγ∗isdH
∗
s (0)
q∏
j=1
K∏
k=1
{
U∗(tk)α
∗
j eα
∗
j (ai+bitk)γ∗ijdH
∗
j (0)
}
q+1∏
j=1
K∏
k=1
∫
y∈Dj
U∗(tk)α
∗
j eα
∗
j (ai+bitk)γ∗ijdH
∗
j (y)
[1 + U∗(tk)α
∗
j eα
∗
j (ai+bitk)γ∗ijH
∗
j (y)]
2
dyfab(a, b|η∗)dadb
=
∫ ∫
ev
0
0ai+v
0
1biγ0isdH0s(0)
q∏
j=1
K∏
k=1
{
U0(tk)
α0jeα0j(ai+bitk)γ0ijdH0j(0)
}
q+1∏
j=1
K∏
k=1
∫
y∈Dj
U0(tk)
α0jeα0j(ai+bitk)γ0ijdH0j(y)
[1 + U0(tk)α0jeα0j(ai+bitk)γ0ijH0j(y)]
2
dyfab(a, b|η0)dadb
∫ ∫
ev
∗
0ai+v
∗
1biγ∗isdH
∗
s (0)
q∏
j=1
K∏
k=1
{
U∗(tk)α
∗
j eα
∗
j (ai+bitk)γ∗ijdH
∗
j (0)
}
fab(a, b|η∗)dadb
=
∫ ∫
ev
0
0ai+v
0
1biγ0isdH0s(0)
q∏
j=1
K∏
k=1
{
U0(tk)
α0jeα0j(ai+bitk)γ0ijdH0j(0)
}
fab(a, b|η0)dadb
(C.22)
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Thus,
γ∗isdH
∗
s (0)
q∏
j=1
K∏
k=1
{
U∗(tk)α
∗
j γ∗ijdH
∗
j (0)
}∫ ∫
ev
∗
0ai+v
∗
1bi+
∑q
j=1
∑K
k=1 α
∗
j (ai+bitk)fab(ai, bi|η∗)dadb
=γ0isdH0s(0)
q∏
j=1
K∏
k=1
{
U0(tk)
α0jγ0ijdH0j(0)
}∫ ∫
ev
0
0ai+v
0
1bi+
∑q
j=1
∑K
k=1 α0j(ai+bitk)fab(ai, bi|η0)dadb
Regularity condition (1) implies that dH∗(0) > 0. Take q = 1, we have
γ∗isdH
∗
s (0)
K∏
k=1
{
U∗(tk)α
∗
1γ∗i1dH
∗
1 (0)
}∫ ∫
ev
∗
0ai+v
∗
1bi+
∑K
k=1 α
∗
1(ai+bitk)fab(ai, bi|η∗)dadb
=γ0isdH0s(0)
K∏
k=1
{
U0(tk)
α01γ0i1dH01(0)
}∫ ∫
ev
0
0ai+v
0
1bi+
∑K
k=1 α01(ai+bitk)fab(ai, bi|η0)dadb
Take log of both sides,
ZTisβ
∗
s + log dH
∗
s (0) +
K∑
k=1
logU∗(tk)α
∗
1 +KZTi1β
∗
1 +K log dH
∗
1 (0)
+
∫ ∫
ev
∗
0ai+v
∗
1bi+
∑K
k=1 α
∗
1(ai+bitk)fab(ai, bi|η∗)dadb
=ZTisβ0s + log dH0s(0) +
K∑
k=1
logU0(tk)
α01 +KZTi1β01 +K log dH01(0)
+
∫ ∫
ev
0
0ai+v
0
1bi+
∑K
k=1 α01(ai+bitk)fab(ai, bi|η0)dadb
ZTis(β
∗
s − β0s) + log
dH∗s (0)
dH0s(0)
+
K∑
k=1
log
U∗(tk)α
∗
1
U0(tk)α01
+KZTi1(β
∗
1 − β01)
+K log
dH∗1 (0)
dH01(0)
+ log
∫ ∫
ev
∗
0ai+v
∗
1bi+
∑K
k=1 α
∗
1(ai+bitk)fab(ai, bi|η∗)dadb∫ ∫
ev
0
0ai+v
0
1bi+
∑K
k=1 α01(ai+bitk)fab(ai, bi|η0)dadb
= 0 (C.23)
Since outcome index q is interchangeable between outcomes, so the equation (C.23)
applies to any outcome j. According to condition (4) and (5), equation (C.23) implies
α∗ = α0, β∗ = β0, η∗ = η0,v∗ = v0, U∗(t) = U0(t) and dH
∗(0) = dH0(0).
Next we show that H∗j = H0j for all j = 1, · · · , J . For j = 1, we integrate yi1k from 0
to x in (C.21). In addition, for j = 2, · · · , J , we integrate yijk out in its domain. For the
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survival outcome, let δi = 1 and we integrate Ti in [0, τ ]. We obtain
∫ ∫
U∗i (tk)
α∗1γ∗i1H
∗
1 (x)
1 + U∗i (tk)α
∗
1γ∗i1H
∗
1 (x)
fab(a, b|η∗)dadb =
∫ ∫
U0i(tk)
α01γ0i1H01(x)
1 + U0i(tk)α01γ0i1H01(x)
fab(a, b|η0)dadb
The two sides of the above equation are strictly monotone in H∗1 (x) and H01(x), respec-
tively. Therefore, we have H∗1 (x) = H01(x). Since the outcome index is arbitrary, the
above result also applies to j = 2, · · · , J . Apply the similar actions to Hs by integrating
out all yi1k in its domain and let δi = 1 and we integrate Ti from 0 to t, we get
∫ ∫
ev
∗
0a+v
∗
1bγ∗isH
∗
s (t)
1 + ev
∗
0a+v
∗
1bγ∗isH∗s (t)
fab(a, b|η∗)dadb =
∫ ∫
ev
0
0a+v
0
1bγ0isH0s(t)
1 + ev
0
0a+v
0
1bγ0isH0s(t)
fab(a, b|η0)dadb
The two sides of the above equation are strictly monotone in H∗s (t) and H0s(t), respec-
tively. Therefore, we have H∗s (t) = H0s(t). Overall, we have H
∗(x) = H0(x) for x ∈ D.
We conclude that ||Ωˆ−Ω0|| → 0, ||Uˆ(t)−U0(t)|| → 0, and ||Hˆ(x)−H0(x)|| → 0 for all
x ∈ D. Thus, we established uniform convergence ∑Jj=1 supyj∈Dj |Hˆj(yj) −H0j(yj)| → 0
and supt∈[0,τ ] |Hˆs(t)−H0s(t)| → 0.
C.2.2 Proof of Theorem IV.2
Consider the set
H = {(v, w1, · · · , wJ+1) : v ∈ Rd+K , wj(·) is a function on Dj, wJ+1(·) is a function on [0, τ ];
|v| ≤ 1, ||wj||BV [Dj ] ≤ 1, j = 1, · · · , J, ||wJ+1||BV [0,τ ] ≤ 1}
where ||wj||BV [Dj ] denotes the total variation of wj(·) in Dj, and d is the dimension of Ω.
Define a sequence Sn(Ω, U,H)[v, w1, · · · , wJ+1] mapping a neighborhood of (Ω0, U0, H0)
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into l∞(H) as follows:
Sn(Ω, U,H)[v, w1, · · · , wJ+1]
=
d
d
n−1`n
(Ω, U)T + v,Hj(y) +  y∫
−∞
wj(x)dHj(x), j = 1, · · · , J + 1
∣∣∣∣∣∣
=0
= An0[v] +
J+1∑
j=1
Anj[wj]
where Anp, p = 0, · · · , J + 1, are linear functionals on Rd+K and BV [D], respectively. Let
˙`
Ω,U and ˙`Hj(wj) be the score function for (Ω, U) and the score for Hj along the path
Hj(y) + 
∫
wj(s)dHj(s), then
An0[v] = Pn[vT ˙`Ω,U ], Anj[wj] = Pn[ ˙`Hj(wj)], j = 1, · · · , J + 1
where Pn denotes the empirical measure based on n independent subjects.
Correspondingly we define the limit map S : (Ω, U,H)→ l∞(H) as
S(Ω, U,H)[v, w1, · · · , wJ+1] = A0[v] +
J+1∑
j=1
Aj[wj],
where the linear functionals Ap, p = 0, · · · , J + 1, are the expectation of the empirical
average of Anp, p = 0, · · · , J + 1. By definition, Sn(Ωˆ, Uˆ , Hˆ) = 0 and S(Ω0, U0, H0) = 0.
Since H is a Donsker class and the functionals Anp, p = 0, · · · , J + 1, are bounded
Lipschitz functionals with respect to H, √n(Sn(Ω0, U0, H0)− S(Ω0, U0, H0)) converges to
a tight Gaussian process on l∞(H). The first condition in Theorem 2 of Murphy (1995)
holds.
By regularity condition (6), the score operator S(Ω, U,H) is Fre´chet differentiable at
Ω0, U0, H0 with a continuously invertible derivative −I0. The hessian matrix In evaluated
at the true values of H and Ω, U is positive definite, and converges in probability to a
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deterministic and invertible operator I0. Thus the second condition in Theorem 2 of
Murphy (1995) holds. The derivative of S(Ω, U,H) at (Ω0, U0, H0), denoted as −I0, is a
map from the space (Ω−Ω0, U −U0, H−H0) to l∞(H). The fourth condition in Theorem
2 of Murphy (1995), the approximation condition below can be verified along the lines of
appendix in Murphy (1995)
sup |(Sn − S)(Ωˆ, Uˆ , Hˆ)− (Sn − S)(Ω0, U0, H0)|
=op
(
n−1/2 ∨
{
||Ωˆ− Ω0||+ ||Uˆ − U0||+
J+1∑
j=1
sup |Hˆj(y)−H0j(y)|
})
.
In order to verify the third condition in Theorem 2 of Murphy (1995), we want to
show that −I0, denoted S˙0, is continuously invertible. S˙0 maps (Ω−Ω0, U −U0, H −H0)
to a bounded functional on H. By Zeng et al. (2005), we will prove the invertibility of
S˙0 by verifying that S˙0(Ω − Ω0, U − U0, H −H0)[v, w1, · · · , wJ+1] = 0 implies v = 0 and
wj(y) = 0 uniformly, j = 1, · · · , J + 1.
For a small constant , choose (Ω, U)T = (Ω0, U0)
T+v,Hj(y) = H0j(y)+
∫ y
−∞wj(x)dH0j(x).
Then,
0 = S˙0(Ω− Ω0, U − U0, H −H0)[v, wj, j = 1, · · · , J + 1] = E
( ˙`
Ω,U [v] +
J+1∑
j=1
˙`Hj [wj]
)2
This means
˙`
Ω,U [v] +
J+1∑
j=1
˙`Hj [wj] = 0 (C.24)
Closely following the lines in Appendix of Zeng et al. (2005), we can see that the equa-
tion (C.24) entails v = 0 and wj(·) = 0 uniformly. Therefore, the derivative of the score
operator at (Ω0, U0, H0), denoted as −I0 is continuously invertible. By Theorem 2 of Mur-
phy (1995),
√
n
{
Ωˆ− Ω, Uˆ − U, Hˆ(·)− Hˆ0(·)
}
converges weakly to a zero-mean Gaussian
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process. Furthermore,
√
nS˙0(Ω− Ω0, U − U0, H −H0)[v, wj, j = 1, · · · , J + 1]
=
√
n(Pn − P)
[
vT ˙`Ω,U +
J+1∑
j=1
˙`
Hj [wj]
]
+ op(1) (C.25)
Thus, Ωˆ, Uˆ is semiparametrically efficient since Ωˆ, Uˆ is asymptotically linear estimator for
Ω0, U0, and its influence function belong to the space spanned by the score function (Zeng
et al. (2005)).
C.2.3 Proof of Theorem IV.3
Observe that
√
nS˙0(Ω − Ω0, U − U0, H − H0)[v, wj, j = 1, · · · , J + 1] is the expecta-
tion of the second derivative of the normalized log-likelihood along the direction (Ωˆ −
Ω0, Uˆ −U0, Hˆ−H0) and the direction
(
v,
∫
wdH0
)
. Therefore,
√
nS˙0(Ω−Ω0, U −U0, H−
H0)[v, wj, j = 1, · · · , J + 1] can be approximated by
√
n(vT , w¯T )(In/n)
(Ωˆ− Ω0, Uˆ − U0)
dHˆ(s)− dH0(s)
 ,
where w¯ denotes the set of vectors {wj(x) : dNijk(x) = 1}. On the other hand,
√
n(Pn − P)
[
vT ˙`Ω,U +
J+1∑
j=1
˙`
Hj [wj]
]
→d (vT , w¯T )(In/n)1/2G
174
where G is standard multivariate Gaussian. Therefore, equation (C.25) implies that
√
n(vT , w¯T )(In/n)
(Ωˆ− Ω0, Uˆ − U0)
dHˆ(s)− dH0(s)
→d (vT , w¯T )(In/n)1/2G
√
n(vT , w¯T )
(Ωˆ− Ω0, Uˆ − U0)
dHˆ(s)− dH0(s)
→d (vT , w¯T )(In/n)−1/2G
Thus,
√
n
{
vT (Ωˆ− Ω0, Uˆ − U0) +
∑J+1
j=1
∫
wjd(Hˆj −H0j)
}
converges to a zero mean Gaus-
sian process with with variance-covariance matrix n(vT , w¯T )I−10 (vT , w¯T )T .
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